--------------------------------------------------------------- Program Number: 19347 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: Directorate for Engineering/NSF Title: Scalable Nanomanufacturing (SNM) Contact: Sumanta Acharya Tel: 703-292-7494 Email: sacharya@nsf.gov Website:          http://www.grants.gov/search/search.do;jsessionid=YDTTPY5ZNp0klg3TBYjx0SgkhcYJb2kckhb2Lm3WXCdjl2DkvlSS!1869518295?oppId=150293&mode=VIEW Full Program:          http://www.nsf.gov/pubs/2012/nsf12544/nsf12544.htm SYNOPSIS: The National Science Foundation (NSF) announces a second year of a program on collaborative research and education in the area of scalable nanomanufacturing, including the long-term societal implications of the large-scale implementation of nanomanufacturing innovations. This program is in response to and is a component of the National Nanotechnology Initiative Signature Initiative: Sustainable Nanomanufacturing - Creating the Industries of the Future (http://www.nano.gov/node/611). Although many nanofabrication techniques have demonstrated the ability to produce relatively small quantities of nanomaterials and devices, the emphasis of this program is research that supports the identification and demonstration of nanomanufacturing processes with high potential to scale to economically and industrially relevant production levels. The mode of support is Nanoscale Interdisciplinary Research Teams (NIRT). --------------------------------------------------------------- Program Number: 97989 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: Environmental Protection Agency Title: National Clean Diesel Funding Assistance Program Contact: Julie Henning Tel: 734-214-4442 Email: henning.julie@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=G4tjPYmD3yhYnybqT2Th4yznvp5FLw5CL12QWn9nqkm1jYhNv0NC!482729280?oppId=166433&mode=VIEW Full Program:          http://www.epa.gov/air/grants_funding.html SYNOPSIS: Under this program, the sponsor is soliciting proposals nationwide for projects that achieve significant reductions in diesel emissions in terms of tons of pollution produced and diesel emissions exposure, particularly from fleets operating in areas designated by the Administrator as poor air quality areas. --------------------------------------------------------------- Program Number: 27201 --------------------------------------------------------------- ***Deadlines: 6/4/2012 Sponsor: National Institute on Minority Health and Health Disparities/NIH/DHHS Title: RFA-MD-12-003--NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01) Contact: Jennifer Alvidrez, PhD Tel: 301-594-9567 Email: alvidrezjl@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-003.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 4, 2012. The deadline for receipt of optional letters of intent is May 4, 2012. The deadline for receipt of full applications is June 4, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute on Minority Health and Health Disparities (NIMHD) invites applications for innovative social, behavioral, health services, and policy research that can directly and demonstrably contribute to the elimination of health disparities. Projects may involve primary data collection or secondary analysis of existing datasets. Projects that examine understudied health conditions; examine the effectiveness of interventions, services, or policies for multiple health disparity populations; and/or directly measure the impact of project activities on levels of health disparities are particularly encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 01252 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: AHRQ Health Services Research Projects (R01) Contact: Kishena Washwani, Ph.D. Tel: 301-427-1556 Email: Kishena.Wadhwani@ahrq.hhs.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-09-070.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor solicits Large Research (R01) Projects, and expresses AHRQ portfolio priority areas of interest for ongoing extramural health services research, demonstration, dissemination, and evaluation grants. This FOA will use the AHRQ Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 21908 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Understanding User Needs and Context to Inform Consumer Health Information Technology (IT) Design (R01) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-199.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on July 6, 2014. SYNOPSIS: The sponsor invites applications for esearch projects that will build a knowledge base of individuals’ personal health information management (PHIM) needs and practices and the design principles related to these activities. The increased interest in and availability of consumer health information technology (IT) applications meant to assist consumers in managing their personal health information has rapidly increased over the past decade. Many other industries have greatly benefited from design principles that take into account user needs and context, which help designers improve the utility of information management tools among a heterogeneous population of users. Individuals are the end users of consumer health IT; however, there is still a lack of basic research around these end users’ PHIM practices and needs and how these methods are influenced by a multitude of other contextual factors (e.g., care settings, demographics, motivations, user capabilities and limitations, informal caregiving networks, technology sophistication, and access to Internet) that, typically, represent a mixture of facilitators or barriers to adequate PHIM. This FOA looks to bridge the chasm that currently exists between consumer health IT designers and the users themselves, by bolstering basic research to better understand users’ PHIM practices, needs, and goals as they are intrinsically shaped by an array of contextual factors. This FOA will use the Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 21914 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Understanding Clinical Information Needs and Health Care Decision Making Processes in the Context of Health Information Technology (IT) (R01) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-198.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on July 6, 2014. SYNOPSIS: The sponsor invites applications for research aimed at elucidating the nature of cognition, task distribution, and clinical work in various health care delivery settings. Research projects funded under this FOA will address current knowledge gaps regarding our understanding of health care providers’ information needs and health care decision making processes, both individually and collectively, and as a health care team (composed of doctors, nurses, therapists, and administrative staff). As the U.S. population continues to make strides in longevity, there also are a growing number of chronic conditions that require consideration when seeking medical attention. Accordingly, health care teams are progressively becoming overwhelmed by the mounting number of tasks that require attention during a typical clinical encounter. These conditions and/or set of conditions are often coupled with various clinical guidelines or best practices meant to guide and inform health care providers when caring for their patients. Furthermore, the volume of clinical guidelines that health care teams are expected to incorporate into patient care is also rapidly increasing. Consequently, these teams must balance information, cognitive tasks, and workflow processes as they make health care decisions. While health information technology (IT) has shown the potential to assist and support health care teams with these requisite tasks in a manner that improves the quality of care while minimizing risk and harm to patients, many health care organizations continue to struggle with the implementation and adoption of health IT. This stems from a variety of contextual factors (e.g., workflow integration, usability of the health IT applications, provider dynamics). To better understand provider needs, basic research is needed on how clinical work is actually done and how it could be done, while incorporating a variety of cognitive analyses (e.g., cognitive work analysis, cognitive task analysis), workflow analyses (e.g., hierarchical task analysis, sequence diagrams), and human-centered design evaluations. This FOA will use the Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28558 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Department of the Air Force Title: RFP -- Classified -- Multi-INT Exploitation and Correlation Contact: Lynn G. White, Contracting Officer Tel: 315-330-4996 Email: Lynn.White@rl.af.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=2e772c58b5324a5885f8f0e4106b4086&tab=core&_cview=0 SYNOPSIS: A -- MULTI-INT EXPLOITATION AND CORRELATION SOL BAA-RIK-12-04 POC Lyn G. White, Phone: (315) 330-4996 WEB: FBO.gov Permalink https://www.fbo.gov/spg/USAF/AFMC/AFRLRRS/BAA-RIK-12-04/listing.html E-MAIL: Lynn.White@rl.af.mil Lynn.White@rl.af.mil NAICS: 541712 ANNOUNCEMENT TYPE: Initial announcement FUNDING OPPORTUNITY NUMBER: BAA-RIK-12-04 CFDA Number: 12.800 I. FUNDING OPPORTUNITY DESCRIPTION: The overall technical objectives of this BAA are to develop innovative,disruptive technologies and methods for the automatic and dynamic cueing and collection of intelligence for situational awareness and assessment, with an emphasis on Machine-to- Machine (M2M) capabilities. Technologies, such as artificial intelligence, ontological reasoning, and knowledge-based processing will be usedto: (1) Automate the exploitation of collected, processed, and stored information in support of Intelligence, Surveillance and Reconnaissance (ISR) within air,space and cyberspace for on-going US missions; (2) Enhance the US exploitation system efficiency, to include multi-platform collections, multi-intelligence correlation, and resource optimization and management; (3) Dynamically characterizeand correlate raw sensor data from existing multi-source, multi-platform, real-time collection systems; and (4) Automate knowledge-based exploitation for Effects-Based Operations (EBO) through assessment, cueing, electronic attack, and battle damage assessment, as a means to achieve mission objectives. These capabilities will enable both automated and "man-on-the-loop" (MoTL) concepts to address the increased volume of data and the increased time criticality of analysis - both of which are necessary to support dynamic exploitation and real-time EBO. Thegeneral focus areas of this BAA are to: (1) Dynamically characterize and correlate data sources on existing multi-source, multi-platform, real-time collection systems; (2) Enhance collection system efficiency to include multi-platform collection for dynamic exploitation; (3) Automate knowledge-based assessments to cuesensors and recommend opportunities to achieve mission objectives; and (4) Automate exploitation of collected, processed, and stored information in support of ISR and Information Operations for current and future US missions. Some of the particular issues related to these specific focus areas include, but are not limited to, the following: (a) Target specific characteristics for identification/correlation. Battlefield management depends heavily on multi-intelligence assets to provide current threat analysis for successful deployment of war-fighting resources. One area that supports this analysis is target specific operating characterization and equipment/unit correlation, which is normally a "brute-force/laborintensive" effort; (b) Automated collection, signal ID, and first/second/third order level processing. Dense, hard-to-get, advanced modulated, and Low Probability of Intercept (LPI) signals, as well as movements and hidden assets, dictate the need for automated, dynamic collection using both on-board and off-board assets. Multi-Intelligence (Multi-INT) ‘fingerprinting' techniques should continue to be investigated as a means of supporting identification and automated tracking efforts; (c) Related enabling engineering constructs and architectures to enable advanced exploitation. For example, the Semantic Service Oriented Architecture (SSOA) construct contextualizes the dynamic knowledge available, therebyenabling dynamic discovery of new services as they become available and providing resources for enabling semantic descriptions of those services. SSOAs enable knowledge acquisition and management over disparate architectures without a priori schema information. Semantic SOA development will provide a flexible way to quickly integrate novel services using an intelligent matching process. Approaches are sought which will allow heterogeneous services to seamlessly interoperate and which may include the use of data mediation/intermediary translation services such as data transformation, aggregation, service orchestration and adaptation. A standards based design approach will be used, and as appropriate, will be compliant with all International Standards and with the Net-Centric; (d) Management software aboard platforms and systems which specifically address exploitation mission objectives. Given current levels of activity, operational requirements, hostile environments, and resources being heavily tasked, collection systems will need to be developed for embedding on advanced collection platforms, such as Unmanned Aerial Vehicles (UAVs). Resident management software processing systems will need to accomplish the automated, dynamic collection of intelligence information as well as auto-collaborating with other sensors in order to share information and to derive knowledge; (e) Advanced knowledge-based processing for exploitation. Timely and accurate decision support to the warfighter requires innovative knowledge-based processing for sensor management, emitter and entity identification, and multi-intelligence cross-cueing, to include, but not limited to, techniques for automated knowledge acquisition and knowledge modeling, real-time inferencing, and real-time operating system; (f) Network-centric collection management, data/information exchange and correlation. Networked Signals Intelligence (SIGINT) sensors extend the sensor virtual collection space, thus significantly enhancing the potential to collect difficult and hard-to-collect intelligence. Therefore, network centric collection management should be investigated to include, but not be limited to, multi-platform signal correlation and Multi-INT sensorcueing; (g) Technologies and capabilities to more fully leverage Motion Imagery(MI) information, to include, but not limited to: object tracking of both stationary and moving targets (robust enough to handle objects being obscured or leaving and returning into the sensors field of view), cross cueing capabilities across heterogeneous collections of sensors and platforms, visualization capabilities to display multiple intelligence data sources in a common geospatial reference, deriving accurate geo-positioning information, automated event cueing to alert on specified activities or configurations, and integration of automated MI or Full Motion Video (FMV) analysis with automated analysis of other intelligence inputs; (h) Technologies and capabilities for the acquisition and storage of Human Intelligence (HUMINT) information. HUMINT provides for up-close human based observation, and is often the first and last data source for evidence collection related to an event. Although this source can be very subjective, it can also be very productive and often times the only method by which the true effects of an action can be evaluated. It is critical to examine methods of representing and storing HUMINT data without compromising the sources; (i) Advanced Digital SignalProcessing (DSP) techniques for use in a network-centric exploitation environment. This will include new algorithms, techniques and methods for meeting the future needs in the areas of Electronic Intelligence (ELINT), Communications Intelligence (COMINT), Audio Processing, Special Signals, Measurement and Signature Intelligence (MASINT), Steganographic Intelligence (STEGINT) and Imagery Intelligence (IMINT), as well as any combination of these. Consideration should be given to "surgical" exploitation techniques for reducing data and processing requirements through intelligent collection; (j) Execution of field testing for innovative MASINT technologies. The development of advanced algorithms which reduce the overall sensor intake, more intelligently process the data among the available resources/nodes, and addresses security, bandwidth, and load-balancing throughout the overall system will be given consideration. FY12 SPECIFIC FOCUS AREA: ELINT The scope of the ELINT focus areas should include, but are not limited to the following: (1) Target characteristic identification/correlation; (2) Automated collection, signal ID sorting and first level processing; (3) Enhanced digital ELINT processing/analysis technology at both the Operational/Tactical and Scientificand Technical Intelligence (S&TI) levels; (4) Software aboard UAV platforms which specifically address SIGINT objectives; (5) Advanced knowledge-based processing; and (6) Multi-sensor/multi-processor collection management. FY12 SPECIFIC FOCUS AREA: MASINT The scope of the MASINT focus areas should include, but are notlimited to the following: (1) Execute field testing of innovative MASINT technologies which includes planning, preparation, and conducting tests; (2) Prepare test plans, coordinate with test site personnel, analyze and document test results; (3) Acquire, transport, deploy, and operate all equipment required for the field demonstrations, including measurement equipment and ground truth sources; (4) Assist in obtaining any necessary frequency authorization for the field demonstration and measure any necessary ground truth and environment data. Testing caninclude collection and exploitation technologies across the broad spectrum of MASINT disciplines including electro-optical, laser, infrared, spectroscopy, radar, materials identification, radio frequency (ultra wideband, electromagnetic pulse, high power microwave, unintended RF emissions), seismic, magnetic, acoustic, and hydroacoustic. FOR THE ABOVE TWO FY12 FOCUS AREAS ONLY, THE FOLLOWING DUE DATES APPLY: First Step : WHITE PAPER DUE DATE AND TIME : White Papers will be accepted on or before 4:00 PM Eastern Standard Time, 05 Jun 2012. Late white paper submissions will not be accepted after this due date. See Section IV for additional information. Only white papers are due at this time. Full proposals will be requested by the Government from those Offerors selected in the white paper evaluation process. Second Step : PROPOSAL DUE DATE AND TIME : Proposals will be accepted on or before 4:00 PM Eastern Standard Time, 09 Jul 2012. NOTE: White Papers/Proposals received after the due date and time stated in the FY12 Focus Areas of this BAA shall be governed by the provisions of FAR 52.215-1(c)(3). It should be noted that this installation observes strict security procedures to enter the facility. These security procedures are NOT considered an interruption of normal Government processes, and white papers/proposals received after the above stated date and time as a result of security delays will be considered "late." Furthermore, note that if Offerors utilize commercial carriers for delivery of white papers/proposals, they may not honor time-of-day delivery guarantees on military installations. Early white paper submission is encouraged. II. AWARD INFORMATION: Total funding for this BAA is approximately $49.9M. The anticipated funding to be obligated under this BAA is broken out by fiscal year as follows: FY 12 - $4.0M; FY 13 - $9.3M; FY14 - $12.9M; FY15 - $11.6M; and FY16 - $12.1M. Individual awards will not normally exceed 36 months with dollar amounts ranging from between $100K to $5M per fiscal year. There is also the potential to make awards up to any dollar value. Awards of efforts as a result of this announcement will be in the form of contracts, grants, and cooperative agreements, depending upon the nature of the work proposed. III. ELIGIBILITY INFORMATION: 1. ELIGIBLE APPLICANTS: All potential applicants are eligible. Foreign or foreign-owned offerors are advised that their participation is subject to foreign disclosure review procedures. Foreign or foreign-owned offerors should immediately contact the contracting office focal point, Lynn G. White, Contracting Officer, telephone (315) 330-4996 or e-mail Lynn.White@rl.af.mil for information if they contemplate responding. The e-mail must reference the title and BAA-RIK-12-04. 2. COST SHARING OR MATCHING: Cost sharing is not a requirement. 3. CCR Registration: Unless exempted by 2 CFR 25.110 all offerors must: a. Be registered in the Central Contractor Registration (CCR) prior to submitting an application or proposal; b. Maintain an active CCR registration with current information at all times during which it has an active Federal award or an application or proposal under consideration byan agency; and c. Provide its DUNS number in each application or proposal it submits to the agency. 4. Executive Compensation and First-Tier Sub-contract/Sub-recipient Awards: Any contract award resulting from this announcement may containthe clause at FAR 52.204-10 - Reporting Executive Compensation and First-Tier Subcontract Awards. Any grant or agreement award resulting from this announcementmay contain the award term set forth in 2 CFR, Appendix A to Part 25 http://ecfr.gpoaccess.gov/cgi/t/text/text-idx? c=ecfr&sid=c55a4687d6faa13b137a26d0eb436edb&rgn=div5&view= text&node=2:1.1.1.41&idno=2#2:1.1.1.4.1.2.1.1 IV. APPLICATION AND SUBMISSION INFORMATION: 1. APPLICATION PACKAGE: THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION. WE ARE SOLICITING WHITE PAPERS ONLY. DO NOT SUBMIT A FORMAL PROPOSAL AT THIS TIME. Those white papers found to be consistent with the intent of this BAA may be invited to submit a technical and cost proposal, see Section VI of this announcement for further details. For additional information, a copy of the AFRL/Rome Research Sites "Broad Agency Announcement (BAA): A Guide for Industry," April 2007, may be accessed at: http://www.fbo.gov/spg/USAF/AFMC/AFRLRRS/Reference% 2DNumber%2DBAAGUIDE/listing.html 2. CONTENT AND FORM OF SUBMISSION: Offerors are required to submit three copies of a 3 to 5 page white paper summarizing their proposed approach/solution. The purpose of the white paper is to preclude unwarranted effort on the part of an offeror whose proposed work is not of interest to the Government. The white paper will be formatted as follows: Section A: Title, Period of Performance, Estimated Cost, Name/Address of Company, Technical and Contracting Points of Contact (phone, fax and email)(this section is NOT included in the page count); Section B: Task Objective; and Section C: Technical Summary and Proposed Deliverables. Multiple white papers within the purview of this announcement may be submitted by each offeror. If the offeror wishes to restrict its white papers/proposals, they must be marked with the restrictive language stated in FAR 15.609(a) and (b). All white papers/proposals shall be double spaced with a font no smaller than 12 pitch. In addition, respondents are requested to provide their Commercial and Government Entity (CAGE) number, their Dun and Bradstreet (D&B) Data Universal Numbering System (DUNS) number, a fax number, and an e-mail address and reference BAA-RIK-12-04 with their submission. All responses to this announcement must be addressed to the technical POC, asdiscussed in paragraph seven of this section. 3. SUBMISSION DATES AND TIMES: Itis recommended that white papers be received by the following dates to maximizethe possibility of award: FY 12 should be submitted by 05 Jun 2012; FY 13 by 01Nov 2012; FY 14 by 01 Nov 2013; FY 15 by 01 Nov 2014; and FY 16 by 01 Nov 2015.White papers will be accepted until 2:00 p.m. Eastern time on 30 Sep 2016, but it is less likely that funding will be available in each respective fiscal year after the dates cited. FORMAL PROPOSALS ARE NOT BEING REQUESTED AT THIS TIME. The closing date for this BAA is 30 Sep 2016. 4. FUNDING RESTRICTIONS: The cost ofpreparing white papers/proposals in response to this announcement is not considered an allowable direct charge to any resulting contract or any other contract,but may be an allowable expense to the normal bid and proposal indirect cost specified in FAR 31.205-18. Incurring pre-award costs for ASSISTANCE INSTRUMENTS ONLY are regulated by the DoD Grant and Agreements Regulations (DODGARS). 5. CLASSIFICATION GUIDANCE FOR WHITE PAPER SUBMISSIONS: AFRL/RIGC will accept classified responses to this BAA when the classification is mandated by classification guidance provided by an Original Classification Authority of the U.S. Government, or when the proposer believes the work, if successful, would merit classification. Security classification guidance in the form of a DD Form 254 (DoD Contract Security Classification Specification) will not be provided at this time since AFRL is soliciting ideas only. After reviewing incoming proposals, if a determination is made that contract award may result in access to classified information, a DD Form 254 will be issued upon contract award. Awards may be classified up toand including Top Secret/SCI. Proposers that intend to include classified information or data in their white paper submission or who are unsure about the appropriate classification of their white papers should contact the technical point of contact listed in Section VII for guidance and direction in advance of preparation. 6. All proposers should review the NATIONAL INDUSTRIAL SECURITY PROGRAM OPERATING MANUAL, (NISPOM), dated February 28, 2006 as it provides baseline standards for the protection of classified information and prescribes the requirementsconcerning Contractor Developed Information under paragraph 4-105. Defense Security Service (DSS) Site for the NISPOM is: http://www.dss.mil/isp/odaa/documents/nispom2006-5220.pdf 7. OTHER SUBMISSION REQUIREMENTS: DO NOT send white papers to the Contracting Officer. All responses, unclassified/classified, to this announcement must be sent U.S. Postal Service, registered mail and addressed to AFRL/RIEG, 525 Brooks Road, Rome, NY 13441-4505, and reference BAA-RIK-12-04. Electronic submission is NOT authorized. Questions can be directed to the cognizant technical POC, Dr. Daniel Stevens, Daniel.Stevens@rl.af.mil, 315-330-2416. V. APPLICATION REVIEW INFORMATION: 1. CRITERIA: White papers and proposals will be evaluated through a peer or scientific review process using the following criteria, which are listed in descending order of importance, and will be used to determine whether white papers and proposals submitted are consistent with the intent ofthis BAA and of interest to the Government: (1) Overall Scientific and Technical Merit - The extent to which the offeror demonstrates the detailed approach, development, and testing of the proposed new technology to achieve relevant new capabilities and enhancements, (2) Related Experience - The extent to which the offeror demonstrates relevant technology and domain knowledge, (3) Openness/Maturity of Solution - The extent to which existing capabilities and standards are leveraged and the relative maturity of the proposed technology in terms of reliability and robustness, and (4) Reasonableness and realism of proposed costs and fees (if any). No further evaluation criteria will be used in selecting white papers/proposals. Individual white paper/proposal evaluations will be evaluated against the evaluation criteria without regard to other white papers and proposals submitted under this BAA. White papers and proposals submitted will be evaluated as they are received. 2. REVIEW AND SELECTION PROCESS: Only Government employees will evaluate the white papers/proposals for selection. The Air Force Research Laboratory's Information Directorate has contracted for various business and staff support services, some of which require contractors to obtain administrative access to proprietary information submitted by other contractors. Administrative access is defined as "handling or having physical control over information for the sole purpose of accomplishing the administrative functions specified in the administrative support contract, which do not require the review, reading, and comprehension of the content of the information on the part of non-technical professionals assigned to accomplish the specified administrative tasks." These contractors have signed general non-disclosure agreements and organizational conflictof interest statements. The required administrative access will be granted to non-technical professionals. Examples of the administrative tasks performed include: a. Assembling and organizing information for R&D case files; b. Accessing library files for use by government personnel; and c. Handling and administration of proposals, contracts, contract funding and queries. Any objection to administrative access must be in writing to the Contracting Officer and shall include a detailed statement of the basis for the objection. VI. AWARD ADMINISTRATION INFORMATION: 1. AWARD NOTICES: Those white papers found to be consistent with the intent of this BAA may be invited to submit a technical and cost proposal. Notification by email or letter will be sent by the technical POC. Such invitation doesnot assure that the submitting organization will be awarded a contract. Those white papers not selected to submit a proposal will be notified in the same manner. Prospective offerors are advised that only Contracting Officers are legally authorized to commit the Government. All offerors submitting white papers will becontacted by the technical POC, referenced in Section VII of this announcement.Offerors can email the technical POC for status of their white paper/proposal no earlier than 45 days after proposal submission. 2. ADMINISTRATIVE AND NATIONALPOLICY REQUIREMENTS: Depending on the work to be performed, the offeror may require a Confidential, SECRET, TOP SECRET or TS/SCI facility clearance and safeguarding capability; therefore, personnel identified for assignment to a classifiedeffort must be cleared for access to SECRET, TOP SECRET or TS/SCI information at the time of award. The offeror may be required to have, or have access to, a certified and Government-approved facility to support work under this BAA. This acquisition may involve data that is subject to export control laws and regulations. Only contractors who are registered and certified with the Defense LogisticsInformation Service (DLIS) at http://www.dlis.dla.mil/jcp/ and have a legitimate business purpose may participate in this solicitation. For questions, contact DLIS on-line at http://www.dlis.dla.mil/jcp or at the DLA Logistics Information Service, 74 Washington Avenue North, Battle Creek, Michigan 49037-3084, and telephone number 1-800-352-3572. You must submit a copy of your approved DD Form 2345, Militarily Critical Technical Data Agreement, with your Proposal. 3. REPORTING: Once a proposal has been selected for award, offerors will be given complete instructions on the submission process. VII. AGENCY CONTACTS: Questions of a technical nature shall be directed to the cognizant technical point of contact, as specified below: Technical POC: Dr. Daniel Stevens Telephone: (315) 330-2416 Email: Daniel.Stevens@rl.af.mil Questions of a contractual/business nature shall bedirected to the cognizant contracting officer, as specified below: Lynn White Telephone (315) 330-4996 Email: Lynn.White@rl.af.mil The email must reference thesolicitation (BAA) number and title of the acquisition. In accordance with AFFARS 5315.90, an Ombudsman has been appointed to hear and facilitate the resolution of concerns from offerors, potential offerors, and others for this acquisitionannouncement. Before consulting with an ombudsman, interested parties must first address their concerns, issues, disagreements, and/or recommendations to the contracting officer for resolution. AFFARS Clause 5352.201-9101 Ombudsman (Apr 2010) will be incorporated into all contracts awarded under this BAA. The AFRL Ombudsman is as follows: Ms. Barbara Gehrs AFRL/PK 1864 4th Street Building 15, Room 225 Wright-Patterson AFB OH 45433-7130 FAX: (937) 656-7321; Comm: (937) 904-4407 All responsible organizations may submit a white paper which shall be considered. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=2e772c58b5324a5885f8f0e4106b4086&tab=core&_cview=0 Posted 05/04/12 (W-SN02739885). (0125) --------------------------------------------------------------- Program Number: 61287 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Directorate for Geosciences/NSF Title: Geophysics Contact: Robin Reichlin, Program Director Tel: 703-292-8556 Email: rreichli@nsf.gov Website:          http://www07.grants.gov/search/search.do?oppId=70033&mode=VIEW Full Program:          http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13682 Deadline Note: Full proposal windows are as follows: May 5, 2012 - June 5, 2012; and November 5, 2012 - December 5, 2012. SYNOPSIS: This program supports basic research in the physics of the solid earth to explore its composition, structure, and processes. --------------------------------------------------------------- Program Number: 03763 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Directorate for Mathematics and Physical Sciences/NSF Title: Mentoring Through Critical Transition Points in the Mathematical Sciences Contact: Dean M. Evasius Tel: 703-292-8132 Email: devasius@nsf.gov Website:          http://www.grants.gov/search/search.do?oppId=89633&mode=VIEW Full Program:          http://www.nsf.gov/pubs/2011/nsf11542/nsf11542.htm SYNOPSIS: The long-range goal of the Division of Mathematical Sciences (DMS) Workforce program is to increase the number of well-prepared U.S. citizens, nationals, and permanent residents who pursue careers in the mathematical sciences and in other NSF-supported disciplines. The Mentoring Through Critical Transition Points in the Mathematical Sciences (MCTP) activity is part of the Workforce Program. MCTP supports education through research involvement of cohorts of trainees at specific stages of professional development that have been identified as crucial to career success. --------------------------------------------------------------- Program Number: 22224 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Directorate for Mathematics and Physical Sciences/NSF Title: Research Training Groups in the Mathematical Sciences (RTG) Contact: Bruce P. Palka Tel: 703-292-4856 Email: bpalka@nsf.gov Website:          http://www.nsf.gov/pubs/2011/nsf11540/nsf11540.htm Full Program:          http://www.grants.gov/search/search.do?oppId=89415&mode=VIEW SYNOPSIS: The long-range goal of the Division of Mathematical Sciences (DMS) Workforce program is to increase the number of well-prepared U.S. citizens, nationals, and permanent residents who pursue careers in the mathematical sciences and in other NSF-supported disciplines. The Research Training Groups in the Mathematical Sciences (RTG) activity is a part of the Workforce program. RTG supports education through research involvement in groups centered on a common research interest that span the entire spectrum of educational levels from undergraduates through postdoctoral associates. --------------------------------------------------------------- Program Number: 02587 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers for Early Detection of Hematopoiietic Malignancies (R01) Contact: Lynn Sorbara, Ph.D. Tel: 301-435-0584 Email: lynns@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-197.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03691 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R01) Contact: Wendy Wang, Ph.D., M.Sc. Tel: 301-594-7607 Email: wangw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-199.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04213 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Diet, Epigenetic Events, and Cancer Prevention (R01) Contact: Sharon A. Ross, PH.D., M.P.H. Tel: 301-594-7547 Email: rosssha@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-234.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications for clinical and preclinical research to determine how diet and dietary factors, including dietary supplements, impact DNA methylation, histone posttranslational modification, noncoding RNA, and other epigenetic processes involved in cancer prevention and development. Another important aim of this FOA is to encourage collaborations between nutrition and epigenetic experts to study bioactive food components with cancer-preventative properties and to examine key epigenetic events in cancer processes (e.g., carcinogen metabolism, cell division, differentiation, and apoptosis) in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04579 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Image-Guided Drug Delivery in Cancer (R01) Contact: Pushpa Tandon, Ph.D. Tel: 301-451-2291 Email: tandonp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-253.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications for innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response. This FOA will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first in human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this FOA. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05273 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Research On Ethical Issues In Human Subjects Research (R01) Contact: Ann Hardy Tel: 301-435-2690 Email: hardyan@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-180.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05909 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Epigenetic Approaches in Cancer Epidemiology (R01) Contact: Mukesh Verma, Ph.D., M.P.H. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-031.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10731 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01) Contact: Vickie L. Shavers, Ph.D. Tel: 301-594-1725 Email: shaversv@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-162.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research to: improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection and statistical/analytical techniques; enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment and outcomes among disadvantaged racial/ethnic minority groups; and reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16329 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers of Infection-Associated Cancers (R01) Contact: Karl Krueger, Ph.D. Tel: 301-435-1594 Email: kruegerk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-158.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20744 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Contact: Young S. Kim, Ph.D. Tel: 301-496-0126 Email: yk47s@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-160.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20887 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01) Contact: Mukesh Verma, Ph.D. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-073.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23222 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Spatial Uncertainty: Data, Modeling, and Communication (R01) Contact: Li Zhu, Ph.D. Tel: 301-594-6546 Email: li.zhu@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-238.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invites applications for innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 26618 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R01) Contact: Joanna M. Brell, M.D. Tel: 301-496-8541 Email: brelljm@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-082.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of optional letters of intent is May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) invites basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN). The majority of acquired peripheral neuropathy research has focused on diabetic and inherited diseases; this FOA intends to stimulate neuroscience researchers to apply their expertise from studying these other neuropathies to the injuries incurred by cancer treatments. More data is necessary to understand the mechanisms of neuronal damage and to identify the targets instrumental to CIPN initiation and maintenance. Preclinical research that focuses not only on peripheral neuropathic pain but also on neurosensory symptoms such as paresthesias and peripheral anesthesias is invited. The ultimate goal of this FOA is to lead to a molecular understanding of CIPN that allows for the rational development of interventions that will treat or prevent CIPN. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 70390 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Improving Diet and Physical Activity Assessment (R01) Contact: Amy Subar, Ph.D. Tel: 301-594-0831 Email: subara@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-224.html Deadline Note: The deadline for receipt of optional letters of intent is May 5, 2012. The deadline for receipt of full applications is June 5, 2012. This FOA will expire on September 8, 2012. SYNOPSIS: The sponsors provide support for innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations; across various age-groups including older adults; improved technology or applications of existing technology; or statistical methods to assess or correct for measurement errors or biases. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 72509 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R01) Contact: Magdalena Thurin, Ph.D. Tel: 301-496-1591 Email: thurinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-013.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This FOA is not appropriate for molecular diagnostics discovery projects. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 90931 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01) Contact: Andrew N Freedman, Ph.D. Tel: 301-435-6819 Email: freedmaa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-025.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91013 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01) Contact: Cindy D. Davis, Ph.D. Tel: 301-594-9692 Email: davisci@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-035.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications to enhance our understanding about the dynamic interrelationship that exists between bioactive food components (and/or combinations thereof) and cancer prevention. Although much evidence exists that dietary components are linked to cancer prevention, the interactions among dietary bioactive compounds and food combinations remains under-investigated. Applications are encouraged to consider either multiple dietary bioactive components, intact foods or multiple foods utilizing physiologically relevant concentrations of the agents. New genetic technologies may be employed to study the impact of dietary components on complex cellular and molecular networks, as part of the effort to better understand the basis for the multifaceted interactions of food components with cancer prevention mechanisms. Specifically, applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to prioritize molecular targets of dietary components are highly encouraged. The sites of action that may be evaluated include carcinogen metabolism, DNA repair, cell proliferation, apoptosis, differentiation, hormonal regulation, energetics, inflammation, and/or angiogenesis. In addition, applications should either evaluate multiple molecular targets within a cancer process or multiple processes in order to prioritize which process(es) is/are most involved in bringing about a phenotypic change. It is hoped that advances in this area may assist in optimizing cancer prevention while minimizing potential toxicity due to food components. The resulting information will help define which foods or food components should be considered in isolation or in combination when developing dietary strategies to reduce cancer risk and/or modify tumor behavior. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91832 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Academic-Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01) Contact: Houston Baker, Ph.D. Tel: 301-594-9117 Email: bakerhou@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-169.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from research partnerships formed by academic and industrial investigators to accelerate the translation of either animal or human in vivo imaging, image guided, and/or spectroscopic systems and methods designed to solve targeted cancer problems for cancer research, clinical trials, and/or clinical practice. The partners on each application will establish an inter-disciplinary, multi-institutional research team to work in a strategic alliance to implement a coherent strategy to develop and translate the proposed system or methods with potential for significant impact on preclinical, single, or multisite clinical studies. Partnerships must include at least one lead academic and one lead industrial organization large or small among their numbers. For either preclinical or clinical research, funding may be requested for limited additional copies of prototype systems and methods in order to optimize and validate them across different platforms and/or research sites. Each partnership is encouraged to plan to solve its choice of targeted cancer problem within the five year funding period. This FOA supports clinical trials that emphasize optimization and validation of the performance of imaging systems, including devices, agents and/or methods. It will not support commercial production. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 98141 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Contact: Robert J. Nordstrom, Ph.D. Tel: 301-496-3428 Email: nordstrr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-150.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. This FOA will expire on May 8, 1014. SYNOPSIS: The sponsor provides support for research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. Proposed projects should include the appropriate development and adaptation/implementation of quantitative imaging methods, protocols and software solutions/tools (using existing commercial imaging platforms and instrumentation), and their application in current and planned Phase 1-2 clinical therapy trials. The proposed projects must focus on imaging-derived quantitative measurements of responses to drugs and/or radiation therapy, and/or image-guided interventions. It is anticipated that these research goals will require multidisciplinary efforts. Therefore, this FOA solicits applications from multi-disciplinary teams to include oncologists as well as clinical and basic imaging scientists. The involvement of industrial partners in the development of the quantitative imaging methods is not required, but is strongly encouraged. Awardees will form a Quantitative Imaging Network (QIN) to share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies. This FOA will utilize the NIH U01 cooperative agreement mechanism. --------------------------------------------------------------- Program Number: 02478 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Eye Institute/NIH/DHHS Title: NEI Clinical Vision Research (U10) Contact: Donald F. Everett, M.A. Tel: 301-451-2020 Email: dfe@nei.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-207.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications for clinical vision research projects, including clinical trials and large-scale epidemiologic studies in vision research. The intent of this funding opportunity announcement is to provide a framework for applicants proposing clinical vision research projects, including clinical trials and epidemiological studies. This FOA will utilize the NIH cooperative agreement (U10) grant mechanism. --------------------------------------------------------------- Program Number: 04735 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R01) Contact: Catherine Loria, Ph.D. Tel: 301-435-0702 Email: loriac@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-243.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications that propose research on the roles of nutrition and physical activity in the development, prevention, and management of cardiovascular diseases (CVD) or pulmonary diseases. In particular, the FOA aims to (1) improve knowledge of the contribution of diet and physical activity to these conditions and how sleep influences these relationships, (2) increase the evidence base for refining public health recommendations and clinical guidelines regarding these lifestyle behaviors, and (3) develop and test strategies to improve the adoption of these recommendations. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 07587 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R01) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-211.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites hypothesis-testing research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences. The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 11840 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01) Contact: Pankaj Qasba, Ph.D. Tel: 301-435-0050 Email: qasbap@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-121.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications that propose collaborative research projects by multi-disciplinary teams to advance our understanding of molecular and cellular mechanisms underlying ribosomal dysfunction. These research areas include effects on hematopoiesis and their role in bone marrow failure syndromes. Multi-disciplinary expertise across basic and clinical components is encouraged. To meet the objectives of this FOA applicants are encouraged to integrate ribosomal biology with bone marrow failure to develop and characterize models of ribosomopathies. The FOA will support projects that integrate multi-investigator, multidisciplinary approaches with a high degree of interplay between clinical components of Bone Marrow Failure (BMF) and experimental approaches to ribosome biology. Collaborative teams supported by this FOA could include researchers from such fields as biomedical, physical, and informatics disciplines. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20022 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Getting from Genes to Function in Lung Disease (R01) Contact: Susan Banks-Schlegel, Ph.D. Tel: 301-435-0202 Email: schleges@nhlbi.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-110.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of standard R01 applications under this announcement is June 5, 2012, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is September 7, 2012, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications that propose to characterize the function of gene(s) and their associated variants identified by genome-wide association studies (GWAS) or other genetic approaches to be involved in lung diseases. Studies should use integrated approaches across scientific disciplines to determine the pathobiological function of these genes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20023 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Toward an Improved Understanding of HDL Function (R01) Contact: Lijuan Liu, Ph.D. Tel: 301-435-0550 Email: lliu@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-143.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadline for receipt of standard R01 applications under this announcement is June 5, 2012, by 5:00 PM local time of applicant organization. The deadline for receipt of AIDS-related applications is September 7, 2012, by 5:00 PM local time of applicant organization. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications that propose to develop, validate, and standardize assays to measure HDL function and biomarkers for HDL function and to identify new pathways and potential HDL targets in the relationship to HDL function. Innovative methods to determine HDL functional properties such as in vivo reverse cholesterol transport (RCT), anti-oxidant, anti-inflammatory, and antithrombotic activities, and biomarkers for HDL function are encouraged. Projects that will explore HDL novel functional pathways and therapeutics related to HDL function are also encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91116 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Nutrition and Diet in the Causation, Prevention, and Management of Heart Failure (R01) Contact: Abby G. Ershow, Sc.D., FAHA Tel: 30-435-0550 Email: ErshowA@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-165.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications on the role of nutrition and diet in the causation, prevention, and treatment of cardiomyopathies and heart failure. Mechanistic, translational, and applied interdisciplinary research applications with rigorous hypothesis-testing designs for projects in humans or animals are of interest. The overall goal is to develop a satisfactory science base for rational nutritional management of patients in various stages of heart failure and for preventive approaches in high-risk individuals. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 58262 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical Legal and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-250.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support for applications from institutions/organizations that propose to study the ethical, legal and social implications (ELSI) of human genome research. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25969 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Research to Advance Vaccine Safety (R01) Contact: Barbara Mulach, Ph.D. Tel: 301-496-1884 Email: bmulach@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-037.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25980 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Investigations on Primary Immunodeficiency Diseases (R01) Contact: David R. Johnson, Ph.D. Tel: 301-496-7104 Email: drjohnson@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-036.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. The Jeffrey Modell Foundation (JMF) will consider applications for independent JMF awards. Interested investigators should send a copy of their application materials to the following address: Jeffrey Modell Foundation 780 Third Avenue New York, NY 10017 Tel: (212) 819-0200 Fax: (212) 764-4180 Email:info@jmfworld.org SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for innovative investigations in primary immunodeficiency diseases. Of particular interest are the detection of primary immunodeficiency diseases, the identification of the molecular basis of these diseases, and the design and pre-clinical development of innovative therapies for these diseases. Clinical trials will not be supported by this FOA. Studies using samples obtained from humans and studies on animal models are encouraged. Investigators who have not received independent NIH funding in this field are encouraged to apply. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27204 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Enhancing Cellular Immunity in the Female Reproductive Tract (R01) Contact: Alan Embry, Ph.D. Tel: 301-435-3751 Email: embrya@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-104.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for research focused on the discovery of mechanisms that mediate the induction and maintenance of effective antigen-specific CD8+ memory T cells in the female reproductive tract (FRT). The ultimate goal is to develop the knowledge base needed to facilitate the development of future vaccines that generate effective and persistent T lymphocyte responses against infection by HIV and other mucosal pathogens in the FRT. This program is not intended to support evaluation of mucosal vaccines or therapies, or research primarily focused on pathogens. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27206 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Functional Glycomics in HIV Vaccine Design (R01) Contact: Thandi M. Onami, Ph.D Tel: 301-594-1321 Email: onamit@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-105.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for research to 1) investigate structural and conformational features of glycosylation that may lead to novel HIV vaccine design approaches, and 2) to elucidate the impact of differential glycosylation on the quality of the immune response to HIV. Ultimately, the discovery of a safe, effective, prophylactic vaccine that provides long-term protection from HIV infection may depend on novel approaches that incorporate new knowledge of the key role glycans play in the elicitation and maturation of broadly neutralizing antibodies and effector immune responses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27207 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Mucosal Environment and HIV Prevention (MEHP) (R01) Contact: Jim A. Turpin, Ph.D. Tel: 301-451-2732 Email: jturpin@niaid.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-106.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications that address the long term goal and objectives of increasing the safety and efficacy of non-vaccine biomedical prevention, such as microbicides and PrEP, through a better understanding of their interactions with the tissue micro- and macro-environments of the genital (male and female) and gastrointestinal mucosa. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27244 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Delivering Therapeutics to Residual Active HIV Reservoirs (R01) Contact: Karl Salzwedel, Ph.D. Tel: 301-496-5332 Email: salzwedelkd@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-107.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012 . The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Mental Health (NIMH) invite applications to encourage new ideas for eliminating cellular reservoirs of HIV that continue to actively produce virus in tissue compartments despite suppression of plasma viremia with antiretroviral therapy. New approaches to delivering antiretrovirals or other anti-HIV agents to these tissues or to specific cell types are needed to block virus production, limit inflammation, and facilitate clearance of these reservoir cells. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27775 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R01) Contact: Hung Tseng, Ph.D. Tel: 301-496-0810 Email: tsengh@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-131.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications for basic and translational studies aimed at understanding the mechanisms of itch sensation and developing methods to modulate and control itch sensation in disease and rehabilitation. The purpose is to accelerate discovery in this nascent field and to apply new knowledge to improve human conditions relevant to the NIAMS mission. This FOA intends to support a broad range of investigations using animal and human models, with an emphasis on multidisciplinary collaboration for rapid bench-to-bedside exchange of information and therapy development. This FOA is not intended to support applications proposing clinical trials. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06164 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Development of Multifunctional Drug and Gene Delivery Systems (R01) Contact: Lori A. Henderson, Ph.D. Tel: 301-451-4778 Email: hendersonlori@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-048.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose the engineering of novel, multifunctional drug and gene delivery systems that can target therapies to particular cells and intracellular compartments and can monitor delivery and determine therapeutic efficacy through the integration of advanced imaging and/or sensing technologies into the delivery system. Applications should propose to develop at least one prototype system by the end of the project period. Applications that are submitted to this FOA should include investigators from both the drug/gene delivery and imaging fields. Applicants are strongly encouraged to use the Multi-PD/PI model to meet the imaging and drug/gene delivery expertise. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16108 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Bioengineering Research Partnerships (BRP)[R01] Contact: Albert Lee, Ph.D. Tel: 301-451-4781 Email: alee@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-234.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological, clinical or biomedical research problems. In the context of this program, a partnership is a multi-disciplinary research team, that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. The partnership must operate according to a clear leadership plan and include appropriate bioengineering or allied quantitative sciences in combination with biomedical and/or clinical components. BRPs may propose, within a 12-page research strategy section, design-directed, developmental, discovery-driven, or hypothesis-driven research at universities, national laboratories, medical schools, large or small businesses, or other public and private entities or combinations of these entities, and will be evaluated against expanded review criteria. It is expected that a BRP will have a well-defined goal or deliverable that will be achieved in a 5-10 year timeframe based on objective milestones specified in the initial application. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 71649 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS Title: Nanoscience and Nanotechnology in Biology and Medicine (R01) Contact: Piotr Grodzinski Tel: 301-594-4177 Email: grodzinp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-148.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries. Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale. Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20703 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) Contact: Melissa A. Parisi, MD, PhD Tel: 301-435-6880 Email: parisima@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-045.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications that propose to develop, validate, and/or calibrate informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This funding opportunity will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This solicitation will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24408 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Gamete Quality in Natural and Assisted Reproduction (R01) Contact: Stuart B. Moss, PhD Tel: 301-435-6979 Email: mossstua@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-326.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to support outstanding research in the area of female and male gamete quality. For both natural and assisted reproduction, a focal point of the initiative is on the production, identification, and use of healthy gametes. In this regard, the identification and validation of biomarkers that assess gamete quality is critical. Additional areas of interest are the impact of nutrition, environmental exposures, disease states, and aging on oocyte and sperm quality. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24410 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Biomarkers: Bridging Pediatric and Adult Therapeutics (R01) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-322.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. Letters of intent may be submitted thirty days prior to the application deadline(s). The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. Projects supported by this FOA will be confined to those biomarkers that correlate with a clinical observation, have been extensively studied in adults, and for which there is solid evidence that they have pediatric applications. Discovery of new biomarkers for use in new drug development or in preclinical studies are not part of this FOA. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82115 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Mechanisms of Adverse Drug Reactions in Children (R01) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-051.html Deadline Note: The sponsor requests that optional letters of intent be submitted thirty days prior to the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications for projects that enhance the state-of-the-science on the molecular and cellular, genetic and epigenetic mechanisms involved in the production of adverse drug reactions in children. The objective of this announcement includes research on the role of ontogeny and the characterization of pharmacogenetic and developmental variations of drug metabolizing enzymes (DMEs), transporters, ion channels, receptors and signaling pathways that are responsible for drug toxicity in the pediatric population. This FOA will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 82960 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on Emergency Medical Services for Children (EMSC) [R01] Contact: Lynne Haverkos, M.D., M.P.H. Tel: 301-435-6881 Email: lh179r@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-141.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Child Health and Human Development (NICHD) and National Institute of Mental Health (NIMH) invite applications dealing with the following areas of research included under the term EMSC: prevention research to reduce the need for emergency care; clinical research to ensure that children receive high-quality and appropriate medical, nursing and mental health care in an emergency; health systems research, from pre-hospital care, to the emergency department, to in-patient care and return to the community; models to improve service and cost efficiency in pediatric emergency care; and methodological studies to improve the quality of research conducted. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 85922 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Innovative Therapies and Tools for Screenable Disorders in Newborns (R01) Contact: Tiina Urv, PhD Tel: 301-402-7015 Email: urvtiin@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-230.html Deadline Note: Optional Letters of Intent will be accepted 30 days prior to the application due date. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invite applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93887 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Developmental Pharmacology (R01) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-11-057.html Deadline Note: The sponsor requests that optional letters of intent be submitted 30 days prior to the application receipt date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications from institutions/ organizations that propose to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 94876 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) Contact: Lorette C. Javois, Ph.D. Tel: 301-496-5541 Email: javoisl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-085.html Deadline Note: This program will expire on January 8, 2014. SYNOPSIS: The sponsors provide support for innovative investigator-initiated R01 applications using animal models in conjunction with translational/clinical approaches that take advantage of advances in genetics, biochemistry, molecular, and developmental biology to identify the specific genetic, epigenetic, environmental, or gene/environment interactions associated with the susceptibility to and variability of structural birth defects in human populations. Applicants funded through this FOA will join the NICHD Birth Defects Working Group and participate in annual meetings designed to provide a forum to discuss research progress, exchange ideas, share resources, and foster collaborations relevant to the goals of the NIHCD's Birth Defects Initiative. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24227 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Building a Genetic and Genomic Knowledge Base in Dental, Oral, and Craniofacial Diseases and Disorders (R01) Contact: Emily L. Harris, PhD, MPH Tel: 301-594-4846 Email: emily.harris@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-317.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for research into dental, oral, and craniofacial diseases and disorders for which there is evidence for genetic heritability but for which we do not have a strong understanding of the genetics/genomics of the disease or disorder. Applicable areas of investigation include identification of promising areas of the genome, and characterization and elucidation of the function(s) of genetic variants that affect disease risk in humans. The ultimate goal of these studies will be to drive development of effective diagnostic, therapeutic, and preventive approaches. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24548 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R01) Contact: Isaac R. Rodriguez-Chavez, Ph.D., M.S., M.H.S. Tel: 301-594-7985 Email: isaac@nidcr.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-334.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after December 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies against HIV, oral co-infections and oral opportunistic infections. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91196 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R01) Contact: Jane C. Atkinson, D.D.S., Director Tel: 301-435-7908 Email: jatkinso@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-082.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to study the underlying pathophysiology of osteonecrosis of the jaw (ONJ), identify risk factors for this condition, establish the natural history of the disease, and generate evidence for its treatment. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 01007 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Health Disparities in NIDDK Diseases (R01) Contact: Lawrence Agodoa, M.D., Director Tel: 301-894-9650 Email: la21j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-262.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for research to understand and mitigate issues of health disparities in high priority diseases within its scope, including diabetes, obesity, nutrition-related disorders, hepatitis C, gallbladder disease, H. Pylori infection, sickle cell disease, kidney diseases, and metabolic, gastrointestinal, hepatic, and renal complications from infection with HIV. This program will use the NIH R01 grant mechanism. --------------------------------------------------------------- Program Number: 02644 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Advances in Polycystic Kidney Disease (R01) Contact: Deborah K, Hoshizaki, Ph.D. Tel: 301-594-7712 Email: dkhosh@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-202.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites experienced and new investigators to submit research grant applications to pursue basic and applied investigations in order to better understand the etiology and pathogenesis of Polycystic Kidney Disease (PKD), in both its autosomal dominant and autosomal recessive forms. The intent of this funding opportunity is to intensify investigator-initiated research, to attract new investigators to the field, and to increase interdisciplinary research. The ultimate aim is to facilitate PKD-related research studies, which will provide the basis for new therapeutic approaches. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03330 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Calcium Oxalate Stone Diseases (R01) Contact: Rebekah S. Rasooly, Ph.D. Tel: 301-594-6007 Email: rr185i@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-213.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to increase investigator interest in research into oxalate metabolism, transport and homeostasis, and oxalate stone diseases. This initiative encourages basic, clinical or epidemiological studies that utilize new and innovative approaches to study the diagnosis, treatment and prevention of these disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 04618 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Erythropoiesis: Components and Mechanisms (R01) Contact: Terry Rogers Bishop, Ph.D. Tel: 301-594-7726 Email: tb232j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-255.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 08, 2012. SYNOPSIS: The sponsors invite applications that propose hypothesis-driven research using erythroid cells. The aim of this program is to support research efforts towards a complete description of the molecular and cellular components of erythropoiesis and how these components contribute to erythropoiesis. Components include genes that are expressed (transcriptome) in erythroid cells, either during development or during differentiation, and the proteins (proteome) that are translated in erythroid cells, especially with post-translational modifications or subcellular localizations that are unique to erythroid cells. A long range goal of this program is to generate a concise description of erythropoiesis that unifies genetics, molecular processes and cytokine determinants in the erythroid lineages so that new therapeutics may be developed to measure and combat anemia. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06030 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) Contact: Terry Rogers Bishop, Ph.D. Tel: 301-594-7726 Email: tb232j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-046.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: TThe Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high quality hematology research relevant to the mission of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In the SHINE program, NIDDK invites investigator-initiated research project grant applications in specific areas of basic and translational hematology research where needs and opportunities for progress are particularly timely. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10378 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Diet Composition and Energy Balance (R01) Contact: Susan Z. Yanovski, M.D. Tel: 301-594-8882 Email: sy29f@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-152.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 2, May 1, and September 1 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications investigating the role of diet composition in energy balance, including studies in both animals and humans. Both short and longer-term studies are encouraged, ranging from basic studies investigating the impact of micro-or macronutrient composition on appetite, metabolism, and energy expenditure through clinical studies evaluating the efficacy of diets differing in micro- or macronutrient composition, absorption, dietary variety, or energy density for weight loss or weight maintenance. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 21483 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01) Contact: Jill L. Carrington, Ph.D. Tel: 301-402-0671 Email: carringj@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-107.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to conduct ancillary studies to the NIDDK Intestinal Stem Cell Consortium (ISCC). Studies will make use of consortium collaborations, techniques, and resources to accelerate research into intestinal stem cells. The proposed ancillary study must be designed to advance the scientific research mission of the NIDDK by focusing on diseases and areas of interest to the Institute and commensurate with the interests and intent of the ISCC. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 78588 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Development of Assays for High-Throughput screening for use in Probe and Pre-therapeutic Discovery (R01) Contact: Ronald Margolis, Ph.D. Tel: 301-594-8819 Email: margolisr@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-213.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to its mission with the intent of using them to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads. The NIH launched a Molecular Libraries and Imaging initiative as part of the NIH Roadmap for Medical Research to establish a network of HTS screening centers which provide access to a large compound library, robotics to carry out the assays, and informatics to interpret the results (http://mli.nih.gov/mli/). This FOA seeks to establish a stream of scientifically and technologically outstanding assays for screening by these and other academic centers. Assays may involve targets indirectly related to disease, but which might provide insight into the biology of relevant diseases. Other targets might be associated with rare and neglected diseases, an area of increasing focus for the NIH (http://www.nih.gov/news/health/may2009/nhgri-20.htm). Assays should be relevant to the scope of the research for at least one of the sponsoring NIH Institutes. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 87094 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Basic and Clinical Studies of Congenital Urinary Tract Obstruction (R01) Contact: Marva M. Moxey-Mims, M.D. Tel: 301-594-7717 Email: mm726k@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-226.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to encourage and facilitate research in congenital obstructive uropathy including the development of objective prognostic markers; the genetic determinants of this congenital disorder; the development of reliable animal models of the disorder; and, evaluation of the long-term effectiveness of various treatment strategies. This PA will use the NIH R01 award mechanism. --------------------------------------------------------------- Program Number: 92836 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Grants for Research in Glomerular Diseases (R01) Contact: Marva Moxey-Mims, M.D. Tel: 301-594-7717 Email: mm726k@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-113.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications from new or established investigators to pursue exploratory investigations of glomerular disease, which would foster development of new ideas enhancing the understanding of disease detection, pathogenesis, pre-emption and/ or treatment. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28028 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Environmental Health Sciences/NIH/DHHS Title: Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01) Contact: Symma Finn, PhD Tel: 919-541-4258 Email: finns@niehs.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-153.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015. SYNOPSIS: National Institute of Environmental Health Sciences (NIEHS) and National Institute of Nursing Research (NINR) invite applications using community-engaged research methods to investigate the potential health risks of environmental exposures of concern to the community and to implement an environmental public health action plan based on research findings. The overall goal is to support changes to prevent or reduce exposure to harmful environmental exposures and improve the health of a community. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02699 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Innovations in Biomedical Computational Science and Technology (R01) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-218.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors offer support for research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations. This program will use the NIH R01 award mechanism. --------------------------------------------------------------- Program Number: 05492 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Technology Development for High-Throughput Structural Biology Research (R01) Contact: Charles. G. Edmonds, Ph.D. Tel: 301-594-4428 Email: edmondsc@nigms.nin.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-073.html Deadline Note: This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to develop novel technologies and methodologies underpinning high-throughput structural biology. Applications for new ideas and approaches for protein production and structure determination for classes of challenging proteins are appropriate. Projects related to high-throughput structure determination by X-ray crystallography and NMR, as well as projects addressing other constituent tasks of structural biology, including structural genomics, are relevant to this FOA. Applications should focus on methods development to solve challenging proteins that are not currently amenable to high-throughput structural biology. These challenging proteins include, but are not limited to, membrane proteins, small protein complexes, and proteins from human and other higher eukaryotes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 06816 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Technology Development for Protein Modeling (R01) Contact: Ward Smith, Ph.D. Tel: 301-443-9375 Email: smithwar@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-076.html Deadline Note: This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites from institutions/organizations that propose to develop novel technologies that will significantly improve the accuracy of comparative modeling methods for protein structure prediction. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 45344 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Structural Biology of Membrane Proteins (R01) Contact: Jean Chin, Ph.D. Tel: 301-594-0828 Email: chinj@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-228.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors provide support to develop research and methods to enhance the rate of membrane protein structure determination and to determine specific membrane protein structures. Innovative methods for expression, oligomerization, solubilization, stabilization, purification, characterization, crystallization, isotopic labeling, and structure determination of unique and biologically significant membrane proteins by x-ray diffraction, nuclear magnetic resonance (NMR), electron microscopic, mass spectrometry, and other biophysical techniques are encouraged. Projects that will lead in the near term to determining the structures of biologically important membrane proteins are also encouraged. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 68933 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Continued Development and Maintenance of Software (R01) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-028.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor provides support for the continued development, maintenance, testing and evaluation of existing software. The proposed work should apply best practices and proven methods for software design, construction, and implementation to extend the applicability of existing biomedical informatics/computational biology software to a broader biomedical research community. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82572 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Collaborations with National Centers for Biomedical Computing (R01) Contact: Peter Lyster, PhD Tel: 301-451-6446 Email: lysterp@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-001.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications for projects from individualinvestigators or small groups to collaborate with the NIH Common Fund for Medical Research National Centers for Biomedical Computing (NCBCs). For a description of the NCBCs see http://www.ncbcs.org/. The intention of the collaborating projects is to engage researchers across the nation in building an excellent biomedical computing environment, using the computational tools and biological and behavioral application drivers of the funded NCBCs as foundation stones. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 85825 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Collaborative Research for Molecular and Genomic Studies of Basic Behavior in Animal Models (R01) Contact: Laurie Tompkins, Ph.D. Tel: 301-594-0943 Email: tompkinL@nigms.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-125.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors offer support for collaborative research, involving behavioral scientists and investigators with expertise in molecular biology and/or genomics, which addresses questions about basic mechanisms of behavior in animal models. This PA will use the R01 award mechanism. --------------------------------------------------------------- Program Number: 00320 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01) Contact: Joel Sherrill, Ph.D. Tel: 301-443-2477 Email: jsherril@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-153.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors offer support for collaborative intervention trials in the treatment, prevention or rehabilitation of those with mental disorders and alcohol use disorders and comorbid mental disorders. Support is also sought for other collaborative clinical studies, including but not limited to mental health services research, AIDS, genetics, psychopathology, stigma, and cultural and social processes. This initiative should be used when two or more sites are needed to complete the study. The collaborating studies share a specific protocol across the sites and are organized as such in order to increase sample size, accelerate recruitment, or increase sample diversity and representation. In studies with a large number of sites, it is expected that one site will be submitted as a coordinating site for data management and/or other centralized administration. This initiative also supports projects involving collaboration between community-based organizations such as consumer or advocacy groups, state or local governments, and Tribal governments with universities and colleges. This program will use the NIH Collaborative Research Project Grant (Collaborative R01) award mechanism. --------------------------------------------------------------- Program Number: 24033 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Molecular and Cellular Substrates of Complex Brain Disorders (R01) Contact: Chiiko Asanuma, Ph.D. Tel: 301-443-5288 Email: cs2j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-299.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsor invites applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25661 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Innovative Pilot Studies of Novel Mechanism of Action Compounds for Treating Psychiatric Disorders (U01) Contact: Lois Winsky, Ph.D. Tel: 301-443-5288 Email: lwinsky@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-007.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012 . Optional letters of intent may be submitted thirty days prior to the application due date(s). The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The sponsor invites applications for experimental medicine-based first in human (FIH) and proof of concept (POC) studies of new mechanism of action, IND-ready candidate medications to treat mental disorders. The objective of the FOA is to accelerate the development of innovative pharmacological treatments through support of early phase human clinical testing. FIH pharmacology studies should assess target engagement, pharmacological effects, safety, and tolerability of novel compounds in order to build a pipeline for initial POC or efficacy trials in patients. POC studies of novel compounds should use pharmacologically based dosing, with assessment of target engagement and evaluation of the impact of compounds on clinically relevant physiological systems as well as clinical indicators of effect. The overall objective is to facilitate rapid collection of data to "de-risk" novel mechanism of action or combination treatments and to attract private funding for further clinical and commercial development of candidate medications. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 26143 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R01) Contact: Yong Yao, Ph.D. Tel: 301-443-6102 Email: yyao@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-058.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. Optional letters of intent may be submitted thirty days prior to the relevant application deadline. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: NIH invites applications to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on assays that provide new insight into important disease targets and processes. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 26152 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Solicitation of Validated Hits for the Discovery of in vivo Chemical Probes (R01) Contact: Yong Yao, Ph.D. Tel: 301-443-6102 Email: yyao@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-060.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. Optional letters of intent may be submitted thirty days prior to the relevant application deadline. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: NIH invites applications to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on assays that provide new insight into important disease targets and processes. This FOA intends to support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes. It is expected that applicants will have in hand the starting compounds (“validated hits”) for chemical optimization and bioassays for testing new analog compounds. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 59812 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Research On Autism And Autism Spectrum Disorders (R01) Contact: Lisa Gilotty, Ph.D. Tel: 301-443-3825 Email: gilottyl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-158.html Deadline Note: This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml). This program will use the NIH Research Project Grant (R01) award mechanism. --------------------------------------------------------------- Program Number: 90982 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Drug Discovery for Nervous System Disorders (R01) Contact: Jamie Driscoll Tel: 301-443-5288 Email: jdrisco1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-001.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10115 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Cooperative Program in Translational Research for Resistant Epilepsy and Epileptogenesis (U01) Contact: Randall Stewart, PhD Tel: 301-496-1917 Email: stewartr@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-154.html Deadline Note: Optional letters of intent will be accepted 30 days prior to each submission date. This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to support preclinical development of new therapies to cure epilepsy, prevent the emergence of epilepsy following brain injury (including status epilepticus, traumatic brain injury, stroke, encephalitis, or other injury) or in other high-risk groups, or to better treat individuals with intractable epilepsy. The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports preclinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of research progress. This FOA will utilize the U01 Cooperative Agreement mechanism. --------------------------------------------------------------- Program Number: 12236 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Validation of Novel Therapeutic Targets for Huntington’s Disease (R01) Contact: Margaret Sutherland, PhD Tel: 301-496-5680 Email: sutherlandm@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-183.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: June 30, 2010 for the first receipt date, then standard receipt dates of February 5, June 5, and October 5 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications aimed at validating novel molecular targets for disease-modifying therapeutic intervention in Huntington’s disease. This FOA is for support of new projects, and not the continuation of projects that have already been initiated with NIH funding. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20370 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Collaborative Studies on The Central Nervous System and Glycemia (R01) Contact: Merrill M. Mitler, Ph.D. Tel: 301-496-99614 Email: mitlerm@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-11-029.html Deadline Note: This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applcations for new interdisciplinary collaborations by researchers in neuroscience and in diabetes/metabolism to further understanding of the mechanisms by which the CNS controls glucose levels and the consequences to the CNS of derangements in these mechanisms. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23969 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Cooperative Program in Translational Research Single-Component Research Projects (U01) Contact: Thomas Miller, Ph.D. Tel: 301-496-1779 Email: tm208y@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-294.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for preclinical development and testing of new therapies for neurological disorders. The program will facilitate encouragement , development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. To be eligible for support, projects must include therapeutic leads and in vivo proof of concept on efficacy. The program supports preclinical optimization and testing of the leads, and projects must be sufficiently advanced that an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as screening. The program also excludes clinical research, basic research, and studies of disease mechanism. The scope includes only therapy development activities, so development of diagnostics, biomarkers, or rehabilitation strategies cannot be supported. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. This FOA will utilize the U01 Research Project Cooperative Agreements grant mechanism. --------------------------------------------------------------- Program Number: 26103 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Advanced Neural Prosthetics Research and Development (U01) Contact: Kip Ludwig, Ph.D. Tel: 301-496-1447 Email: kip.ludwig@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-053.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. Optional letters of intent will be accepted one month prior to the appropriate application due date. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: NIH invites applications to pursue translational and pilot clinical studies for neural prosthetics. The program will utilize the cooperative agreement mechanism to enable support for milestone-driven projects for the design, development, and demonstration of clinically-useful neural prosthetic devices. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for clinical study, and proof-of-concept or pilot clinical studies. This FOA will utilize the U01 Research Project Cooperative Agreement grant mechanism. --------------------------------------------------------------- Program Number: 91465 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Neurobiology of Migraine (R01) Contact: Linda L. Porter, Ph.D. Tel: 301-496-9964 Email: porter@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-258.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05218 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Mechanisms, Models, Measurement and Management in Pain Research (R01) Contact: Dr. Susan Marden, Ph.D., Program Director Tel: 301-496-9623 Email: mardens@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-006.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 23550 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Obesity and Asthma: Awareness and Management (R01) Contact: Karen Huss, PhD, RN, APRN-BC, FAAN, FAAAI Tel: 301-594-5970 Email: hussk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-245.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on . SYNOPSIS: The sponsor invites applications for research to examine the interconnections of asthma and obesity. The prevalences of both asthma and obesity have significantly risen in the past few decades. Although the association between these 2 conditions has been found in many studies, the exact mechanisms for how this association arises are unresolved. Because both of these conditions have their beginnings in early life, an aspect of the association between them that requires more understanding is their common exposures in early life. Studies that investigate the molecular pathways linking asthma and obesity are encouraged. In addition, intervention studies targeting asthma or obesity and their effects on each one, and possible mechanisms of action are encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24461 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01) Contact: Linda S. Weglicki, Ph.D., R.N., M.S.N. Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-327.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 26219 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01) Contact: Xenia Tigno, PhD, Program Director Tel: 301-594-2775 Email: tignoxt@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-061.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Nursing Research (NINR) invites applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27871 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R01) Contact: Karen Huss, PhD, RN, APRN-BC, FAAN, FAAAAI Tel: 301-594-5970 Email: hussk@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-133.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2016. SYNOPSIS: National Institute of Nursing Research (NINR) and National Institute of Environmental Health Sciences (NIEHS) invite applications for interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes, assisted living and long-term care facilities. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93601 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Reducing Health Disparities Among Minority and Underserved Children (R01) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-104.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02502 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R01) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-193.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 6, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03346 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms Underlying the Links Between Psychosocial Stress, Aging, the Brain and the Body (R01) Contact: Suzana S. Petancesksa, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-216.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite multidisciplinary and interdisciplinary research to elucidate the mechanistic links between psychosocial stress and health in aging, as well as how the aging process and age-related diseases affect the responses to psychosocial stressors. Generally, research should be focused on (1) aging and how neural mechanisms respond to psychosocial stress and affect other body systems, (2) characterizing the behavioral, psychological and social mechanisms and pathways involved in transducing psychosocial stressors into health outcomes, (3) how stressors modulate physiological process underlying life-span, immune mechanisms, and metabolism, and (4) how psychosocial stress contributes to the development or progression of geriatric syndromes, chronic medical conditions, and disabilities in later life. Research is strongly encouraged that aims to identify appropriate targets for intervention, at any level of analysis, from societal to molecular. Research spanning multiple levels of analysis is particularly encouraged. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 03421 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: The Role of Apolipoprotein #, Lipoprotein Receptors and CNS Lipid Homeostasis in Brain Aging and Alzheimer's Disease (R01) Contact: Suzana S. Petancesksa, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-217.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites multidisciplinary and interdisciplinary research to elucidate how Apolipoprotein E, lipoprotein receptors and CNS lipid homeostasis influence brain aging and the transition to neurodegeneration in Alzheimer’s disease (AD). The ultimate goal is to gain an in depth understanding of the mechanisms by which the Apolipoprotein E e4 allele confers increased AD risk for the purpose of advancing the overall search for efficacious AD treatments and Apolipoprotein E e4-directed therapeutics in particular. To this end we encourage research spanning multiple levels of analysis in multiple species (from mice to man). Studies aimed at identifying new therapeutic targets for the treatment of AD and other age-related neurodegenerative conditions associated with lipid neurobiology are strongly encouraged. Also of great interest are projects that aim to use lipidomics, various types of imaging and other cutting edge technologies to identify and develop early biomarkers of neurodegeneration associated lipid dyshomeostasis. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05092 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Contact: Chhanda Dutta, Ph.D. Tel: 301-435-3048 Email: duttac@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-265.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to support short term projects involving secondary analysis of existing data sets or stored biospecimens, to address clinically-related issues on aging changes influencing health across the life span, and/or on diseases and disabilities in older persons. This funding opportunity announcement (FOA) will support activities addressing specific hypotheses in clinical aging research and/or to inform the design and implementation of future epidemiologic or human intervention studies, or current geriatric practice in maintenance of health, management of disease, and prevention of disability. Existing data sets may also be used to develop and test new statistical analytical approaches. Costs for archiving of data to be made publicly available may be included in the budget, as long as the archival activities are related to the proposed secondary analyses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05622 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Development and Characterization of Animal Models for Aging Research (R01) Contact: Mahadev Murthy, Ph.D., M.B.A. Tel: 301-402-7749 Email: mmurthy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-014.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics. This FOA encourages applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 05962 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Critical Illness and Injury in Aging (R01) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-042.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 05, June 05, and October 05 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 12226 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Aging Studies in the Pulmonary System (R01) Contact: Mahadev Murthy, Ph.D., M.B.A. Tel: 301-496-6402 Email: mmurthy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-179.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsors invite esearch project grant applications that explore age-associated changes in pulmonary physiology, pathology and function, and their relationship to respiratory conditions and diseases that occur commonly in older populations. The goal of this FOA is to support basic, clinical and translational research to address physiological mechanisms underlying progressive functional declines in the pulmonary system. This research will likely enhance our basic understanding of molecular and cellular aspects of pulmonary aging, which may translate into improvements in the prevention and management of pulmonary diseases in older persons. Projects involving in vitro studies, animal models, and/or human subjects are of significant interest to NIA and NHLBI. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 17824 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Asthma in Older Adults (R01) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-263.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors invite applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24238 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Behavioral and Social Genomics of Aging: Opportunities in the Health and Retirement Study (R01) Contact: Erica L. Spotts, Ph.D. Tel: 301-496.3136 Email: spottse@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-318.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications taking advantage of newly available genetic data to advance the understanding of how genetic, behavioral, and psychosocial factors affect the health and well-being of older Americans. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 24276 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Single Cell Studies in Aging Research (R01) Contact: Dr. Jose Velazquez Tel: 301-496-6428 Email: jvelazqu@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-320.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications hat propose to develop research on single cell biology to enhance the understanding of the mechanisms of normal aging and of age-related diseases. Applications using -omics technologies, imaging, optofluidic platforms, mass spectroscopy, whole genome sequencing, and other tools and technologies at the single cell level are encouraged since it is expected that the single cell approach will improve the determination of unique and biologically significant properties of tissues and organs during the aging process. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25845 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms Mediating Osteoarthritis in Aging (R01) Contact: John P. Williams, Ph.D. Tel: 301-496-6402 Email: williamsj6@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-019.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases invite applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms mediating osteoarthritic progression. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 46815 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Alzheimer's Disease Pilot Clinical Trials (R01) Contact: Laurie M. Ryan, Ph.D. Tel: 301-496-9350 Email: ryanl@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-100.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 18, 2011; and then the standard deadlines of June 5, October 5 and February 5 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 84872 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Alzheimer's Disease Drug Development Program (U01) Contact: Suzana Petanceska, Ph.D. Tel: 301-496-9350 Email: petanceskas@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-015.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Aging (NIA) invites applications for pre-clinical development of new therapies aimed at modifying the behavioral symptoms in Alzheimer's disease (AD); or delaying the onset or slowing the progression of AD, mild cognitive impairment (MCI), or age-related cognitive decline. This program is specifically directed at projects focused on the optimization of therapeutic leads with demonstrated activity against an intended disease target. Projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the funding period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research and basic, mechanistic research. This is a milestone-driven cooperative agreement program involving participation of NIA program staff both in the development of the project plan and monitoring of research progress. This FOA will utilize the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 98216 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Translational Research at the Aging/Cancer Interface (TRACI) (R01) Contact: Susan G. Nayfield, M.D., M.Sc., Chief Tel: 301-496-6761 Email: nayfiels@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-136.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: >National Institute on Aging (NIA)and National Cancer Institute (NCI) invite applications for translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 01699 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Mechanistic Studies of Pain and Alcohol Dependence (R01) Contact: Mark Egli, Ph.D. Tel: 301-594-6382 Email: megli@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-267.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct mechanistic studies on the relationship between alcohol drinking, alcohol dependence and pain. An association between chronic pain conditions and alcohol dependence has been revealed in numerous studies with episodes of alcohol abuse antedating chronic pain in some people and alcohol dependence emerging after the onset of chronic pain in others. Pain transmission and alcohol’s reinforcing effects share overlapping neural substrates giving rise to the possibility that chronic pain states significantly affect alcohol use patterns and promote the development of dependence and addiction. In addition, long term alcohol intoxication and alcohol dependence induce pain symptoms and may exacerbate chronic pain arising from other sources. The objective of this FOA is to understand genetic, pharmacological and learning mechanisms underlying the association between the propensity to drink alcohol and pain responses. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 09872 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R01) Contact: Max Guo, Ph.D. Tel: 301-443-0639 Email: Max.Guo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-085.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study biological processes involving the cellular organelles in alcohol-induced tissue injury. Excessive alcohol consumption can damage many organ systems including the liver, heart, pancreas, brain, and lung. However, the mechanisms for these injuries are currently not fully understood. Cellular organelles play an important role in cellular functions and are significantly involved in alcohol-induced tissue injury. Thus, studies of alcohol’s effects on the structure and function of cellular organelles are critical to better understand the mechanisms of alcohol-induced injuries and to develop new strategies for their diagnosis and treatment. The purpose of this FOA is to: (1) better understand how acute or chronic alcohol consumption affects the structure and function of cellular organelles, and in turn, how these changes contribute to alcohol-induced injury; (2) investigate how variations of proteins in cellular organelles, or their regulation and function, including cellular signaling pathways, contribute to an individual’s response to acute or chronic alcohol intake and alcohol-induced tissue injury; (3) develop potential biomarkers for prognosis and diagnosis of tissue injury, or identify new targets for therapeutic interventions. This FOA aims to foster the utilization of innovative experimental design and emerging technologies, such as genomics, proteomics, metabolomics, bioinformatics, as well as novel microscopic imaging techniques that illuminate functions in intact cells and tissues, to generate new mechanistic and clinical insights into alcohol-induced tissue injuries. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 09877 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Stress Pathways in Alcohol Induced Organ Injury and Protection (R01) Contact: Andras Orosz, Ph.D. Tel: 301-443-2193 Email: orosza@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-093.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose studying the role of cellular stress responses, the cytoplasmic classical stress response or heat shock response (HSR) and the endoplasmic reticulum (ER) stress, in alcohol-induced tissue injury and tissue protection. While excessive alcohol use causes organ damage, moderate alcohol consumption may be beneficial. The underlying molecular mechanisms for this apparent dichotomy of alcohol’s harmful and salutary effects are currently not fully understood. Alcohol induces cellular stress pathways in the cytoplasm and in the endoplasmic reticulum that may significantly be involved in alcohol-induced tissue injury or mediate tissue protection depending on the quantity, frequency, duration, and temporal pattern of drinking. Hence, studies of the effects of alcohol on cellular stress pathways are critical to understand the mechanisms of alcohol-induced injuries or protection to develop new strategies for prevention, diagnosis and treatment. The purpose of this FOA is to: (1) acquire insight into how acute or chronic alcohol consumption affects cellular stress pathways and in turn, how these changes contribute to alcohol-induced injury/protection; (2) investigate how alcohol induced stress responses mediate cell survival and death signaling pathways at macromolecular, organelle, cellular and organism level contributing to alcohol-induced tissue injury/protection; (3) develop potential stress related biomarkers for prognosis, diagnosis of tissue injury/protection, furthermore identify new targets for their therapeutic interventions. Utilizing innovative experimental design and emerging technologies, such as deep sequencing, genomics, proteomics, metabolomics, bioinformatics, and novel imaging techniques these investigations are expected to provide a more comprehensive understanding of how alcohol affects the evolutionally conserved stress pathways and elucidate their roles in tissue injuries and repair. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16033 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Secondary Analysis of Existing Alcohol Epidemiology Data (R01) Contact: Wenxing Zha, Ph.D. Tel: 301-443-0633 Email: zhaw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-308.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct secondary analysis of existing data sets. NIAAA seeks to enhance the understanding of the patterns of alcohol consumption and the epidemiology of alcohol-related problems. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16240 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R01) Contact: Qi-Ying Liu, M.D. Tel: 301-443-2678 Email: liuqiy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-249.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the roles and underlying mechanisms of endocannabinoid signaling in alcohol preference, consumption, intoxication and alcohol use disorders, and to explore endocannabinoid signaling system as potential targets for alcohol pharmacotherapy. With increasing knowledge of the function of eCBs in the developing and adult brain and recent behavioral and pharmacological evidence linking alcohol and eCB signaling system, there is now great potential to explore the role of eCB signaling system in alcohol-related behaviors and alcohol use disorders. Studies supported with this FOA will help to gain knowledge about the role and underlying mechanisms of eCB signaling in alcohol preference and consumption; the interactions of acute and chronic alcohol exposure with eCBs at synapses; the effects of such interactions on short- and long-term synaptic plasticity; the role of eCB signaling in the development and maturation of the central nervous system; and the eCB signaling system in fetal alcohol spectrum disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16842 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Treatment of Co-Occurring Alcohol Use Disorders and Depression/Anxiety Disorders (R01) Contact: Deidra Roach, M.D. Tel: 301-443-5820 Email: droach@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-251.html Deadline Note: The sponsor encourages optional letters of intent no more than thirty days before the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on September 8, 2010. SYNOPSIS: The sponsor invites applications to support research on the treatment of individuals with co-occurring alcohol use disorders and depression/anxiety. Anxiety disorders include generalized anxiety disorder, social phobia, and posttraumatic stress disorder. The scope of interest includes innovative pharmacological and behavioral treatments based on biological, psychological, behavioral, and social/cultural models of etiology and treatment of comorbid alcohol use disorders and depression/anxiety. In addition, this FOA accepts Comparative and Effectiveness Research applications which compare two or more different existing treatments in this comorbid population. This FOA is limited to depression and anxiety because of the high prevalence of these psychiatric disorders in individuals with alcohol use disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 16989 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R01) Contact: Ivana Grakalic, Ph.D. Tel: 301-443-7600 Email: igrakalic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-255.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 20844 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Neuroimmune Mechanisms Of Alcohol Related Disorders (R01) Contact: Changhai Cui, PhD Tel: 301-443-1678 Email: changhai.cui@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-064.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25814 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01) Contact: M. Katherine Jung, PhD Tel: 301-443-8744 Email: jungma@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-025.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from researchers with broad ranges of expertise to study the consequences of alcohol consumption on immune function with the ultimate goal of alleviating infection and reversing alcohol-induced organ damage. Susceptibility to infection and organ damage are the two most common causes of alcohol-related morbidity and mortality. These consequences of alcohol abuse are closely associated with profound impairment of the host innate and adaptive immune systems. The mechanisms of these immune alterations and their link with alcohol-related medical problems are, in most cases, poorly understood. The goal of this FOA is to attract applications on basic and translational research: 1) to identify how alcohol alters immune function; 2) to establish functional links between immune alterations and alcohol related infections and organ damage; and 3) to develop means for mitigating immune impairment with the goal of alleviating alcohol-induced pathology. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25819 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Effects of Adolescent Binge Drinking on Brain Development (R01) Contact: Dr. Lawrence Baizer Tel: 301-443-9334 Email: baizerl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-027.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28360 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R01) Contact: Dr. Lindsey Grandison Tel: 301-443-0606 Email: lindsey.grandison@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-177.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. This program will expire on June 6, 2015. SYNOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies in humans and animal models on the relationships between alcohol abuse, circadian rhythms and sleep disorders. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 94749 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Program for Extramural/Intramural Alcohol Research Collaborations (U01) Contact: Peter Silverman, Ph.D., J.D., Deputy Director Tel: 301-402-6966 Email: psilverm@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-11-189.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2011. The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor provides support to encourage collaboration between alcohol researchers in the extramural community and those within the NIAAA intramural research program. The objective of this Funding Opportunity Announcement is to bring together the research expertise that, as a functioning collaborative unit, will address key alcohol-based research questions that would not otherwise be possible by the same individuals working towards similar goals in isolation. The goal of the research proposed by the collaborating investigators should address questions that advance the alcohol research field with respect to issues surrounding alcohol use disorders including dependence, and the effects of alcohol on health. This program will use the NIH U01 cooperative agreement award mechanism. --------------------------------------------------------------- Program Number: 74352 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: The Central Processing of Taste Information (R01) Contact: Barry J. Davis, Ph.D., Director Tel: 301-402-3464 Email: davisb1@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-201.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations studying the role of the central nervous system in the processing of taste information and the perception of taste quality. The purpose of this FOA is to foster basic and clinical research on the central mechanisms underlying the perception of taste quality. A broad range of experimental approaches is encouraged. The NIDCD encourages applications from investigators who are conducting research outside the field of gustation and who are using methodological approaches that have not been typically applied to but which would greatly promote scientific progress within the field. The NIDCD also encourages applications from new investigators in the early stages of establishing an independent research program. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 88582 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: Proteomics in Auditory Developmental and Disease Processes (R01) Contact: Nancy L. Freeman, Ph.D., Scientific Program Director Tel: 301-402-3458 Email: FreemanN@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-228.html Deadline Note: This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications that focus on “Proteomics in Auditory Developmental and Disease Processes”. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 02097 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-018.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to support the innovative analysis of existing social science and behavioral data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, and other drug), HIV risk behaviors, related disorders, prevention and treatment of these behaviors, and health service utilization including quality, access, and costs. NIDA and NCI encourage coordinated analyses of substance abuse research data that are in public use or that are privately held by a principal investigator. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its effort to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this announcement. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 07860 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01) Contact: Shoshana Y. Kahana, Ph.D. Tel: 301-443-2261 Email: kahanas@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-117.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) invites applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 10625 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Neuroscience Research on Drug Abuse (R01) Contact: Nancy S. Pilotte, Ph.D., Chief Tel: 301-435-1317 Email: npilotte@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-268.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 32276 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Epidemiology of Drug Abuse (R01) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-230.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor offers support for research projects to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 39381 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Contact: Da-Yu Wu, PhD, Program Director Tel: 301-443-1887 Email: wudy@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-027.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to study the development of the frontal and prefrontal cortices, together with the subcortical areas of the limbic system, that play significant roles in mediating emotional and motivated behavior. This initiative is designed to support the basic neuroscience research into the fundamental mechanisms of development of the frontal and prefrontal cortices, as well as the midbrain and basal forebrain structures that mediate a number of functions related to drug abuse and psychiatric disorders including: the euphoric properties of drugs, actions of psychotherapeutic agents, and memory, cognitive and emotional functions. An additional major goal of this initiative is to understand how exposure to drugs of abuse affects the cellular and molecular mechanisms underlying nervous system development of circuits implicated in drug reward and addiction. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 72593 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R01) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-012.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites applications for Stage II or Stage III research to conduct clinical trials, examine mechanisms of behavior change, determine dose-response, optimize combinations, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 75292 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-047.html Deadline Note: Applicants may be submitted through Grants.gov on or after January 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 75875 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) Contact: Joni L. Rutter, Ph.D. Tel: 301-443-1887 Email: jrutter@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-026.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for research projects that identify and/or validate chromosomal loci and variations in genes that are associated with vulnerability to addiction and that inform the likelihood of responsiveness to treatment. Applications that propose to examine intermediate phenotypes or endophenotypes to assess the molecular genetics of drug addiction, addiction vulnerability and/or their associated co-morbidities and how they are related to drug addiction are especially encouraged. Also encouraged are genetic as well as computational and large-scale genomic approaches, which may include but are not limited to linkage, linkage disequilibrium, case-control or family-based studies, and integration of data from other databases that may supplement substance abuse genetics and genomics data. Data may be collected from the general population, special populations, recent admixed populations, and/or animal models. Investigators are encouraged to include, as a component of their project and as appropriate, gene x gene interactions, gene x environment interactions, gene x environment x development interactions, pharmacogenetics, and non-human models. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 91125 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction Functional (R01) Contact: John Satterlee, Ph.D. Tel: 301-435-1020 Email: satterleej@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-033.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 93878 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Gene-Environment Interplay in Substance Use Disorders (R01) Contact: Naimah Weinberg, M.D. Tel: 301-402-1908 Email: nw46w@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-235.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 18247 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Library of Medicine/NIH/DHHS Title: NLM Express Research Grants in Biomedical Informatics (R01) Contact: Dr. Hua-Chuan Sim Tel: 301-594-4882 Email: simh@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-208.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor provides support for research grants that advance the science of biomedical informatics. Informatics is concerned with the optimal organization, management, dissemination and use of information. Biomedical informatics can be defined as the intersection of computer and information sciences with an application domain such as health care, public health, basic biomedical research, or clinical translational research. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28140 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: National Library of Medicine/NIH/DHHS Title: NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp) Contact: Valerie Florance, Ph.D. Tel: 301-496-4621 Email: florancev@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-158.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 5, 2012. The sponsor will not accept letters of intent under this FOA. The deadline for receipt of full applications is June 5, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Library of Medicine (NLM) and other participating Institutes of NIH invite applications for Administrative Supplements available to eligible NIH awardees with active R01 grants and, in some cases, with active P01, P30, P50 and U01 grants. These administrative supplements provide funds to supported research and center grants in order to enhance the storage, organization, management and use of electronic research data through the involvement of informationists, also known as in-context information specialists. The purposes of this administrative supplement program are (1) to enhance collaborative, multi-disciplinary basic and clinical research by integrating an information specialist into the research team in order to improve the capture, storage, organization, management, integration, presentation and dissemination of biomedical research data and (2) to assess and document the value and impact of the informationist’s participation. --------------------------------------------------------------- Program Number: 24151 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: PAR-11-314--Systems Science and Health in the Behavioral and Social Sciences (R01) Contact: Patricia L. Mabry, PhD Tel: 301-402-1753 Email: mabryp@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-314.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2011. Letters of intent may be submitted thirty days prior to application receipt dates. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28762 --------------------------------------------------------------- ***Deadlines: 6/5/2012 Sponsor: U.S. Geological Survey/Department of the Interior Title: Cooperative Ecosystem Studies Unit, Great Lakes Northern Forest CESU Contact: Faith Graves Tel: 703-648-7356 Email: fgraves@usgs.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=171333 The US Geological Survey is offering a funding opportunity to a CESU partner to conduct genetics research on lake sturgeon in the St. Clair Detroit River System (SCDRS), Great Lakes. --------------------------------------------------------------- Program Number: 06810 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: Prostate Cancer Research Program--Exploration - Hypothesis Development Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/prgdefault.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157753&mode=VIEW Deadline Note: Pre-application Submission Deadline is 5:00 p.m. Eastern time (ET), June 6, 2012. Invited Application Submission Deadline is 11:59 p.m. ET, June 20, 2011 SYNOPSIS: The Exploration - Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based or initial proof-of-principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described. The PCRP seeks applications from the wide spectrum of basic, population-based, translational, and clinical research. In addition, applicants are required to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. --------------------------------------------------------------- Program Number: 27854 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: DoD Prostate Cancer Collaborative Undergraduate HBCU Student Summer Training Program Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157613&mode=VIEW Deadline Note: Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited submissions are due 11:59 p.m. ET, June 20, 2012. SYNOPSIS: The PCRP Collaborative Undergraduate HBCU1 Student Summer Training Program Award (STPA) supports the training of the next generation of prostate cancer researchers. This award funds new or existing summer training programs in prostate cancer research for undergraduate students from Historically Black Colleges and Universities (HBCU) at host institutions with ongoing prostate cancer research. Training programs are highly encouraged to include, among the projects proposed, exposure to and/or experiences in prostate cancer health disparity research. This award also requires the Program Director [designated as the Principal Investigator (PI)], who should be an established prostate cancer researcher at the host institution, to collaborate with faculty advisors from the undergraduate trainees’ HBCU. Applicants must enroll a minimum of four undergraduate HBCU trainees per year, who may be recruited from multiple HBCU. --------------------------------------------------------------- Program Number: 27855 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: DoD Prostate Cancer Postdoctoral Training Award Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/default.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157674&mode=VIEW Deadline Note: Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited Application Submission Deadline is 11:59 p.m. ET, June 20, 2012. SYNOPSIS: The Postdoctoral Training Award supports prostate cancer research training opportunities for recent doctoral graduates. These awards primarily provide salary support for the Principal Investigator (PI); the postdoctoral trainee is considered the PI of the application. The PI must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of prostate cancer research; however, the PI is not required to have previous prostate cancer research experience. Applications must include at least one mentor, appropriate to the proposed training and research project, who has experience in prostate cancer research and training as demonstrated by a record of funding, publications, and successful mentorship. The selected mentor(s) should demonstrate a clear commitment to the PI’s training and be well qualified to contribute significantly to the development of the PI toward independence as a prostate cancer researcher. The PI must outline an individualized, prostate cancer-focused training plan, which may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, and/or other activities that will provide the PI with experience in key areas relevant to the proposed work and foster the PI’s development as a prostate cancer researcher. An environment appropriate to the proposed training and research project must be clearly described. All applications for the Postdoctoral Training Award are to be written by the PI, with appropriate direction from the mentor(s). --------------------------------------------------------------- Program Number: 28385 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: RFP -- Spill Response Training Contact: Brian Vaughan Tel: 0711-729-2945 Email: brian.d.vaughan.mil@mail.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=2fcb4aa6fcd271466a22a885af24de40&tab=core&_cview=0Posted U -- SPILL RESPONSE TRAINING SOL W91WFU-12-T-0010 DUE 060613 POC Brin Vaughan, 0711-729-2945 POP RCO Stuttgart (PARC Europe, 409th CSB) UNIT 30401, APO AE 09107 WEB: FBO.gov Permalink https://www.fbo.gov/notices/2fcb4aa6fcd271466a22a885af24de40 E-MAIL: RCO Stuttgart (PARC Europe, 409th CSB) brian.d.vaughan.mil@mail.mil NAICS: 611519 This is a synopsis for a commercial acquisition using contracting by negotiation. (Reference FAR Parts 12 and 15). THIS IS A SYNOPSIS AS REQUIRED BY FAR PART 5.2 - THIS IS NOT A REQUEST FOR QUOTE/PROPOSAL. VENDORS SHOULD NOT SUBMIT FORMAL QUOTES/PROPOSALS UNTIL THE RFP IS POSTED TO THIS WEBSITE. This synopsis is not to be construed as a commitment by the Government nor will the Government pay for information solicited. The 409th CSB, RCO Stuttgart anticipates a requirement for the Environmental section of the Department of Public Works, Stuttgart. This is a non-personal services performance-based contract to provide spill response classroom training and hands-on exercises. Twelve class sessions per year are expected, each class session will be provided to approximately 15 students, last no longer than 4 hours, and encompass both instruction and hands-on exercises with simulated spills. The Government will provide the contractor with classroom space and student attendance. The contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform services defined in the Performance Work Statement (PWS) except for those items specified as government furnished property and services. Responsibilities encompass planning course instruction, developing spill scenarios, executing classes and executing spill scenarios with hands-on training. The Contractor shall perform the services within the USAG Stuttgart geographical area; classes will take place on Kelley Barracks, Patch Barracks, Stuttgart Army Airfield, and Panzer Kaserne, as directed by the Government. Period of performance for the basic year is contemplated 18 June 2012 through 17 June 2013. Anticipated award date is 11 June 2012. Three one-year options may be awarded. In addition, the Government may further extend the performance period for up to six months under FAR 52.217-8.Also, the Government may extend the term of this contract by written notice to the Contractor before expiration of contract period under FAR 52.217-9. This is an unrestricted full and open competitive acquisition. The government intends to make a single award to the lowest priced, technically acceptable offeror. Solicitation No: W91WFU-12-T-0010 will be issued as a Request for Proposal. It is advertised with a Standard Industrial Code (SIC) of 8249, business size of $7M and a North American Industry Classification System (NAICS) code of 611519. All responsible sources may submit a proposal, which shall be considered by the agency. Potential offerors must be currently registered in the Central Contractor Registry to be eligible for award to include German vendors. (See Internet Site: http://www.ccr.gov). Payment for this acquisition will be made through the Wide Area Workflow (WAWF) System. Contractors must be registered in WAWF to include German vendors, see internet site: https://wawf.eb.mil for registration. Information concerning this solicitation will be issued electronically and posted on or about01 May 2012 at www.fbo.gov. Proposals may be submitted via hard copy, or e-mail. NO HARD COPIES OF THE SOLICITATION WILL BE ISSUED FOR ANY REASON. Point of contact is Brian Vaughan, 409th CSB, RCO Stuttgart, Germany, brian.d.vaughan.mil@mail.mil. Phone calls will not be accepted. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=2fcb4aa6fcd271466a22a885af24de40&tab=core&_cview=0Posted 04/26/12 (W-SN02732884). (0117) --------------------------------------------------------------- Program Number: 72400 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Department of the Army Title: Prostate Cancer Research Program--Physician Research Training Award (CDMRP) Contact: Congressionally Directed Medical Research Program Tel: 301-682-5507 Email: help@cdmrp.org Website:          http://cdmrp.army.mil/funding/prgdefault.shtml Full Program:          http://www07.grants.gov/search/search.do;jsessionid=wRwyPs2W6s1xLQtC111rXN2bCpnGyF1YYDNcnY6wzCC3qgyjt0jG!1869518295?oppId=157653&mode=VIEW Deadline Note: Pre-application Submission Deadline: 5:00 p.m. Eastern time (ET), June 6, 2012. Invited submissions are due 11:59 p.m. ET, June 20, 2012. SYNOPSIS: The PCRP Physician Research Training Award (PRTA) supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. This award emphasizes equally the quality of both the research and the training proposed. The trainee is considered the Principal Investigator (PI) of the application. All applications for the PRTA are to be written by the PI, with appropriate direction from the mentor(s). The PI must demonstrate a commitment to a career as an investigator at the forefront of prostate cancer research and clinical practice; however, the PI is not required to have previous prostate cancer research experience. Applications must include a robust description of an individualized, prostate cancer-focused training plan that will provide the PI with experience in key areas relevant to the proposed work and foster the PI’s development as a prostate cancer researcher. This award requires the involvement of at least one designated mentor with an established research program in prostate cancer, evidenced by publications, funding, and successful mentorship. The PI and mentor(s) should work together to design robust training and mentoring plans, which may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, and/or other activities appropriate to the area of study. Training plans inclusive of basic and population-based research, in addition to or in lieu of translational or clinical research, are highly encouraged. In --------------------------------------------------------------- Program Number: 27616 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: Directorate for Social, Behavioral and Economic Sciences/NSF Title: Research on the Science and Technology Enterprise: Statistics and Surveys Contact: Nirmala Kannankutty Tel: 703-292-7797 Email: nkannank@nsf.gov Website:          http://www.grants.gov/search/search.do;jsessionid=wYMLPfDdVxsgtglDJ0hXTsQ0NVGvVQXP9XqdGXvJJp9zRXQLX17K!-889918338?oppId=151953&mode=VIEW Full Program:          http://www.nsf.gov/pubs/2012/nsf12545/nsf12545.htm SYNOPSIS: The National Center for Science and Engineering Statistics (NCSES) of the National Science Foundation (NSF) is one of the thirteen principal federal statistical agencies within the United States. It is responsible for the collection, acquisition, analysis, reporting and dissemination of objective, statistical data related to the science and engineering enterprise in the United States and other nations that is relevant and useful to practitioners, researchers, policymakers and the public. NCSES uses this information to prepare a number of statistical data reports as well as analytical reports including the National Science Board's biennial report, Science and Engineering (S&E) Indicators, and Women, Minorities and Persons with Disabilities in Science and Engineering. The Center would like to enhance its efforts to support analytic and methodological research in support of its surveys, and to engage in the education and training of researchers in the use of large-scale nationally representative datasets. NCSES welcomes efforts by the research community to use NCSES data for research on the science and technology enterprise, to develop improved survey methodologies for NCSES surveys, to create and improve indicators of S&T activities and resources, and strengthen methodologies to analyze and disseminate S&T statistical data. To that end, NCSES invites proposals for individual or multi-investigator research projects, doctoral dissertation improvement awards, workshops, experimental research, survey research and data collection and dissemination projects under its program for Research on the Science and Technology Enterprise: Statistics and Surveys. --------------------------------------------------------------- Program Number: 21667 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: National Aeronautics & Space Administration Title: NASA Innovative Advanced Concepts (NIAC) Contact: Tel: Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={B3180A7B-F67C-A701-17F8-343FABB54615}&path=open Full Program:          http://nspires.nasaprs.com/external/viewrepositorydocument/cmdocumentid=319823/solicitationId=%7BB3180A7B-F67C-A701-17F8-343FABB54615%7D/viewSolicitationDocument=1/NIAC_FY12_Ph%20II_NRA_2012-04-24_final.pdf SYNOPSIS: NIAC supports innovative research through two phases of study. Phase I awards are one-year efforts to explore the overall feasibility and viability of visionary concepts. This Phase II proposal call is being released to eligible recipients of Phase I awards, past and present, to further develop the most promising Phase I concepts for up to two years and to explore potential infusion options within NASA and beyond. All current Phase I Fellows, or their designees, of the NASA Innovative Advanced Concepts Program are eligible to submit Phase II proposals based on their Phase I study. --------------------------------------------------------------- Program Number: 19016 --------------------------------------------------------------- ***Deadlines: 6/6/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1) Contact: Deborah Winn, Ph.D. Tel: 301-594-9499 Email: winnde@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-167.html Deadline Note: The deadlines for receipt of optional letters of intent are:June 6, 2012, October 8, 2012, February 8, 2013, June 10, 2013, October 8, 2013. The deadlines for receipt of full applications are: July 6, 2012, November 8, 2012, March 8, 2013, July 10, 2013, November 8, 2013. This FOA will expire on November 9, 2013. SYNOPSIS: The sponsor invites applications to provide targeted infrastructure support for the core functions of Cancer Epidemiology Cohorts (CECs) and methodological research. This infrastructure can support existing or new CECs. This FOA will support core functions for CECs currently funded through other grant mechanisms by the Epidemiology and Genetics Program (EGRP) and other components of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI). This FOA will utilize the UM1 Multi-Component Research Project Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28410 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: Department of the Navy Title: RFP -- Broad Agency Announcement (BAA) to Establish Long Term Partnership With NAWCAD to Enhance Science Technology and Engineering and Math (STEM) Education and Collaborate on Advanced Research in Contact: Anthony M Langer Tel: 301-737-2577 Email: anthony.langer@navy.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=5320b9e7462cf39cc8f6e5093344f5d3&tab=core&_cview=0 A -- BROAD AGENCY ANNOUNCEMENT (BAA) TO ESTABLISH LONG TERM PARTNERSHIP WITH NAWCAD TO ENHANCE SCIENCE TECHNOLOGY AND ENGINEERING AND MATH (STEM) EDUCATION AND COLLABORATE ON ADVANCED RESEARCH IN SUPPORT OF NAVAL AVIATION SOL N0421-12-R-0035 POC Anthony M Langer, Phone: 3017372577, Dora L Hill, Phone: (301) 737-2495 POP NAWCAD and the participating institution's location., United States WEB: FBO.gov Permalink https://www.fbo.gov/spg/DON/NAVAIR/N00421/N00421-12-R-0035/listing.html E-MAIL: anthony.langer@navy.mil, dora.hill@navy.mil anthony.langer@navy.mil, dora.hill@navy.mil NAICS: 541712 THE INTENT OF THIS BROAD AGENCYANNOUNCEMENT (BAA) IS TO ESTABLISH GOVERNMENT-UNIVERSITY AQUISITION VEHICLES INCLUDING, BUT NOT LIMITED TO, TRADITIONAL FAR/DFARS TYPE CONTRACTS AND/OR NON-PROCUREMENT AGREEMENTS (eg. COOPERATIVE AGREEMENTS AND OTHER TRANSACTIONS) IN SUPPORT OF BASIC AND APPLIED RESEARCH AND EDUCATIONAL PROGRAMS FOR THE NAVAL AIR SYSTEMS COMMAND. 1. INTRODUCTION The Naval Air Warfare Center Aircraft Division is soliciting proposals from Universities to develop a long term partnership with NAWCAD to enhance Science Technology and Engineering and Math (STEM) education and collaborate on advanced research in support of Naval Aviation. 2. BACKGROUND The purpose of this broad agency announcement is to establish a collaborative relationship between NAWCAD and an academic institution to improve the scope of advanced research and educational program development which relate to Naval Aviation. Under this effort the participants will work on a broad range of research and educational projects pursued at NAWCAD, the participating academic institution or both depending on the availability of qualified personnel and facilities at each location. NAWCAD and the participating institution will provide appropriate access to their facilities in support of these educational and research projects. These efforts will be conducted primarily at the agreement holder's site, but NAVAIR facilities may also be available and/or used depending on project needs By combining the personnel and facilities of NAWCAD and the academic institution, both parties will improve the overall ability to conduct research needed to solve current and future technological challenges pertinent to naval aviation weapons systems. New educational opportunities shall be developed between NAWCAD and the academic institution which will focus on meeting the future technology needs for Naval Aviation. Types of collaborative efforts will include the development of undergraduate and graduate educational opportunities. These opportunities could involve the development of curriculum, assisting in participating as course instructors and the establishment of a cooperative educational program. Because of the nature of this type of collaboration, it is anticipated that the work will require personnel from the academic institution and NAWCAD to be able to meet frequently and on relatively short notice in each other's place of business. 3. SPECIFIC AREAS OF INTEREST The Navy is interested in, but not limited to, researching the following areas: • Human Systems - Development of thermoelectric devices for manufacture - CFD development of vector curves for parachute opening (kinematics modeling) • Propulsion & Power - 3-D CFD flow analysis - Rotor spin pit analysis, modeling of thermal gradients - Aircraft generator systems diagnostics & health management - Analysis of high density power generation, distribution, and energy storage - Propulsion of Rotorcraft Systems - Propulsion prognosis and life management - Probabilistic risk assessment of engines • Air Vehicles and Unmanned Systems - Air Vehicle prognosis - Airframe reliability and risk assessment methodology - Probability-based life prediction of dynamic components - Analysis and design of composite structures - Outwash modeling - Full scale 3-D velocimetry - Improved hover performance prediction • Avionics - Software integrity assurance 4. CONTRACT/AGREEMENT TYPE NAVAIR is willing to consider various types of acquisition vehicles including, but not limited to, traditional FAR/DFARS type contracts and/or non-procurement agreements (e.g. Cooperative Agreements and Other Transactions). Other Transactions will be entered into under the authority of 10 U.S.C. 2371 (Congressional direction requires that at least 50 percent (50%) of the cost of a project under this initiative be provided by industry) and Section 845, Authority to Carry Out Certain Prototype Projects. Information concerning Other Transactions can be found at http://www.darpa.mil/cmo/pages/other_trans.html and http://www.acq.osd.mil/ddre/research. Final decision(s) on acquisition type (contract/agreement) will be made by the government. NOTE: Typically, research findings result in the need for additional services/supplies, which are not possible to anticipate or project. Contract modifications may be executed to satisfy these requirements; thereby providing for flexibility in technology assessment (with technology transition the ultimate goal). In the event that this is required, it shall be considered to be within the scope of this BAA and the resulting contract, and therefore will have met the requirements of the FAR/DFARS and the Competition in Contracting Act. 5. PROPOSAL SUBMISSION The submission is a two-phased approach as described below. PHASE II IS BY INVITATION ONLY. No further Request for Information (RFI), solicitation, or other announcement will be made. Proposals may be submitted at any time up to the closing date of the BAA. Offerors may submit proposals within one or more of the areas of interest listed in previous paragraphs. 5.1 PHASE I - PROPOSAL ABSTRACTS Submit Proposal Abstract, not to exceed fifteen pages, any time during the above stated open period. All proprietary portions of the abstract shall be clearly identified and will be treated in the strictest confidence. Offerors are hereby notified that non-government participants may have access to the offeror's proposals, and that submission of an offer shall constitute consent to the disclosure of proprietary information to all non-government participants in the source selection. The non-government participants are employees of commercial firms under contract to the Government, and if they serve as technical advisors they will be authorized access to only those portions of the proposal data and discussions that are necessary to enable them to provide specific technical advice on specialized matters or on particular problems. Abstracts shall identify the following: 1. BAA Number; N00421-12-R-0035; 2. Organization Name; 3. Other Team Members and type of business for each; 4. Technical Points of contact (including phone, fax, and e-mail information); 5. Administrative Point of Contact; 6. Overview of the Proposed Work to include: A summary of proposed concept (including commercial applications), an estimated timeframe for project completion, a brief description of the technical approach and facilities involved, and a brief resume of the principle investigator(s); and, 7. A rough order of cost magnitude with type of acquisition vehicle (contract/agreement) being proposed, and, if applicable, the anticipated sharing arrangement. 8. Mail all submissions to: NAVAL AIR WARFARE CENTER AIRCRAFT DIVISION (NAWCAD) (Code 2.5.1.4.), 22299 Exploration Dr. Suite 301 Lexington Park, MD 20653 Or email submissions to anthony.langer@navy.mil and dora.hill@navy.mil 5.1.1 Proposal abstract (Phase I) submitted in response to this announcement will be reviewed by the Director of Education and Research Partnerships (DERP). Only offerors whose Phase I proposal abstracts that are of interest to the Government and considered capable of meeting Program requirements will be requested to submit a Phase II full proposal. 5.1.2 Important Information for Prospective Contractors Registration in the DoD's Central Contractor Registration(CCR) database will be a prerequisite for receiving an award resulting from this BAA. For more information please contact the CCR Assistance Center at 1-888-227-2423. 5.2 PHASE II - FULL PROPOSAL 5.2.1 General Information Request for submission of a full proposal does not guarantee award selection. Offerors will not be reimbursed for bid and proposal costs. Proposals shall be submitted in original, with the signature of an authorizing official, with five (5) copies to the address noted above. Proposal submission is not restricted in any way to any particular entity. Historically Black Colleges and Universities, Minority Institutions, Tribal Colleges and Universities are encouraged to participate. The NAICS Code for this BAA is 541712. Submit Full Proposals in two (2) volumes; (1) VOLUME I - TECHNICAL PROPOSAL, not to exceed thirty (30) pages, should include the following three sections: 1) Section 1 - Executive Summary: Provide a brief technical and business description of the contents of the proposal. The technical area should address the proposal's technical goals, approach, and expected results. The business area should address business and/or commercial applications of the proposal technology. 2) Section 2 - Technical Issues: Detail the technical approach, objectives, staffing and resources relating to the development of the proposed technology for military and commercial (if applicable) use; discuss specifically in realistic terms the technical objectives of this proposed effort; provide a Statement of Work (SOW) that discusses the specific tasks to be accomplished, tied to the specific approach and goals of the project; provide resumes for Principle Investigator(s) and other key research personnel; describe the current and planned facilities and equipment to accomplish the research objectives; and, give a description of past performance on similar efforts. 3) Section 3 - Business Issues: Discuss the business issues relating to the commercial applications of the proposed development and its impact on the market; detail benefits to the Department of Defense (DoD). (2) VOLUME II - COST/FUNDING PROPOSAL. Cost/funding proposals are not restricted in length, have no specific page layout requirements, and should address funding periods of performance. Formal work breakdown structures (WBS) and certified cost or pricing data are neither required nor desired, however, NAVAIR reserves the right to request this information for proposals using FAR/DFARS type contracts. Organize Cost/Funding proposals to include four (4) sections in the following order: 1) Section 1 - Total Project Cost: This section will give a detailed breakdown of costs of the project. Cost should also be broken for each task appearing in the Statement of Work (SOW) and should include all of the proposed costs to the Government and cost shared by the offeror. Present the following information for each phase of the effort: total cost ofthe particular project phase; total offeror cost share (mandatory for certain "other transaction agreements" see above); funding requested from the Government; and elements of cost (labor, direct materials, travel, other direct costs, equipment, software, patents, royalties, indirect costs, and cost of money). Sufficient information should be provided in supporting documents to allow the Government to evaluate the reasonableness of these proposed costs, including salaries, overhead, equipment purchases, fair market rental value of leased items, and the method used for making such valuations. Profit should not be included as a cost element if the contract type to be awarded will be cost sharing. 2) Section 2 - Cost Sharing and In-Kind Contributions: This section will include: (i) the sources of cash and amounts to be used for matching requirements; (ii) the specific in-kind contributions proposed, their value in monetary terms, and the methods by which their values were derived; and (iii) evidence of the existence of adequate cash or commitments to provide sufficient cash in the future. Affirmative, signed statements are required from outside sources of cash. Provide sufficient information regarding the sources of the offerors' cost share so that a determination may be made by the Government regarding the availability, timeliness, and control of these resources. For example: How will the funds and resources be applied to advance the progress of the proposed effort? What is the role of any proposed in-kind contributions? 3) Section 3 - Cost to the Government: This section will specify the total costs proposed to be borne by the Government and any technical or other assistance including equipment, facilities, and personnel of Federal laboratories, if any, required to support these activities. The cost to the Government should be that portion of the proposed effort which is not covered by the contractor's portion of the cost share. The costs incurred and work performed by any DoD or national laboratory "partnering" with the offeror under the proposal shall normally be considered costs of the Government and not costs of the offeror for purposes of the cost-sharing requirement. Present sufficient information regarding the resources to be provided by the Government so that an evaluation of their availability, timeliness, and control may be made. 4) Section 4 - Off-Budget Supporting Resources: This section will show cash or in-kind resources which will support the proposed activity but which are not intended to be included in the total project cost. Items in this category do not count as cost share or as Federal funds, which must be matched. Examples of items to place in this category include: Commitments of cash or in-kind resources from other Federal sources, such as national laboratories, and projections of fee-based income where there is substantial uncertainty about the level which will actually be collected and where the income is not needed to meet cost-share requirements. NOTE: Proposals will not be accepted after the due date stated on Page One (1). 6. EVALUATION CRITERIA The government will evaluate proposals responsive to any or all of the areas of interest discussed herein. Proposals will not be evaluated against each other since each is a unique technology with no common work statement. 6.1 EVALUATION CRITERIA The primary evaluation criteria are: (A) Scientific and technical merits of the proposed research to include, (1) the degree to which proposed research and development objectives support the targeted technical topic and (2) validity of the technical basis for the approach offered. (B) The offeror's capabilities, related experience, past performance on similar efforts, research investigators/personnel, facilities, techniques or unique combination of these which are integral factors for achieving the proposal objectives. (C) The realism and reasonableness of cost, including proposed cost sharing. (D) The proximity of the institution to NAWCAD necessary to allow use and access to the facilities at both the NAWC and the institution while minimizing cost in time and travel. 7.AWARDS NAVAIR is planning to make awards within the overall Program Objectives stated in Section 2 and 3. All awards will be based on merit competition. The Government reserves the right to select all, some, or none of the proposals received in response to this announcement. Any awards are subject to the availability of appropriations. There is no commitment by the Navy to be responsible for any monies expended by the offeror before award of a contract/agreement. For awards made as contracts, the socio-economic merits of each proposal will be evaluated based on the commitment to provide meaningful subcontracting opportunities with small business, small disadvantaged business, woman-owned small business concerns, and HBCU/MIs. If a full cost proposal is requested by the contracting officer, and the total exceeds $550,000, any large business is required to include a Small, Small Disadvantaged and Women-Owned Subcontracting Plan with its proposal package in accordance with FAR 52.219-9. Contracting Office Address: NAWCAD Pax Annex I Exploration Building IV 22299 Exploration Drive, Suite 301 Lexington Park, Maryland 20653 United States Primary Point of Contact: Anthony Langer, Contract Specialist Anthony.langer@navy.mil Phone: (301) 737-2577 Secondary Point of Contact: Dora Hill, Contracting Officer dora.hill@navy.mil Phone: (301) 737-2495 CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=5320b9e7462cf39cc8f6e5093344f5d3&tab=core&_cview=0 Posted 05/07/12 (W-SN02741421). (0128) --------------------------------------------------------------- Program Number: 08117 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Archives and Records Administration Title: Electronic Records Projects Contact: Nancy Melley, Director for Technology Initiatives Tel: 202-357-5452 Email: nancy.melley@nara.gov Full Program:          http://www.archives.gov/nhprc/announcement/electronic.html Deadline Note: Draft (optional) Deadline: April 2, 2012 Final Deadline: June 7, 2012 SYNOPSIS: The National Historical Publications and Records Commission seeks proposals that will increase the capacity of archivists and archival repositories to create electronic records archives that preserve records of enduring historical value. The NHPRC supports efforts by archivists and records managers to meet the challenges of electronic records. Projects to increase repository capacity must involve institutions that have already established archives and records management programs. --------------------------------------------------------------- Program Number: 88471 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: National Historical Publications & Records Commission Title: Digitizing Historical Records Contact: Nancy Melley, Director for Technology Initiatives Tel: 202-357-5452 Email: nancy.melley@nara.gov Website:          http://www.archives.gov/nhprc/announcement/digitizing.html Deadline Note: Optional draft letters are due April 2, 2011. Proposals must be received by June 7, 2012. SYNOPSIS: The National Historical Publications and Records Commission seeks proposals that use cost-effective methods to digitize nationally significant historical record collections and make the digital versions freely available online. Projects must make use of existing holdings of historical repositories and consist of entire collections or series. The materials should already be available to the public at the archives and described so that projects can re-use existing information to serve as metadata for the digitized collection. --------------------------------------------------------------- Program Number: 03947 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: Natural Resources Conservation Service/Department of Agriculture Title: Conservation Innovation Grants - New Hampshire Contact: Deborah Weymouth Tel: 603-868-9931 x 102 Email: deb.weymouth@nh.usda.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=nKWPP0mKDPJpRyLD2lJ09W0CnbCFDxQyYdtQLNgQ4k12DK5ZrdFT!109354571?oppId=170999&mode=VIEW SYNOPSIS: The New Hampshire State Office of the USDA Natural Resources Conservation Service (NRCS) requests applications for Conservation Innovation Grants (CIG) to stimulate the development and adoption of innovative conservation approaches and technologies. Applications will be accepted from any eligible entity for projects within the State of New Hampshire. Funds will be awarded through a statewide competitive grants process. Applications are requested from eligible government or non-government organizations or individuals within the State of New Hampshire for competitive consideration of grant awards for projects between one and three years in duration. NRCS anticipates the availability of up to $134,000 of funds during fiscal year 2012 for the New Hampshire CIG program competition. --------------------------------------------------------------- Program Number: 86920 --------------------------------------------------------------- ***Deadlines: 6/7/2012 Sponsor: Natural Resources Conservation Service/Department of Agriculture Title: Conservation Innovation Grants--Pacific Islands Area Contact: Colleen Simpson, Acting CIG Program Specialist Tel: 808-541-2600x132 Email: Colleen.Simpson@pb.usda.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=tjjPP2GHTJ8S1y14fMRmd70LSkG4fQRj3hY29WVQppF2JdgnvSqR!1694693328?oppId=171453&mode=VIEW SYNOPSIS: The sponsor requests applications for Conservation Innovation Grants (CIG) to stimulate the development and adoption of innovative conservation approaches and technologies. Applications are accepted from the Pacific Islands Area (Hawaii, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands). For fiscal year 2012, up to $263,000 is available for the Pacific Islands Area statewide CIG competition. Applications are requested from eligible governmental or non-governmental organizations or individuals for competitive consideration of grant awards for projects between 1 and 3 years in duration. --------------------------------------------------------------- Program Number: 03500 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Environmental Protection Agency Title: Region 2 Wetland Program Development Grants Contact: Kathleen Drake, Grant Coordinator Tel: 212-637-3817 Email: Drake.kathleen@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=QQPvPh7KpPptBhLvk32G2hs5hhRbmY1TyFMrTTlDPcVwnGKlnLR5!267572332?oppId=167173&mode=VIEW Full Program:          http://www.epa.gov/region2/water/wetlands/R2_FY12_WPDG_RFP.pdf SYNOPSIS: Wetland Program Development Grants (WPDGs) provide eligible applicants an opportunity to conduct and promote the coordination and acceleration of research, investigations, experiments, training, demonstrations, surveys, and studies relating to the causes, effects, extent, prevention, reduction, and elimination of water pollution. The goals of EPA’s wetland program include increasing the quantity and quality of wetlands in the U.S. by conserving and restoring wetland acreage and improving wetland condition. In pursuing these goals, EPA seeks to build the capacity of all levels of government to develop and refine effective, comprehensive programs for wetland protection and management. WPDGs provide States, Tribes, local governments, interstate agencies, and intertribal consortia an opportunity to carry out projects to develop and refine comprehensive wetland programs. --------------------------------------------------------------- Program Number: 28622 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Environmental Protection Agency Title: Special Studies - S. Florida Geographic Initiative, Water Quality Protection Pgm for the FL Keys National Marine Sanctuary, & the Southeast FL Coral Reef Initiative/Land-Based Sources of Pollution Contact: Ms. Morgan Jackson Tel: 404-562-9393 Email: jackson.morgan@epa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=QnglPrQJCLfFzGZW674ffNyJDKL6dZFG7pWvYtphg0GNf11sTJGl!884034953?oppId=169200&mode=VIEW Full Program:          http://www.epa.gov/region4/water/southflorida/documents/finalhqschanges_reg4fy12_south_florida_rfpmay2at242.pdf SYNOPSIS: The Florida Keys National Marine Sanctuary (FKNMS) was created with the signing of Public Law 101-605, the Florida Keys National Marine Sanctuary and Protection Act of 1990. Included in the Sanctuary are 2,900 square nautical miles of nearshore waters extending from Biscayne Bay to the Dry Tortugas. The 1990 Act directed the Environmental Protection Agency and the State of Florida, in consultation with the National Oceanic and Atmospheric Administration (NOAA), to develop a Water Quality Protection Program (WQPP) for the Sanctuary. The FKNMS is the first designated marine sanctuary required to have a WQPP. Beginning in 1991, the EPA and the State of Florida worked with NOAA and other federal, state, and local government agencies, university scientists, environmental groups, and the public to develop a WQPP for the Sanctuary. The “Final Water Quality Protection Program Document” was approved by the WQPP Steering Committee in September 1996 and contains the rationale and strategies to achieve the goals of the WQPP. The National Marine Sanctuaries Program Amendments Act of 1992 requires the EPA and the State of Florida to implement the WQPP in cooperation with NOAA. Special Studies assist in the identification and understanding of the processes that drive spatial and temporal changes occurring within the FKNMS ecosystem. Under this announcement, EPA seeks proposals addressing the Research Needs that have been identified as “High Priority” in the FKNMS Comprehensive Science Plan. --------------------------------------------------------------- Program Number: 02710 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Laboratory Analysis of Returned Samples Contact: Dr. Jeffrey Grossman Tel: 202-358-1218 Email: HQ-LARS@mail.nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={FB48203E-A59C-0E9A-5CA3-3F9C3430A54C}&path=open Full Program:          http://www.grants.gov/search/search.do;jsessionid=H0NXP0ZGp8xPYrY1TN91pv3yQWHr5vhbGGmCXsFcmt5QVylpg7QJ!-2099600874?oppId=159494&mode=VIEW Deadline Note: A brief letter of intent is requested, although not required, and should be submitted by April 13, 2012. Full applications will be due on June 8, 2012. SYNOPSIS: The goal of the Laboratory Analysis of Returned Samples (LARS) Program is to maximize the scientific return from the samples provided by missions such as Genesis, Stardust, and beginning with this solicitation, Hayabusa through development of laboratory instrumentation and advanced analytical techniques required for the complete analyses of the samples they return. In addition, this program supports analytical work on samples returned by recent Planetary Science Division missions, including Genesis and Stardust, as well as samples returned by Hayabusa. --------------------------------------------------------------- Program Number: 11277 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Near Earth Object Observations Contact: Lindley N. Johnson Tel: 202-358-2314 Email: HQ-NEOO@mail.nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={1DD4D019-4A71-D405-3863-1D313A2C4D1A}&path=open Full Program:          http://www.grants.gov/search/search.do?oppId=164513&mode=VIEW Deadline Note: The sponsor requests, but does not require, submission of optional letters of intent by April 13, 2012. The deadline for submission of applications is June 8, 2012. SYNOPSIS: Near Earth Objects (NEOs) are defined as asteroids or comet nuclei whose perihelia are less than 1.3 AU. NASA is committed to discovering all NEOs with diameters greater than or equal to ~1 km and to characterizing that population through determination of their orbital elements, with the goal of detecting more than 90 percent of this population as soon as possible. In support of NASA’s commitment and goal, this program supports NEO investigations whose primary objective is to complete the inventory of the population of NEOs with diameters greater than or equal to 1 km. In addition to this goal, the U.S. Congress has expressed an interest for NASA to extend the survey down to objects as small as 140 meters which might pose a hazard to impacting the Earth. Therefore, investigations that provide capability to detect the subset of NEOs in this category, Potentially Hazardous Objects (PHOs) down to 140 meters in size, will receive additional consideration. --------------------------------------------------------------- Program Number: 14833 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Aeronautics & Space Administration Title: National Space Biomedical Research Institute Postdoctoral Fellowship Contact: Amanda Smith Hackler Tel: 713-798-7412 Email: postdoc@nsbri.org Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={0F3A5A9E-7921-979A-D273-43B749592F7A}&path=open Full Program:          http://nspires.nasaprs.com/external/viewrepositorydocument/cmdocumentid=309512/solicitationId=%7B0F3A5A9E-7921-979A-D273-43B749592F7A%7D/viewSolicitationDocument=1/NSBRI-RFA-12-02%20Post%20Doc.pdf SYNOPSIS: NSBRI is a NASA-funded, nonprofit research consortium charged with developing biomedical countermeasures and technologies for potential health problems that could occur in astronauts either during long-duration spaceflight, on exploration missions or on their return to Earth. NSBRI’s current program, aligned with NASA’s exploration objectives, consists of approximately 50 science and technology projects organized into research teams. NSBRI invites ground-based research applications. Proposals can address one of the seven existing NSBRI research teams, which has importance to both NSBRI and the NASA Human Research Program (HRP). --------------------------------------------------------------- Program Number: 28134 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Center for Emerging and Zoonotic Infectious Diseases/CDC/DHHS Title: Strengthening Surveillance for Diseases Among Newly-Arrived Immigrants and Refugees Contact: Heather Burke, Project Officer Tel: 404-639-3408 Email: HBurke@cdc.gov Full Program:          http://www.grants.gov/search/search.do;jsessionid=pvnTPFTTZj62yzxnpQp4s5pxQj1CH6WQgyCKBsTVhCSWWcTkjzGy!545677704?oppId=162755&mode=VIEW Deadline Note: The deadline for receipt of optional letters of intent is May 9, 2012. The deadline for receipt of full applications is June 8, 2012. SYNOPSIS: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) invites applications to conduct surveillance to detect, prevent and control diseases and evaluate existing health programs to improve the health of refugees and/or immigrants that are newly arrived in the United States. A total of approximately $4.0 million is available. --------------------------------------------------------------- Program Number: 27301 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: RFA-NS-13-003--NIH Blueprint for Neuroscience Research Grand Challenge: Discovering Novel Drugs for Disorders of the Nervous System (U01) Contact: Jill Heemskerk, PhD Tel: 301-496-1779 Email: jill.heemskerk@nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-13-003.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 8, 2012. The deadline for receipt of optional letters of intent is May 8, 2012. The deadline for receipt of full applications is June 8, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institutes of Health (NIH) and its participating Centers and Institutes invite applications from investigators working with small molecule compounds to gain access to a robust ‘virtual pharma’ network to discover neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug discovery services that are not typically available to the academic research community. Funding will be provided through a U01 cooperative agreement mechanism to conduct biological testing of compound analogs in disease assays and models in the investigator’s laboratory. No-cost drug discovery services will also be provided, including medicinal chemistry optimization, IND-directed pharmacology and toxicology, and Phase I clinical testing. Researchers in possession of disease assays and small molecule compounds that show promise for treating nervous system and psychiatric disorders, but that are not yet suitable for clinical testing, are strongly encouraged to apply. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 26879 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: Office of Naval Research Title: Electronic Warfare Technology Contact: Dr. Peter Craig Tel: Email: peter.craig@navy.mil Full Program:          http://www07.grants.gov/search/search.do;jsessionid=XntdPmvG6vlWW93SyXcSQXF1vm69bPQ5P3N330Q0nZPw9yNyYzCg!98924490?oppId=140913&mode=VIEW Deadline Note: White Papers are due 03/16/2012. Full Proposals are due 06/08/2012 SYNOPSIS: The goal of Electronic Warfare (EW) is to control the Electro-Magnetic Spectrum (EMS) by exploiting, deceiving, or denying enemy use of the spectrum while ensuring its use by friendly forces. To that end, the Office of Naval Research’s (ONR's) EW Discovery and Invention (D&I) program invests in Science and Technology (S&T) initiatives that will provide naval forces (including Navy and Marine Corps) with improved threat warning systems; Electronic warfare Support (ES); decoys and countermeasures against weapon tracking, and guidance systems; Electronic Attack (EA) against adversary Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR); and Electronic Protection (EP) of our own weapons and C4ISR from intentional and unintentional interference. --------------------------------------------------------------- Program Number: 28353 --------------------------------------------------------------- ***Deadlines: 6/8/2012 Sponsor: U.S. Army Corps of Engineers/Department of Defense Title: RFP -- AMENDMENT--Military Terrain and Hydrologic Analyses, Databases and Environmental Studies of Selected Areas III Contact: Lauren Levy, Tel: 703-428-3603 Email: lauren.levy@usace.army.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=2ed6443fdc6badb20ee878539e45e8df&tab=core&_cview=0 SYNOPSIS: A -- MILITARY TERRAIN AND HYDROLOGIC ANALYSES, DATABASES AND ENVIRONMENTAL STUDIES OF SELECTED AREAS III SOL W5J9CQ12R0006 DUE 060812 POC Lauren Lev, 703-428-3603 POP USACE Geospatial Center CONTRACTING DIVISION, 7701 TELEGRAPH RD BLDG 2592 ALEXANDRIA VA 22315-3864 WEB: FBO.gov Permalink https://www.fbo.gov/notices/2ed6443fdc6badb20ee878539e45e8df E-MAIL: USACE Geospatial Center lauren.levy@usace.army.mil NAICS: 541370 The US Army Corps of Engineers - Army Geospatial Center (AGC) is issuing a pre-solicitation notice for Military Terrain andHydrologic Analyses, Databases and Environmental Studies of Selected Areas III under Full and Open Competition. This procurement is a Multiple Award Task OrderContract (MATOC) estimated at $247M. The Request for Proposal (RFP) release date for Military Terrain III under Full and Open Competition will be no later than10 May 2012. The RFP will be available on the http://fedbizopps.gov/ website for download. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=2ed6443fdc6badb20ee878539e45e8df&tab=core&_cview=0 Posted 04/25/12 (W-SN02730853). (0116) --------------------------------------------------------------- Program Number: 28075 --------------------------------------------------------------- ***Deadlines: 6/9/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-13-020--Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25) Contact: Drew Carlson, Ph.D. Tel: 301-435-0535 Email: carlsonde@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-13-020.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 9, 2012. The deadlines for receipt of optional letters of intent are: June 9, 2012; January 7, 2013; January 7, 2014. The deadlines for receipt of full applications are: July 9, 2012; February 7, 2013; February 7, 2014, by 5:00 PM local time of applicant organization. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications to promote diversity in undergraduate and health professional participant populations by providing short-term research education support to stimulate career development in cardiovascular, pulmonary, hematologic, and sleep disorders research. The overall goal of the program is to provide research opportunities for individuals from backgrounds underrepresented in biomedical science, including individuals from disadvantaged backgrounds, individuals from underrepresented racial and ethnic groups, and individuals with disabilities that will significantly contribute to a diverse research workforce in the future. The research opportunities should be of sufficient depth to enable the participants, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of research, and help prepare participants interested in research to pursue competitive fellowships, or other research training or career development awards. This FOA will utilize the NIH R25 Education Projects award mechanism. --------------------------------------------------------------- Program Number: 28868 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Department of the Army Title: RFP--Improved Data Modem (IDM) Replacement on the CH-47F Platform Contact: Lori Moore Tel: 256-842-7564 Email: lori.e.moore@us.army.mil Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=87e36f1704eba2513f11c2819bf7879a&tab=core&_cview=0 SYNOPSIS: B -- IMPROVED DATA MODEM (IDM) REPLACEMENT ON THE CH-47F PLATFORM. DIRECT YOUR REQUESTS AND COMMUNICATIONS ATTN: LORI E. MOORE, CONTRACT SPECIALIST, VIA EMAIL LORI.E.MOORE@US.ARMY.MIL OR FAX NUMBER 256-876-9066 SOL W58RGZ04G00230292 DUE 061112 POC Lori Moore, 256-842-7564 POP ACC-RSA - (Aviation) ATTN: AMSAM-AC, Building 5303, Martin Road Redstone Arsenal AL 35898-5280 WEB: FBO.gov Permalink https://www.fbo.gov/notices/87e36f1704eba2513f11c2819bf7879a E-MAIL: ACC-RSA - (Aviation) lori.e.moore@us.army.mil NAICS: 336411 ****ATTENTION****FORMAL COMMUNICATION RELATED TO THIS ACQUISITION SHOULD BE DIRECTED TO: Lori E. Moore. You may FAX or mail your request ATTN: CCAM-CH-C, Fax Number 256-876-9606. NO TELEPHONE REQUEST WILL BE ACCEPTED. Establish on the Basic Ordering Agreement W58RGZ-04-G-0023, to provide additional product improvement program productionization effort, update training manuals, and wiring diagrams for the CH-47 aircraft.Authority for this action is 10 U.S.C. 2304(c)(1). This item is restricted to The Boeing Company, CAGE Code 77272, because this service must be acquired from amanufacturing source(s) specified on a source control or selected item drawing as defined by the current DoD-STD-100. Adequate technical data is not available for this acquisition. All offerors must meet prequalification requirements in order to be eligible for award. Firms that recognize and can provide the required service described above are encouraged to identify themselves. Firms are encouraged to seek source approval in order to compete for future solicitations by accessing the website www.redstone.army.mil/cmo/ and looking under Qualification Procedures for Aviation requirements. All responsible sources may submit an offer which shall be considered by the Agency. The closing date annotated is an estimated date and may be adjusted dependent upon the date of release for solicitation;however, the solicitation will not close prior to the date stated above. 'THIS ACQUISITION CONTAINS TECHNICAL DATA WHOSE EXPORT IS RESTRICTED BY THE ARMS EXPORT CONTROL ACT (TITLE 22,USC.,SEC 2751 ET SEQ) OR THE EXPORT ADMINISTRATION ACT (TITLE 50, USC., APP 2401-2402)EXECUTIVE ORDER 121470. THIS INFORMATION CANNOT BERELEASED OUTSIDE THE UNITED STATES WITHOUT PRIOR APPROVAL OF THE GOVERNMENT.' NOTES 23 and 26 CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=87e36f1704eba2513f11c2819bf7879a&tab=core&_cview=0 Posted 05/21/12 (W-SN02753258). (0142) --------------------------------------------------------------- Program Number: 27657 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Environmental Protection Agency Title: RFP -- Environmental Finance Education & Training Contact: Nicole Humphrey Tel: Email: humphrey.nicole@epa.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=5600e639a06cfda7f3cef5234adfc633&tab=core&_cview=0 SYNOPSIS: U -- ENVIRONMENTAL FINANCE EDUCATION & TRAINING SOL RFQ-PR-OCFO-11-0303 DUE 041212 POC Nicole Humphrey WEB: FBO.gov Permalink https://www.fbo.gov/spg/EPA/OAM/HQ/RFQ-PR-OCFO-11-00303/listing.html E-MAIL: Contracting Officer humphrey.nicole@epa.gov NAICS: 611710 Response Date/Time: 1:00PM ET ? April 12, 2012This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation;proposals are being requested and a written solicitation will not be issued.Thetitle and RFQ number for this request for proposals ?Environmental Finance Education & Training? ? RFQ-PR-OCFO-11-00303; shall be referenced on any quotation. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-54. The Center for EnvironmentalFinance (CEF) in the Office of the Chief Financial Officer (OCFO) seeks contractor support for providing environmental finance education and training to EPA employees. The purpose of this requirement is to support the design and implementation of an educational and training program in environmental finance. This program shall consist of graduate-level college courses in environmental finance strategies and solutions, environmental finance project analysis, environmental law and finance, and public policy and the environment. The courses shall be taught by the faculty of a college, university, or other organization both of which (faculty and institution) are accredited by an U.S. Department of Education-recognized accreditation association. The program shall be offered on-site at an EPA headquarters facilities location. Any firm believing itself to be capable of meeting EPA?s requirement, as stated within the RFP, Instructions, and the Statement of Work, may submit a proposal, which, if received by the response date and timeof this announcement shall be considered. LATE RESPONSES WILL NOT BE ACCEPTED. Prospective sources are reminded that an award can only be made to a Contractor who is registered in the Central Contractor Registration (CCR) database in accordance with FAR 4.11. A formatted copy of the Statement of Work, including the evaluation factors and quote submission instructions can be found at the address identified below. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=5600e639a06cfda7f3cef5234adfc633&tab=core&_cview=0 Posted 03/13/12 (W-SN02695601). (0073) --------------------------------------------------------------- Program Number: 28865 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: In-Space Propulsion Technology Program: Astrodynamics Research Grants Contact: Gordon Johnston Tel: 202-358-4685 Email: gordon.johnston@nasa.gov Website:          http://nspires.nasaprs.com/external/viewrepositorydocument/cmdocumentid=325408/solicitationId=%7B4DF6A47E-EDC1-20F2-11FB-8BDF6890024A%7D/viewSolicitat Full Program:          http://nspires.nasaprs.com/external/solicitations/solicitationAmmendments.do?method=init&solId={4DF6A47E-EDC1-20F2-11FB-8BDF6890024A}&path=open Deadline Note: Notices of Intent are due by June 11, 2012 and 7-page proposals are due by August 20, 2012. The In-Space Propulsion Technology: Astrodynamics Research Grants (ISPT:ARG) Program is seeking astrodynamics research that falls into two categories: 1) Research or development of an astrodynamics algorithm or methodology suitable for infusion into one of ISPT’s existing tools (Mystic, MALTO, Copernicus, SNAP, and/or OTIS) and 2) Research or development applicable to the development of a new tool to meet the needs of future NASA planetary science missions. --------------------------------------------------------------- Program Number: 27970 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: RFA-CA-12-503--A Data Resource for Analyzing Blood and Marrow Transplants (Limited Competition U24) Contact: William D. Merritt, Ph.D. Tel: 301-496-8866 Email: merrittw@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-503.html Deadline Note: The deadline for receipt of optional letters of intent is May 11, 2012. The deadline for receipt of full applications is June 11, 2012. SYNOPSIS: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID) invite applications to continue the support for the Center for International Blood and Marrow Transplant Research (CIBMTR). This database resource collects consecutive outcomes data from transplant centers worldwide and makes them accessible to transplant investigators, patients, and healthcare policy makers. In addition, the CIBMTR provides quality data to transplant researchers for observational research studies on patients who had blood and marrow transplants. This FOA will utilize the NIH U24 Resource-Related Research Projects – Cooperative Agreements mechanism. --------------------------------------------------------------- Program Number: 05677 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-12-024--Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R41/R42) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-12-024.html Deadline Note: The deadlines for receipt of optional letters of intent are: June 13, 2011 (passed) and June 11, 2012. The deadlines for receipt of full applications are: July 11, 2011 and July 11, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to teach, motivate, visualize outcomes, and to extend the health care and learning environments for patients with obesity and diabetes. The VR technology proposed should foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral and pedagogical sciences. The overall goal is to develop the potential of Virtual Reality technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This FOA will utilize the NIH R41/R42 Small Business Technology Transfer (STTR) Grants - Phase I, Phase II, and Fast-Track award mechanisms. --------------------------------------------------------------- Program Number: 27202 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Institute on Minority Health and Health Disparities/NIH/DHHS Title: RFA-MD-12-004--NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01) Contact: Nishadi Rajapakse, PhD, MHS Tel: 301-796-4338 Email: chandima.rajapakse@nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-12-004.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 11, 2012. The deadline for receipt of optional letters of intent is May 11, 2012. The deadline for receipt of full applications is June 11, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute on Minority Health and Health Disparities (NIMHD) invites innovative grant applications on: 1. Biological and genetic research to explore disease mechanisms or pathways that influence health outcomes in minority and health disparity populations; and 2. Clinical and translational research linking basic science discovery with effective treatment or clinical practice. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 97142 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: National Nuclear Security Administration Service Center/Department of Energy Title: National Laser Users' Facility Program (NLUF) Contact: William J. Parras Tel: 505-845-4021 Email: Bill.Parras@nnsa.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=95ZHPthGGchjR8x2yb1wWmcJCSplpDVGXWvCL0Lh0mFCQyy5yTQJ!64499778?oppId=169973&mode=VIEW SYNOPSIS: The NLUF program is part of the Joint Program in High Energy Density Laboratory Plasmas, which is sponsored jointly by the U.S. Department of Energy (DOE)/National Nuclear Security Administration (NNSA), Office of Defense Science, and the Office of Fusion Energy, Office of Science. The NLUF provides access to the OMEGA Laser Facility for University and Industrial Scientists to conduct university and industry-led experiments in high-energy-density (HED) and Inertial Confinement Fusion (ICF). --------------------------------------------------------------- Program Number: 28167 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: Office of Public Health and Science/DHHS Title: Training and Technical Assistance Projects Supported by the Office of Population Affairs and the Division of STD Prevention Contact: Steven J Shapiro Tel: 404-639-8868 Email: sjs4@cdc.gov Website:          http://www.grants.gov/search/search.do?oppId=164153&mode=VIEW Full Program:          https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=14334 SYNOPSIS: This announcement is issued by the Office of Population Affairs (OPA) within the Office of the Assistant Secretary for Health in collaboration with the Division of STD Prevention within the Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (CDC), and seeks applications from public and private nonprofit entities to establish and operate training and technical assistance projects. --------------------------------------------------------------- Program Number: 28583 --------------------------------------------------------------- ***Deadlines: 6/11/2012 Sponsor: U.S. Geological Survey/Department of the Interior Title: National GAP Analysis Program - FY 2012 PAD-US State Grants Contact: Faith Graves, Contract Specialist Tel: 703-648-7356 Email: fgraves@usgs.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=169434 SYNOPSIS: The sponsor announces the availability of funds for the National GAP Analysis Program - FY 2012 PAD-US State Grants. The Gap Analysis Program (GAP) of the U.S. Geological Survey (USGS) is offering grant and/or cooperative agreement opportunities to States, local governments, or other recipients for projects performed in partnership with USGS GAP. This year, GAP program managers are interested in expanding this partnership in the following states (states chosen because of the USGS-defined need to update information currently available to the USGS in these states): Alabama, Arkansas, Arizona, Indiana, Kansas, New Jersey, Texas, Nevada and Oklahoma. --------------------------------------------------------------- Program Number: 51663 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Independent Scientist Award (K02) Contact: Kay Anderson, Ph.D. Tel: 301-427-1555 Email: Kay.Anderson@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-086.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. NOTE: AHRQ has suspended the submission of individual career development grant applications for the February 12, 2012 application receipt date for new applications and March 12, 2012 receipt date for re-submission applications. SYNOPSIS: The sponsor provides support to foster the development of outstanding health service researchers and enable them to expand their potential to make significant contributions to their field of research. The award provides three, four, or five years of salary support and “protected time” for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Applicants must focus their research careers on areas that would have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans. This program represents the continuation of an AHRQ program. This FOA will utilize the Independent Scientist Award (K02) mechanism. --------------------------------------------------------------- Program Number: 52645 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: AHRQ Mentored Clinical Scientist Research Career Development Award (K08) Contact: Kishena Wadhwani, Ph.D., M.P.H. Tel: 301-427-1556 Email: Kishena.Wadhwani@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-085.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. NOTE: AHRQ has suspended the submission of individual career development grant applications for the February 12, 2012 application receipt date for new applications and March 12, 2012 receipt date for re-submission applications. SYNOPSIS: The sponsor provides support to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans. This program represents the continuation of an AHRQ program that provides support and “protected time” to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in health services research. The award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances. The award is also available to promote research workforce diversity by providing enhanced research career development opportunities. Candidates interested in pursuing careers in patient-oriented research are eligible to apply for this award at AHRQ. This FOA will utilize the Mentored Clinical Scientist Research Career Development Award (K08) mechanism. --------------------------------------------------------------- Program Number: 94994 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Mentored Research Scientist Reseach Career Development Award (K01) Contact: Kay Anderson, PhD. Tel: 301-427-1555 Email: Kay.Anderson@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-087.html Deadline Note: This FOA will expire on January 8, 2013. SYNOPSIS: The sponsor provides to help ensure that a diverse pool of highly trained health services researchers are available in adequate numbers and in appropriate research areas to address the mission and priorities of AHRQ. The primary purpose of the AHRQ Mentored Research Scientist Research Career Development Awards (K01) program is to prepare qualified individuals for careers that have a significant impact on the quality, safety, efficiency, and effectiveness of health care for all Americans. This program represents the continuation of an AHRQ program that provides support and “protected time” to individuals with a research doctoral degree for an intensive, supervised research career development experience in health services research. This FOA will utilize the Mentored Research Scientist Research Career Development Award (K01) mechanism. --------------------------------------------------------------- Program Number: 26221 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Contact: John O. Ojeifo, MD, PhD, MBA. Tel: 301-496-8589 Email: ojeifojo@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-050.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the Mentored Research Scientist Development Award (K01)to provide support and “protected time” (three, four, or five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. This Funding Opportunity Announcement (FOA) will utilize the NIH Mentored Research Scientist Development Award (K01) mechanism. --------------------------------------------------------------- Program Number: 26222 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Contact: John O. Ojeifo, MD, PhD, MBA. Tel: 301-496-8589 Email: ojeifojo@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-051.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the NCI Mentored Clinical Scientist Research Career Development Awards (K08). The primary purpose to support and protected time to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research. This NCI-sponsored K08 award is specifically designed to promote career development of clinical scientists from diverse backgrounds that have been shown to be underrepresented in health-related science and for those who are committed to a career in basic biomedical, behavioral or translational cancer research, including research on cancer health disparities. This Funding Opportunity Announcement (FOA) will utilize the NIH K08 Clinical Investigator Award (CIA) mechanism. --------------------------------------------------------------- Program Number: 26223 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23) Contact: John O. Ojeifo, MD, PhD, MBA. Tel: 301-496-8589 Email: ojeifojo@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-052.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the NIH Mentored Patient-Oriented Research Career Development Award (K23). The primary purpose is to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented cancer research. This Funding Opportunity Announcement (FOA) will utilize the NIH K23 Mentored Patient-Oriented Research Career Development Award mechanism. --------------------------------------------------------------- Program Number: 26358 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Contact: Susan N. Perkins, Ph.D., Program Director Tel: 301-496-8580 Email: perkinsu@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-067.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Cancer Institute (NCI) invites applications for the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award. The award is intended to support the career development of junior investigators with research or health professional doctoral degrees who want to become cancer-focused academic researchers in cancer prevention, cancer control, or the behavioral or population sciences. This FOA will utilize the NIH Academic Career Award (K07) mechanism. --------------------------------------------------------------- Program Number: 27879 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: NHLBI Career Transition Award (K22) Contact: Herbert M. Geller, Ph.D. Tel: 301-451-9440 Email: direducation@nhlbi.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-137.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 7, 2015. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) provides highly qualified postdoctoral fellows with an opportunity to receive mentored research experience in the NHLBI Division of Intramural Research and then to provide them with bridge funding to facilitate the transition of their research programs as new investigators at extramural institutions. This Funding Opportunity Announcement (FOA) will utilize the NIH Career Transition Award (K22) mechanism. --------------------------------------------------------------- Program Number: 04623 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Dentist Scientist Pathway to Independence Award (K99/R00) Contact: Leslie A. Frieden, Ph.D. Tel: 301-496-4263 Email: friedenla!mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-256.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications for the Pathway to Independence Award (K99/R00). The primary purpose of the Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented NIH-supported independent investigators. The program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm. This Funding Opportunity Announcement (FOA) will utilize the NIH Pathway to Independence Award (K99/R00) mechanism. --------------------------------------------------------------- Program Number: 93747 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Environmental Health Sciences/NIH/DHHS Title: Short Term Career Development Award in the Environmental Health Sciences for Established Investigators (K18) Contact: Carol Shreffler, Ph.D. Tel: 919-541-1445 Email: shreffl1@niehs.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-090.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides funding for short term career development awards to allow established, well funded clinician investigators to expand research programs to answer questions relevant to the environmental health sciences, and to provide established environmental health sciences research investigators the tools to expand their efforts to translational research. This FOA will utilize the NIH Career Enhancement Award (K18) mechanism. --------------------------------------------------------------- Program Number: 28010 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) Contact: Michelle D. Jones-London, Ph.D., Program Director Tel: 301-451-7966 Email: jonesmiche@ninds.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-152.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program expires on May 8, 2015. SYNOPSIS: National Institute of Neurological Disorders and Stroke (NINDS) provides the Career Development Award to Promote Diversity in Neuroscience Research to provide junior faculty support and protected time (up to three years) for an intensive, supervised career development experience in neuroscience research. This Funding Opportunity Announcement (FOA) will utilize the NIH Mentored Research Scientist Development Award (K01) mechanism. --------------------------------------------------------------- Program Number: 28166 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) Contact: Michelle Jones-London, Ph.D. Tel: 301-451-7966 Email: jonesmiche@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-163.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 12, 2012. The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12, annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Neurological Disorders and Stroke (NINDS) invites applications for the NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. Individuals from diverse backgrounds underrepresented in neuroscience research are eligible for support under this award if they have doctoral research degrees (Ph.D., P.h.D./M.D. or equivalent) and between 2 and 5 years of postdoctoral research experience at the time of application. The primary objectives of this Funding Opportunity Announcement (FOA) are to: (1) assist talented underrepresented scientists to transition from postdoctoral training to a secure, independent research position and (2) enhance the conditions that promote establishing a strong and innovative independent program of research. This FOA will utilize the NIH K22 Career Transition Award mechanism. --------------------------------------------------------------- Program Number: 19244 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Contact: Debra Grossman, M.A. Tel: 301-443-2249 Email: dgrossman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-177.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (scholars) leading to research independence in the area of drug abuse and addiction. Candidates selected for support as scholars must hold a clinical or research doctorate and can commit a minimum of 9 person-months (equivalent to 75% of full-time professional effort) conducting clinical research and career development activities associated with the proposed program. This FOA will use the NIH Institutional Research Career Development K12 grant mechanism. --------------------------------------------------------------- Program Number: 21909 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: National Institutes of Health/DHHS Title: Mentored Quantitative Research Development Award (Parent K25) Contact: Tel: Email: grantinfo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-196.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 8, 2011. The deadlines for receipt of standard applications are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor provides support for the Mentored Quantitative Research Career Development Award (K25), to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. This FOA will utilize the Mentored Quantitative Research Development Award (K25) mechanism. --------------------------------------------------------------- Program Number: 25798 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research (K26) Contact: Oleg Mirochnitchenko, Ph.D. Tel: 301-435-0744 Email: oleg.mirochnitchenko@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-021.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 12, June 12, and October 12 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Center for Research Resources (NCRR) invites applications for the Midcareer Investigator Award in Mouse Pathobiology and Comprehensive Phenotyping Research Award. The NCCR seeks to support established, outstanding scientists by providing protected time for mouse pathobiology research and comprehensive phenotyping of genetically modified mice as well as mentoring of junior investigators, thus relieving them of time-consuming institutional service obligations and administrative responsibilities. This FOA will utilize the NIH K26 Midcareer Investigator Award in Biomedical and Behavioral Research. --------------------------------------------------------------- Program Number: 25547 --------------------------------------------------------------- ***Deadlines: 6/12/2012 Sponsor: Office of Science/Department of Energy Title: Community Sequencing Program - Quarterly Microbial Proposals Contact: Jim Bristow Tel: 925-296-5609 Website:          http://www.jgi.doe.gov/CSP/index.html Full Program:          http://www.jgi.doe.gov/CSP/user_guide/propschedule.html Deadline Note: Proposals for microbial isolates and resequencing proposals (<10 isolates) are accepted on a continuous basis and will be reviewed every quarter. Letters of intent are not required. Deadline for submission is 30 days prior to the review date. SYNOPSIS: The Community Sequencing Program (CSP) was created to provide the scientific community at large with access to high-throughput sequencing at the Department of Energy Joint Genome Institute (JGI) for projects of relevance to DOE missions. Sequencing projects will be chosen based on scientific merit--judged through independent peer review--and relevance to issues in global carbon cycling, alternative energy production, and biogeochemistry. --------------------------------------------------------------- Program Number: 27919 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: Directorate for Biological Sciences/NSF Title: Core Techniques and Technologies for Advancing Big Data Science & Engineering (BIGDATA) Contact: Vasant G. Honavar Tel: 703-292-7129 Email: vhonavar@nsf.gov Full Program:          http://www.nsf.gov/pubs/2012/nsf12499/nsf12499.htm Deadline Note: Deadlines are as follows: June 13, 2012 -- Mid-Scale Projects; and July 11, 2012 -- Small Projects. SYNOPSIS: The Core Techniques and Technologies for Advancing Big Data Science & Engineering (BIGDATA) solicitation aims to advance the core scientific and technological means of managing, analyzing, visualizing, and extracting useful information from large, diverse, distributed and heterogeneous data sets so as to: accelerate the progress of scientific discovery and innovation; lead to new fields of inquiry that would not otherwise be possible; encourage the development of new data analytic tools and algorithms; facilitate scalable, accessible, and sustainable data infrastructure; increase understanding of human and social processes and interactions; and promote economic growth and improved health and quality of life. The new knowledge, tools, practices, and infrastructures produced will enable breakthrough discoveries and innovation in science, engineering, medicine, commerce, education, and national security-laying the foundations for US competitiveness for many decades to come. --------------------------------------------------------------- Program Number: 28025 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: RFA-HL-13-011--Limited Competition: NHLBI Research Centers at Minority Serving Institutions - Phase II (P50) Contact: Dina N. Paltoo, Ph.D., M.P.H. Tel: 31-435-00513 Email: paltood@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-011.html Deadline Note: The deadline for receipt of optional letters of intent is May 13, 2012. The deadline for receipt of standard full applications is June 13, 2012. The deadline for receipt of full AIDS-related applications is September 7, 2012. This program will expire on September 8, 2012. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) announces a limited competition to solicit applications from investigators funded under Phase I of the NHLBI Research Centers at Minority-Serving Institutions program. http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-019.html The purpose is to establish research centers to augment and strengthen research capabilities and resources in biomedical and behavioral research related to heart, lung, and blood diseases and disorders, with the ultimate goal to increase diversity in the biomedical and behavioral research enterprise. The program is intended to occur in two phases: Phase I (the recruitment/retention phase and establishment of the External Advisory Board, 2 years) and Phase II (the development of the research program and research operations, 5 years). This FOA is intended to support Phase II only, and is dependent upon the success from Phase I. This FOA will utilize the NIH P50 Specialized Center award mechanism. --------------------------------------------------------------- Program Number: 55833 --------------------------------------------------------------- ***Deadlines: 6/13/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: HIV Vaccine Research and Design (HIVRAD) Program (P01) Contact: Alan M Schultz, Ph.D. Tel: 301-594-2518 Email: schultzam@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-087.html Deadline Note: The deadline for receipt of optional letters of intent is May 13 annually. The corresponding deadline for receipt of full applications is June 13 annually. This program will expire on July 14, 2014. SYNOPSIS: National Institute of Allergy and Infectious Diseases (NIAID) invites applications for the HIV Vaccine Research and Design (HIVRAD) Program, a multi-component, multi-disciplinary projects that address important scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included. The NIH Program Project (P01) mechanism will be used. --------------------------------------------------------------- Program Number: 28294 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Centers for Disease Control and Prevention/DHHS Title: RFP -- AMENDMENT -- Development of Components for Breathing Escape Apparatus Contact: Howard D. Bish Tel: 412-386-5848 Email: hbish@cdc.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=47fdddb42a3359b9bb80b40e62947770&tab=core&_cview=0 A -- DEVELOPMENT OF COMPONENTS FOR BREATHING ESCAPE APPARATUS SOL 202-N-14294 POC Howard D. Bish, Phone: 4123865848 WEB: FBO.gov Permalink https://www.fbo.gov/spg/HHS/CDCP/CMBP/2012-N-14294/listing.html E-MAIL: hbish@cdc.gov hbish@cdc.gov NAICS: 541712 The Centers for Disease Control and Prevention (CDC) is responsible for conducting acquisitions in support of the National Institute for Occupation Safety and Health (NIOSH). NIOSH has a requirement to deliver working prototypes of docking/switch-over valves, hoods/masks with a passive communication element that will be used in the next generation of escape breathing apparatus, and very high pressure oxygen cylinders for use in the next generation ofSelf-Contained Self-Rescuer (SCSR) designs. These components must be designed and developed with due consideration to ease of use, compact size, durability andadaptability to selected breathing apparatus. Specifically, the project addresses the development of working prototypes for the following components: (1) Docking and switch-over valves (2) Hood/mask with a passive communication element and(3) very high pressure oxygen cylinder. This requirement is solicited on a fulland open competition - unrestricted basis. The complete solicitation document and reference material will be available for downloading at www.fedbizopps.gov onor about 15 calendar days after the posting of this notice. No verbal or written requests for copies will be accepted. It is the responsibility of prospective offerors to stay abreast of additional postings regarding this solicitation at the FedBizOpps Internet site. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=47fdddb42a3359b9bb80b40e62947770&tab=core&_cview=0 Posted 04/23/12 (W-SN02728491). (0114) --------------------------------------------------------------- Program Number: 28690 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Department of the Navy Title: RFP -- Research Subject Matter Expert for Control and Optimization Laboratories at the Naval Postgraduate School Contact: Jennifer Lee Tel: 831-656-2034 Email: jllee@nps.edu Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=02672ddd0f853e813f71201c1ec0f082&tab=core&_cview=0 A -- RESEARCH SUBJECT MATTER EXPERT FOR CONTROL AND OPTIMIZATION LABORATORIES AT THE NAVAL POSTGRADUATE SCHOOL SOL N6227112Q1073 POC JENNIFER LEE 81-656-2034 NPS CONTRACTING OFFICE POINT OF CONTACT WEB: FBO.gov Permalink https://www.fbo.gov/notices/02672ddd0f853e813f71201c1ec0f082 E-MAIL: nps.edu
--------------------------------------------------------------- Program Number: 27447 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: RFA-GM-13-004--Collaborations for Macromolecular Interactions in Cells (R01) Contact: James F. Deatherage, Ph.D. Tel: 301-594-0828 Email: deatherj@nigms.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-004.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 14, 2012. The deadline for receipt of optional letters of intent is May 14, 2012. The deadline for receipt of full applications is June 14, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of General Medical Sciences (NIGMS) invites applications for inter-disciplinary collaborative projects to advance studies of macromolecular interactions and their relationship to function in cells. These collaborations are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems. Grantees may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology; (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening); (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, superresolution light microscopy); (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. This FOA invites unconventional research strategies, including exploratory, descriptive, and statistical approaches, and encourages discovery and hypothesis generation as research objectives. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 27449 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: RFA-GM-13-005--Research Networks for Macromolecular Interactions in Cells (U54) Contact: James F. Deatherage, Ph.D. Tel: 301-594-0828 Email: deatherj@nigms.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-13-005.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 14, 2012. The deadline for receipt of optional letters of intent is May 14, 2012. The deadline for receipt of full applications is June 14, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Institute of General Medical Sciences (NIGMS) invites applications for iinter-disciplinary collaborative research networks to advance studies of macromolecular interactions and their relationship to function in cells. These networks are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems. Invetigators may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology; (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening); (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, superresolution light microscopy); (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. This FOA invites unconventional research strategies, including exploratory, descriptive, and statistical approaches, and encourages discovery and hypothesis generation as research objectives. This FOA will use the NIH U54 Specialized Center- Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 28722 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: National Institute of Standards & Technology/Technology Administration/DOC Title: RFP -- Amendment -- Support for Disaster and Failure Studies Program Contact: Divya Soni Tel: 301-975-6394 Email: divya.soni@nist.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=9df917f626b212d17fac5a53dbc1a757&tab=core&_cview=0 SYNOPSIS: B -- SUPPORT FOR DISASTER AND FAILURE STUDIES PROGRAM - RFP SOL SB131-12-RP-0027 POC Divya Soni, Phone: 3019756394 WEB: FBO.gov Permalink https://www.fbo.gov/spg/DOC/NIST/AcAsD/SB1341-12-RP-0027/listing.html E-MAIL: divya.soni@nist.gov divya.soni@nist.gov NAICS: 541712 See attached RFP. This is a Request for Proposals (RFP) for a contractor to provide support services to the National Institute of Standards and Technology's Disaster and Failure Studies Program. This notice follows the Pre-solicitation notice entitled "Pre-Solicitation Notice:Support for Disaster and Failure Studies Program". Offerors will be responsiblefor obtaining related amendments to this solicitation, if any, from www.fbo.gov. It is the responsibility of each potential offeror to monitor www.fbo.gov for any amendments or other information related to this solicitation; the Governmentwill not be maintaining a mailing list. Any communications regarding this acquisition must be made in writing and forwarded via email to divya.soni@nist.gov, and shall identify the solicitation number, company name, company address, as well as point of contact email address and phone number. THIS PROCUREMENT IS BEING COMPETED UNDER FULL AND OPEN COMPETITION. The standard classification NAICS codeis 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) with a small business size standard of 500 employees. FAR Part 15 Contracting by Negotiation will be used. This RFP is for an Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract with a ceiling amount of $9,900,000.00 for a one-year base period, plus four one-year option periods. The official RFP document is attached here, entitled "SB1341-12-RP-0027." The Offeror shall submit eight original hardcopies of the Technical Volume and two original hardcopies of the Business Volume, marked as such, and one (1) compact disc (CD)inclusive of the complete proposal, no later than 12:00 pm EST on June 14, 2012. Proposals must be received by NIST on or before the due date and time specified above. Only information received on or before the due date and time shall be considered for award. Any proposal, or part thereof, received after the due date and time, shall be deemed late and not considered for award. Proposals must be submitted so that they are received at the following address: Divya Soni NIST Building 301, Room B152 100 Bureau Drive Stop 1640 Gaithersburg, MD 20899-1640 E-mail proposals shall not be accepted. Facsimile proposals shall not be accepted. However, as noted in the instructions in the Past Performance Information Questionnaire, the Part II of the Questionnaire (if applicable) shall be submitted by the Offeror's references electronically so that it is received at divya.soni@nist.gov no later than 12:00 PM EST on June 14, 2012. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=9df917f626b212d17fac5a53dbc1a757&tab=core&_cview=0 Posted 05/15/12 (W-SN02749005). (0136) --------------------------------------------------------------- Program Number: 09589 --------------------------------------------------------------- ***Deadlines: 6/14/2012 Sponsor: Office of Postsecondary Education/Department of Education Title: Fulbright-Hays Doctoral Dissertation Research Abroad (DDRA) Fellowship Program Contact: Amy Wilson Tel: 202-502-7689 Email: ddra@ed.gov Website:          http://www.gpo.gov/fdsys/pkg/FR-2012-05-15/pdf/2012-11681.pdf Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=170796 SYNOPSIS: The Fulbright-Hays DDRA Fellowship Program provides opportunities to doctoral candidates to engage in full-time dissertation research abroad in modern foreign languages and area studies. The program is designed to contribute to the development and improvement of the study of modern foreign languages and area studies in the United States. --------------------------------------------------------------- Program Number: 28761 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Bureau of Land Management/Department of the Interior Title: Dwarf Bear Claw Poppy Arctomecon humilis Pollinator Study Contact: Andrea J Ramos Tel: 801-539-4145 Email: aramos@blm.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=171253 SYNOPSIS: The sponsor announces the availability of funds for the Dwarf Bear Claw Poppy Arctomecon humilis Pollinator Study. The objective of this study is to conduct a pollinator study of the endangered dwarf bear claw poppy. --------------------------------------------------------------- Program Number: 28184 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Bureau of Reclamation/Department of the Interior Title: Estimation of fish mortality due to passage through the Thayn Hydroelectric Project, Green River, UT Contact: Heidi Hansen, Grants Management Specialist UC-823 Tel: 801-524-3760 Email: heidihansen@usbr.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=164533 SYNOPSIS: The sponsor announces the availability of funds for the estimation of fish mortality due to passage through the Thayn Hydroelectric Project, Green River, UT. The Upper Colorado River Endangered Fish Recovery Program (Recovery Program) is a unique partnership of local, state, and federal agencies, water and power interests, and environmental groups working to recover endangered fish in the Upper Colorado River Basin (humpback chub Gila cypha, Colorado pikeminnow Ptychocheilus lucius, bonytail Gila elegans, and razorback sucker Xyrauchen texanus) while water development proceeds in accordance with federal and state laws and interstate compacts. --------------------------------------------------------------- Program Number: 02726 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Department of Defense Title: Research and Studies for the Office of Net Assessment Contact: Natalie Melomed, Contract Specialist Tel: 703-545-3357 Email: natalie.melomed@whs.mil Website:          http://www07.grants.gov/search/search.do;?oppId=46090&flag2006=false&mode=VIE Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=396bd0b3f4ab2b18ec1bce849f8ec765&tab=core&_cview=0 Deadline Note: Proposals will be valid for 12 months from the date of submission. No further awards will be made after June 15, 2014 or sooner if this BAA solicitation is amended to change the final date. The delivery address for proposals is: WHS/Acquisition Directorate ATTN: Julie Hammond 2521 S. Clark Street, Suite 3000 Arlington VA 22202. Only those proposals delivered by mail or hand-delivery to the address above will be accepted. SYNOPSIS: The Office of Net Assessment conducts and sponsors analyses that compare the standing, trends, and future prospects of U.S. and foreign military capability and military potential. Priority is given to assessing aspects of the security environment and parts of the world that are likely to change in the future, and that may present threats or opportunities to the U.S. Assessments may focus on specific theaters, regions, functions, mission areas, major weapons categories, doctrine, etc., as well as on demographic, economic, and political developments that may affect the power and strategies of nations. --------------------------------------------------------------- Program Number: 27957 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Department of Transportation Title: RFP -- Field Operational Experiment and Data Analysis Contact: Jeremy Barrasso, Contracting Officer Tel: 617-494-2282 Email: Jeremy.Barrasso@dot.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=46606e7675e0ef17ce1710a9c99bf88c&tab=core&_cview=0 SYNOPSIS: A -- FIELD OPERATIONAL EXPERIMENT AND DATA ANALYSIS SOL DTRT57-12-R-0013 POC Jeremy Barrasso, Phone: 617-494-2282, Thomas A. Wilga, Phone: 617-494-2177 WEB: FBO.gov Permalink https://www.fbo.gov/spg/DOT/RITA/VNTSC/DTRT57-12-R-20013/listing.html E-MAIL: Jeremy.Barrasso@dot.gov, Thomas.Wilga@dot.gov Jeremy.Barrasso@dot.gov, Thomas.Wilga@dot.gov NAICS: 541712 The U.S. Department of Transportation, Research and Innovative Technology Administration, John A. Volpe National Transportation Systems Center (Volpe Center), Cambridge, MA, intends to issue a solicitation to acquire professional services to obtain data collection and analysis from a field operational experiment (FOE), to assess driver adaptation to vehicle-based crash warning and avoidance products based on long-term exposure in a naturalistic driving environment. The primary objectives of the FOE are to assess the safety impact and determine driver acceptance of crash warning and avoidance systems. Participants in the FOE will be recruited to drive instrumented vehicles equipped with crash warning and avoidance products in place of their personal cars, driving wherever, whenever, and however they choose. The driving is thereby largely unmanaged by the Contractor and derives, instead, from the personal mobility needs of the individual participants. The primary deliverablesfrom the FOE will be a dataset that captures driver-vehicle performance and thedriving environment, and an analysis of this dataset. Objective and subjective data will need to be collected and analyzed to meet the FOE objectives. Objective data are obtained based on observable evidence, undistorted by emotion or personal bias of the FOE participants. Objective data generally consist of numericaland video data that capture host vehicle states and maneuvers, surrounding traffic, system operation, and driver behavior. The Contractor will acquire/lease the vehicles and will provide and install data acquisition systems to collect numerical and video data. Subjective data are collected to obtain driver background information before participation in the FOE, and to assess driver perception andopinion of the crash warning and avoidance products in terms of ease of use andlearning, willingness to use, and safety impact after their participation in the FOE. This will be a Full and Open competitive acquisition conducted in accordance with Federal Acquisition Regulation (FAR) Part 15, Contracting by Negotiation. The North American Industry Classification System (NAICS) Code is 541712 for this acquisition with a small business size standard of 500 for the number of employees. The estimated release date of the solicitation will be on or about May 15, 2012. Proposals will be due approximately 30 days following the issuance of the solicitation. The solicitation will be issued utilizing the following contract types: Firm-Fixed-Price and Cost-Plus-Fixed-Fee. The performance period of this contract will be sixteen months from date of contract award. The contract will include a twelve month option period if exercised by the Government, which will extend the performance period to twenty-eight months from date of contract award. The Volpe Center uses electronic commerce to issue Request for Proposals (RFP) and amendments to RFPs. Paper copies of the RFP or amendments will not be available. The solicitation and any documents related to this procurement will be available in electronic format only from the Government-wide Point of Entry at the Federal Business Opportunities website at the following address: https://www.fbo.gov/. Potential offerors desiring to receive electronic notification of the solicitations posting and availability for downloading must register at the FedBizOpps site. Contractors are warned that when they register to receive solicitation amendments and other notices, the responsibility for providing the Governmentwith an accurate and complete e-mail address lies with the contractor. The Government will make no additional efforts to deliver information when the system indicates that transmissions cannot be delivered to the email address provided. Nohard copies of the solicitation will be mailed. For questions concerning the acquisition, contact the contracting official in writing by email at jeremy.barrasso@dot.gov. ANY INQUIRIES VIA TELEPHONE WILL NOT BE HONORED. All contractors must be registered in the Central Contractor Registration (CCR) in order to receivean award from a DOT Agency. Contractors may access the site at https://www.bpn.gov/ccr/ to register and/or obtain information about the registration process. Additionally, solicitation Representation and Certifications are no longer provided within the solicitation and must be submitted online through the Online Representations and Certifications Application (ORCA). ORCA is a web-based system that centralizes and standardizes the collection, storage and viewing of the Representations and Certifications required by the Federal Acquisition Regulations. Potential offerors are highly encouraged to complete the online provisions within the Representations and Certifications at the earliest, at https://orca.bpn.gov/. This notice is for informational purposes for Minority, Women-owned, and Disadvantaged Business Enterprises (DBEs); The Department of Transportation (DOT), Short-Term Lending Program (STLP) offers working capital financing in the form of lines of credit to finance accounts receivable for transportation related contracts. Maximum line of credit is $750,000. For further information, call (800) 532-1169. Internet address: http://osdbu.dot.gov/. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=46606e7675e0ef17ce1710a9c99bf88c&tab=core&_cview=0 Posted 03/30/12 (W-SN02710370). (0090) --------------------------------------------------------------- Program Number: 55509 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Directorate for Biological Sciences/NSF Title: Research Coordination Networks (RCN) Contact: Tel: Website:          http://www.grants.gov/search/search.do?oppId=86453&mode=VIEW Full Program:          http://www.nsf.gov/pubs/2011/nsf11531/nsf11531.htm#cont Deadline Note: Deadlines are as follows: May 24, 2011 -- RCN SEES Track; June 15, 2011 -- RCN UBE and UBE Incubator Track; February 03, 2012 -- RCN SEES Track; June 15, 2012 -- RCN UBE and UBE Incubator Track; and February 04, 2013 -- RCN SEES Track. SYNOPSIS: The goal of the RCN program is to advance a field or create new directions in research or education. Groups of investigators will be supported to communicate and coordinate their research, training and educational activities across disciplinary, organizational, geographic and international boundaries. RCN provides opportunities to foster new collaborations, including international partnerships, and address interdisciplinary topics. Innovative ideas for implementing novel networking strategies, collaborative technologies, and development of community standards for data and meta-data are especially encouraged. --------------------------------------------------------------- Program Number: 23498 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Directorate for Engineering/NSF Title: Innovation Corps Program (I-Corps) Contact: Errol Arkilic Tel: 703-292-8095 Email: earkilic@nsf.gov Website:          http://www.nsf.gov/pubs/2011/nsf11560/nsf11560.pdf Full Program:          http://www.grants.gov/search/search.do;jsessionid=Y1G4T2TXcRnvfJfW0gGt1xM06cMyjW1LftkbcZ3mtT1yr1hs1dp7!1166104791?oppId=109833&mode=VIEW Deadline Note: The submission windows are as follows: August 17, 2011 - September 09, 2011 October 01, 2011 - December 15, 2011 January 01, 2012 - March 15, 2012 April 01, 2012 - June 15, 2012 July 01, 2012 - September 15, 2012 SYNOPSIS: The sponsor seeks to develop and nurture a national innovation ecosystem that builds upon fundamental research to guide the output of scientific discoveries closer to the development of technologies, products and processes that benefit society. In order to jumpstart a national innovation ecosystem, NSF is establishing the NSF Innovation Corps (NSF I-Corps). The NSF I-Corps' purpose is to identify NSF-funded researchers who will receive additional support - in the form of mentoring and funding - to accelerate innovation that can attract subsequent third-party funding. The purpose of the NSF I-Corps grant is to give the project team access to resources to help determine the readiness to transition technology developed by previously-funded or currently-funded NSF projects. The outcome of the I-Corps projects will be threefold: 1) a clear go/no go decision regarding viability of products and services, 2) should the decision be to move the effort forward, a transition plan to do so, and 3) a technology demonstration for potential partners. --------------------------------------------------------------- Program Number: 95509 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Directorate for Mathematics and Physical Sciences/NSF Title: Workforce Program in the Mathematical Sciences Contact: Bruce Palka Tel: 703-292-4856 Email: bpalka@nsf.gov Website:          http://www07.grants.gov/search/search.do?oppId=45617&mode=VIEW Full Program:          http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503233 Deadline Note: The window for full proposals is between May 15, 2012 and June 15, 2012. SYNOPSIS: The program is interested in activities centered on education through research involvement for trainees at the undergraduate through postdoctoral educational levels. Activities that broaden participation in the mathematical sciences are of significant interest to the Division of Mathematical Sciences. --------------------------------------------------------------- Program Number: 28190 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Health Resources and Services Administration/DHHS Title: RFP -AMENDMENT - Stem Cell Therapeutic Outcomes Database Contact: Greg Ribovich, Contract Specialist Tel: 301-443-4175 Email: gribovich@hrsa.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=69f6685094899d98a39ef817ad04c7b4&tab=core&_cview=0 SYNOPSIS: R -- STEM CELL THERAPEUTIC OUTCOMES DATABASE SOL 12HSB63-SOL-GR POCreg Ribovich, Phone: 301-443-4175, Francis R Murphy, Phone: (301) 443-5165 POP5600 Fishers Lane, Rockville, Maryland, 20857, United States 20857 WEB: FBO.govPermalink https://www.fbo.gov/notices/69f6685094899d98a39ef817ad04c7b4 E-MAIL: gribovich@hrsa.gov, fmurphy@hrsa.gov gribovich@hrsa.gov, fmurphy@hrsa.gov NAICS:541990 The Health Resources and Services Administration (HRSA) will be soliciting proposals to establish and operate a Stem Cell Therapeutic Outcomes Database,one component of the C.W. Bill Young Cell Transplantation Program (Program). The government is seeking proposals from organizations with the capability to collect and maintain information related to patients who have received stem cell therapeutic products in a standardized electronic format. This includes informationthat is necessary to conduct an ongoing evaluation of the scientific and clinical status of transplantation involving recipients of a stem cell therapeutic product from a donor. The organization should also have the capability to: 1) prepare and submit an annual report on patient outcomes at each transplant center and, 2) make scientific information available to the public in the form of summaries and data sets. The scope of data collection under this contract will include: 1. allogeneic transplantation for hematopoietic reconstitution using cells from donors not related to the patient; 2. allogeneic transplantation for hematopoietic reconstitution using cells from donors who are related to the patient; and, 3. emerging clinical applications of cells derived from bone marrow, peripheral blood, and umbilical cord blood. The period of performance will be a one-year base, and four one-year options. These services are defined under NAICS code 541990. It is anticipated that a Cost Reimbursement type contract will result from this requirement. This acquisition is being conducted under Full and Open competition. The solicitation will be posted on or about May 1, 2012. It will be available at this website as an attachment to this announcement (www.fbo.gov under HHS, Health Resources and Services Administration). It is the offeror's responsibility to monitor the site for amendments to the solicitation. The agency will consider proposals from all responsible sources. Should you have any questions contactGreg Ribovich, Contract Specialist, Phone 301-443-4175, Fax 301-443-5462, Emailgribovich@hrsa.gov. Please indicate the solicitation number and title in all communications. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=69f6685094899d98a39ef817ad04c7b4&tab=core&_cview=0 Posted 04/13/12 (W-SN02721821). (0104) --------------------------------------------------------------- Program Number: 28519 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Idaho Operations Office/Department of Energy Title: Development of LWR Fuels with Enhanced Accident Tolerance Contact: Heather J. Merrill Tel: 208-526-1650 Email: merrilhj@id.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=Q6JyPvjGGTKJMc6zRgWsj1ZNZxP12VfTT1sDwQyYQTLYJSVT6JjY!477727685?oppId=168693&mode=VIEW Full Program:          https://www.fedconnect.net/Fedconnect/PublicPages/PublicSearch/Public_Opportunities.aspx Deadline Note: Letters of Intent must be received by May 17, 2012. Applications must be received by June 15, 2012. SYNOPSIS: The U.S. Department of Energy (DOE) Office of Nuclear Energy, through this Funding Opportunity Announcement (FOA), seeks to facilitate the development and initial testing of light water reactor (LWR) fuel concepts with accident tolerant features. Program funding will be provided at a minimum of 20% industry cost-share, 80% Federal cost-share, to the awardee(s) for the purposes of completing early phase analysis and empirical data collection to assess the impacts of novel ATF. The total Government funding available for awards under this FOA is anticipated at $10M over two (2) years, subject to availability of funds. --------------------------------------------------------------- Program Number: 23367 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: Institute of Museum & Library Services Title: Grants for Learning Labs in Libraries and Museums Contact: Allison Boals, Program Specialist Tel: 202-653-4702 Email: aboals@imls.gov Website:          http://www.imls.gov/about/learning_labs.aspx Full Program:          http://www.imls.gov/call_for_applications_learning_labs_in_libraries_and_museums.aspx SYNOPSIS: The sponsor offers grants that will support the planning and designing of up to 30 Learning Labs in libraries and museums throughout the country. --------------------------------------------------------------- Program Number: 04074 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Heliophysics Research: Geospace Science Contact: Dr. Mona Kessel Tel: 202-358-0064 Email: mona.kessel@nasa.gov Website:          http://nspires.nasaprs.com/external/viewrepositorydocument/cmdocumentid=307594/solicitationId=%7B4DF6A47E-EDC1-20F2-11FB-8BDF6890024A%7D/viewSolicitat Full Program:          http://www.grants.gov/search/search.do;jsessionid=nSbKPpTpQxGg1QQ1XycyQMrLGwqJJy19tDmHf4WvyHynvhhJQqv7!-335065855?oppId=156493&mode=VIEW Deadline Note: Step-1 proposals should be submitted by April 13, 2012. Step-2 proposals will be due on June 15, 2012. SYNOPSIS: The goal of the G/Science program is to understand the space that surrounds the Earth and how it is influenced by the various solar system bodies. These studies range over regions that begin with the Earth’s upper atmosphere, including the mesosphere and thermosphere, and extend outward through the ionosphere, into and beyond the magnetosphere. The G/Science program also supports studies of the space plasma environments of other solar system bodies. --------------------------------------------------------------- Program Number: 08665 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01) Contact: Tracy Lively, Ph.D. Tel: 301-496-1591 Email: livelyt@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-151.html Deadline Note: The deadline for receipt of optional letters of intent is May 15 annually. The deadline for receipt of full applications is June 15 annually. This FOA will expire on June 16, 2012. SYNOPSIS: The sponsor invites applications for support of the clinical application of multi-analyte molecular signatures derived from comprehensive molecular annotation of tumors. There is growing recognition in the clinical cancer research community that annotation of tumor specimens with data that integrates information about molecular alterations at the levels of DNA, RNA, and protein provides not only a more complete understanding of tumor biology but also provides a significant opportunity for developing new clinical tools to improve cancer treatment. Translating the knowledge gained from this molecular annotation into tools that can be used in clinical decision-making remains a major challenge. The purpose of this initiative is to build on recent demonstrations that molecular signatures correlate with important clinical parameters in cancer. The goal of this initiative is also to create publications and data sets that will be available and accessible to the scientific community in order to further the development, design, and conduct of future clinical trials (e.g., incorporation of molecular signatures into future clinical trials and large clinical validation studies) and to encourage appropriate commercialization to benefit the public health. The NCI invites investigators to form strategic partnerships that will bring together the multi-disciplinary expertise and resources needed to determine how the information derived from comprehensive molecular analyses can be used to improve patient care and, ultimately, patient outcomes. This FOA will utilize the NIH U01 cooperative agreement mechanism. --------------------------------------------------------------- Program Number: 12262 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: National Institute of Food and Agriculture/Department of Agriculture Title: Farm Business Management and Benchmarking Competitive Grants Program Contact: Susan S. Shockey, Ph.D Tel: 202-690-2674 Email: sshockey@nifa.usda.gov Website:          http://www.nifa.usda.gov/funding/rfas/pdfs/12_fbmb.pdf Full Program:          http://www07.grants.gov/search/search.do;jsessionid=tJ8TPyTH1v1SQy7bLbsVDJHbQ3P48fbRfq224R9M3wL3Gng66V0x!-668392920?oppId=169153&mode=VIEW SYNOPSIS: NIFA announces the availability of grant funds and requests applications for the Farm Business Management and Benchmarking (FBMB) Competitive Grants Program for fiscal year (FY) 2012 to improve the farm management knowledge and skills of agricultural producers; and maintain a national, publicly available farm financial management database to support improved farm management. The amount available for support of this program in FY 2012 is approximately $1.3 million. --------------------------------------------------------------- Program Number: 26893 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: U.S. Agency for International Development Title: Mexican Partnership Program Contact: Maritza Sarmiento, Acquisition Specialist Tel: 503-2501-3325 Email: mexicoaps@usaid.gov Full Program:          http://www07.grants.gov/search/search.do;jsessionid=7PKDPndG6m7fLcGXVNh1NKK7gVYhLC2cWTy9r3X1gWSRGVQ8xR1n!-992301837?oppId=141597&mode=VIEW Deadline Note: If the concept paper is judged to have sufficient merit, USAID will invite organizations to submit a full application. USAID/Mexico will inform unsuccessful applicants in writing, explaining briefly why the concept paper was not selected for the submission of a full application. Unsuccessful applicants may resubmit revised concept papers for consideration. SYNOPSIS: The United States Agency for International Development (USAID) Mission in Mexico is seeking concept papers and, later, applications from Mexican for‐profit and non‐for‐profit organizations to implement activities to support the Mexican Partnership Program related to global climate change, economic competitiveness, youth, human rights and rule of law. Eligible organizations include, but are not limited to, non‐government organizations (NGOs), associations, cooperatives, universities, civil society organizations, foundations, and private companies. USAID plans to hold regular information sessions on the APS in different locations in Mexico during February and March 2012. The information sessions will be organized by the five technical areas of the APS. USAID plans to hold information sessions as follows: Global Climate Change (Mexico city, Chiapas, Oaxaca); Competitiveness (Mexico City); Youth (Monterrey, Tijuana, Ciudad, Juarez); and Human Rights and Criminal Justice (Mexico City). Additional information sessions may be added depending on interest. Please contact Tere Garduño (tgarduno@usaid.gov) to be included on the invitation list for these sessions, and note which of the five technical areas is of interest. --------------------------------------------------------------- Program Number: 28704 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: U.S. Fish & Wildlife Service/Department of the Interior Title: Status of the Birds in Region 6 Contact: Stephanie Jones Tel: 303-236-8680 Email: stephanie_jones@fws.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=170513 SYNOPSIS: The sponsor announces the availability of funds for the Status of the Birds in Region 6 program. The Migratory Bird Program anticipates an unprecedented increase in the number of permit requests for direct take of migratory birds. Presently, we do not have the capability to assess the impacts of direct take on relevant populations and subpopulations, nor do we have an efficient means to assess current population status both regionally and locally. In order for the Service to address permit requests in a timely manner, we must be able to assess information on the status and relative vulnerability of nongame bird species populations to varying levels of take. As populations of a growing number of North American bird species continue to decline, an assessment of the contribution of Migratory Bird Treaty Act (MBTA) permit mortality to these declines is clearly desirable. Moreover, the USFWS is presently considering regulations allowing for incidental take of birds protected under the MBTA which may greatly increase permitted take. Unfortunately, the Migratory Bird Program simply does not have the ability to efficiently determine the level of acceptable take for most bird population identified under the MBTA. To remedy this problem, we propose selecting a sample of priority bird species of conservation interest to Region 6, and then constructing individual species accounts that would provide quick access to current population status, data limitations and gaps, and if reasonable, project potential impacts of increased direct take on relevant populations regionally and locally. During the species selection process, we will consider if representative or umbrella and surrogate species are valid for these accounts. If these accounts prove useful, we could extend this effort to more priority bird species in Region 6 as resources allow. This project would also evaluate whether these assessments could serve as a resource guide for delivering strategic conservation activities for bird populations. The proposed project would complement and somewhat mirror a current Canadian Wildlife Service effort to provide a systematic evaluation of take. This effort would serve as a pilot, designed to estimate the required amount of staff time, the quantity and quality of existing data, as well as resource availability to complete an assessment for the complete set of priority species presently identified to be of conservation interest to Region 6. --------------------------------------------------------------- Program Number: 28611 --------------------------------------------------------------- ***Deadlines: 6/15/2012 Sponsor: U.S. Trade and Development Agency Title: RFP -- Romania - Aviation Surveillance Modernization Technical Assistance Project Contact: Anthony O'Tapi Tel: 703-875-4357 Email: aotapi@ustda.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=6d897d6685b9ec9a4d8e9745f0e3797d&tab=core&_cview=0 SYNOPSIS: B -- ROMANIA - AVIATION SURVEILLANCE MODERNIZATION TECHNICAL ASSISTANCE PROJECT SOL 2012-21014A POC Anthony O'Tapi, Phone: 703-875-4357 WEB: FBO.govPermalink https://www.fbo.gov/spg/TDA/TDA1/TDA1/2012-21014A/listing.html E-MAIL: aotapi@ustda.gov aotapi@ustda.gov NAICS: 541690 POC Anthony O'Tapi, USTDA 1000Wilson Boulevard, Suite 1600 Arlington, VA 22209-3901 Tel: (703) 875-4357 Fax: (703) 875-4009 ***Please do not contact contracts office*** Proposal Submission Place: Mr. Bogdan Donciu Romanian Air Traffic Services Administration 10, Ion Ionescu de la Brad Blvd 013813, Bucharest Romania Tel: 40-21-208-3102 Fax: 40-21-230-2335 Email: bogdan.donciu@mt.ro The Grantee invites submission of qualifications and proposal data (collectively referred to as the "Proposal") from interested U.S. firms that are qualified on the basis of experience and capability to perform Technical Assistance ("TA") on the Romania Aviation Surveillance Modernization ("Project"). The Project will enable the Romanian Air Traffic Services Administration (ROMATSA) (the "Grantee") to establish an airspace modeling and simulation capability that specifically assesses airspace system performance, analyzes and identifies airspace-related performance issues, and provides analytical capabilities to assess future changes or procedures to the airspace system prior to deployment. The TA will develop high-level operational and technical recommendations regarding automation, surveillance, data communications, traffic flow management, and performance based navigation. ROMATSA is Romania's only air trafficoperator and has oversight of air traffic management facilities throughout the country. The Romanian airspace plays a significant role in the European transportation network of the South-East Europe region, acting as a bridge between North, South, East and West Europe. While air traffic has been steadily increasing, forecasts predict further higher traffic demand driven by the economic growth in the region, by the emergence of new areas of cooperation and commitment within the European Union, as well as an increase in European tourism and business travelers. As part of the Single European Sky (SES) aviation program, Romania joined in 2004 with Bulgaria to create a Functional Airspace Block (FAB) called the Danube FAB, which will be established latest on 04th December 2012, when the implementation of the DANUBE FAB Project will start. This FAB is one of nine such entities that comprise the SES community. Each FAB will retain local autonomy as identified in the new European Single Sky Implementation strategy, but must nonetheless remain in line with the EUROCONTROL Air Traffic Management (ATM) Master Plan, which is the European equivalent of the Federal Aviation Administration's NextGen program. As such, the Danube FAB must ensure that its surveillance, data communications, traffic flow management, and performance-based navigation systems conform to SES requirements. Beyond the Danube FAB, ROMATSA's 2012 National Performance Plan identifies a number of measures, changes and goals to be achieved for the organization to increase efficiency and to expand its leading role in themarket. This plan strongly focuses on increasing the number of operations served by controllers and decreasing costs at 16 airports where ROMATSA provides services. Additional pressure to reach these goals is exerted by the airlines, as they have expressed a concern regarding operation cost. Accordingly, ROMATSA is inthe process of working with stakeholders to assess potential charge modifications in the near future. This TA will support the implementation of modern airspace technologies to meet SES requirements, its recent entrance in the Danube FAB, and its 2012 National Performance Plan. Portions of a background Definitional Mission Romania: Aviation Projects is provided for reference in Annex 2. The U.S. firm selected will be paid in U.S. dollars from a $513,170 grant to the Grantee from the U.S. Trade and Development Agency (USTDA). A detailed Request for Proposals (RFP), which includes requirements for the Proposal, the Terms of Reference, and portions of a background definitional mission/desk study report are available from USTDA, at 1000 Wilson Boulevard, Suite 1600, Arlington, VA 22209-3901. To request the RFP in PDF format, please go to: https://www.ustda.gov/businessopps/rfpform.asp Requests for a mailed hardcopy version of the RFP may also be faxed to the IRC, USTDA at 703-875-4009. In the fax, please include your firm's name, contact person, address, and telephone number. Some firms have found that RFPmaterials sent by U.S. mail do not reach them in time for preparation of an adequate response. Firms that want USTDA to use an overnight delivery service should include the name of the delivery service and your firm's account number in therequest for the RFP. Firms that want to send a courier to USTDA to retrieve theRFP should allow one hour after faxing the request to USTDA before scheduling apick-up. Please note that no telephone requests for the RFP will be honored. Please check your internal fax verification receipt. Because of the large number of RFP requests, USTDA cannot respond to requests for fax verification. Requests for RFPs received before 4:00 PM will be mailed the same day. Requests received after 4:00 PM will be mailed the following day. Please check with your courier and/or mail room before calling USTDA. Only U.S. firms and individuals may bid onthis USTDA financed activity. Interested firms, their subcontractors and employees of all participants must qualify under USTDA's nationality requirements as of the due date for submission of qualifications and proposals and, if selected to carry out the USTDA-financed activity, must continue to meet such requirementsthroughout the duration of the USTDA-financed activity. All goods and services to be provided by the selected firm shall have their nationality, source and origin in the U.S. or host country. The U.S. firm may use subcontractors from the host country for up to 20 percent of the USTDA grant amount. Details of USTDA's nationality requirements and mandatory contract clauses are also included in the RFP. Interested U.S. firms should submit their Proposal in English directly to the Grantee by 4:00 PM, LOCAL TIME, on JUNE 15, 2012, at the above address. Evaluation criteria for the Proposal are included in the RFP. Price will not be a factor in contractor selection, and therefore, cost proposals should NOT be submitted. The Grantee reserves the right to reject any and/or all Proposals. The Grantee also reserves the right to contract with the selected firm for subsequent work related to the project. The Grantee is not bound to pay for any costs associated with the preparation and submission of Proposals. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=6d897d6685b9ec9a4d8e9745f0e3797d&tab=core&_cview=0 Posted 05/08/12 (W-SN02741681). (0129) --------------------------------------------------------------- Program Number: 99421 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Small Research Grant to Improve Health Care Quality through Health Information Technology (IT) (R03) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-08-268.html Deadline Note: This program will expire on November 17, 2012. SYNOPSIS: The sponsor provides support for a wide variety of research designs in order to improve the quality, safety, effectiveness, and efficiency of health care through the implementation and use of health IT. These designs include: small pilot and feasibility or self-contained health IT research projects; secondary data analysis of health IT research; and economic (prospective or retrospective) analyses of health IT implementation and use. Through economic analyses estimates of health IT implementation and use costs and benefits will be generated. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 99425 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Agency for Healthcare Research and Quality/DHHS Title: Exploraratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT) (R21) Contact: Angela Lavanderos Tel: 301-427-1505 Email: Angela.Lavanderos@ahrq.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-08-269.html Deadline Note: This program will expire on November 17, 2012. SYNOPSIS: The sponsor provides support for short-term preparatory, pilot or feasibility studies that will inform larger scale real world health IT implementation and use or the conduct of more comprehensive health IT implementation research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02626 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers for Early Detection of Hematopoiietic Malignancies (R21) Contact: Lynn Sorbara, Ph.D. Tel: 301-435-0584 Email: lynns@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-198.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites research grant applications from institutions/organizations for the development and validation of biomarkers for: a) early detection, prediction of progression, and recurrence of hematopoietic malignancies, especially in high-risk individuals; and, b) for risk assessment of primary and secondary hematopoietic malignancies. This FOA is also encourages the development and improvement of specific technologies and methods for quantitative detection of novel biomarkers associated with hematopoietic malignancies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02628 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R21) Contact: Wendy Wang, Ph.D., M.Sc. Tel: 301-594-7607 Email: wangw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-200.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations on the discovery and characterization of non-coding (nc) RNAs in preneoplasias and early stage cancers to: 1) improve early cancer detection, intervention, and prevention; 2) predict risk of progression from preneoplasia to cancer, and 3) distinguish benign lesions from precancerous lesions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04214 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Diet, Epigenetic Events, and Cancer Prevention (R21) Contact: Sharon A. Ross, PH.D., M.P.H. Tel: 301-594-7547 Email: rosssha@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-235.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications for clinical and preclinical research to determine how diet and dietary factors, including dietary supplements, impact DNA methylation, histone posttranslational modification, noncoding RNA, and other epigenetic processes involved in cancer prevention and development. Another important aim of this FOA is to encourage collaborations between nutrition and epigenetic experts to study bioactive food components with cancer-preventative properties and to examine key epigenetic events in cancer processes (e.g., carcinogen metabolism, cell division, differentiation, and apoptosis) in order to begin to establish linkages between epigenetics, methylation patterns, and tumor incidences/behaviors. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05914 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Epigenetic Approaches in Cancer Epidemiology (R21) Contact: Mukesh Verma, Ph.D., M.P.H. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-032.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications that propose to evaluate profiles of methylation, histone modifications and micro RNA (miRNA) and their association with risk of developing cancer in different populations. The overarching goal of this FOA is to provide support for population based studies to define the role of epigenetic markers (methylation, histone and micro RNA profiles) changes to understand cancer etiology. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 07216 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Research On Ethical Issues In Human Subjects Research (R03) Contact: Ann Hardy Tel: 301-435-2690 Email: hardyan@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-181.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 10518 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Research On Ethical Issues In Human Subjects Research (R21) Contact: Ann Hardy Tel: 301-435-2690 Email: hardyan@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-182.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 12299 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) Contact: Vickie L. Shavers, Ph.D. Tel: 301-594-1725 Email: shaversv@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-164.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research to: improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection and statistical/analytical techniques; enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment and outcomes among disadvantaged racial/ethnic minority groups; and reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 16444 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomarkers of Infection-Associated Cancers (R21) Contact: Karl Krueger, Ph.D. Tel: 301-435-1594 Email: kruegerk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-159.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 20894 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21) Contact: Mukesh Verma, Ph.D. Tel: 301-594-7344 Email: vermam@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-074.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: June 16, October 16, and February 16 annually. The deadlines for AIDS and AIDS-related applications are: May 7, September 7, and January 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to develop and validate new mitochondrial-related biomarkers for cancer early detection, diagnosis, prognosis, risk assessment, and response to preventive and ameliorative treatments. This program will use the NIH Research Project (R21) award mechanism. --------------------------------------------------------------- Program Number: 20999 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Contact: Young S. Kim, Ph.D. Tel: 301-496-0126 Email: yk47s@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-161.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites applications for research efforts aimed at establishing the physiological significance of dietary components in modulating the tumoricidal cell activity of natural killer (NK) cells for cancer prevention. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 21407 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) Contact: Vickie L. Shavers, Ph.D. Tel: 301-594-1725 Email: shaversv@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-163.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor offers support for research to: improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection and statistical/analytical techniques; enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment and outcomes among disadvantaged racial/ethnic minority groups; and reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination on health care delivery systems in the United States. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23225 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Spatial Uncertainty: Data, Modeling, and Communication (R21) Contact: Li Zhu, Ph.D. Tel: 301-594-6546 Email: li.zhu@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-239.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invites applications for innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23226 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Spatial Uncertainty: Data, Modeling, and Communication (R03) Contact: Li Zhu, Ph.D. Tel: 301-594-6546 Email: li.zhu@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-240.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invites applications for innovative research that identifies sources of spatial uncertainty (i.e., inaccuracy or instability of spatial or geographic information) in public health data, incorporates the inaccuracy or instability into statistical methods, and develops novel tools to visualize the nature and consequences of spatial uncertainty. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 26622 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R21) Contact: Joanna M. Brell, M.D. Tel: 301-496-8541 Email: brelljm@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-083.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadline for receipt of optional letters of intent is May 5, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institutes of Health (NIH) invites basic biologic research on damage to the peripheral nervous system instigated by pharmacologic cancer treatments, known as chemotherapy-induced peripheral neuropathy (CIPN). The majority of acquired peripheral neuropathy research has focused on diabetic and inherited diseases; this FOA intends to stimulate neuroscience researchers to apply their expertise from studying these other neuropathies to the injuries incurred by cancer treatments. More data is necessary to understand the mechanisms of neuronal damage and to identify the targets instrumental to CIPN initiation and maintenance. Preclinical research that focuses not only on peripheral neuropathic pain but also on neurosensory symptoms such as paresthesias and peripheral anesthesias is invited. The ultimate goal of this FOA is to lead to a molecular understanding of CIPN that allows for the rational development of interventions that will treat or prevent CIPN. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87105 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Improving Diet and Physical Activity Assessment (R21) Contact: Amy Subar, Ph.D. Tel: 301-594-0831 Email: subara@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-225.html Deadline Note: The deadlines for receipt of optional letters of intent for new standard applications are: January 16, 2011 (passed); September 16, 2011; May 16, 2012. The corresponding deadlines for receipt of full (new) applications are: February 16, 2011; October 16, 2011; June 16, 2012. This program will expire on September 8, 2012 SYNOPSIS: The sponsors provide support for innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations across various age-groups including children and older adults; improved technology or applications of existing technology; statistical methods to assess or correct for measurement errors or biases, methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87502 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R21) Contact: Magdalena Thurin, Ph.D. Tel: 301-496-1591 Email: thurinm@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-014.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) encourages the submission of Research Project Grant (R01) applications from institutions and organizations to validate the clinical utility of new molecular diagnostics for determining prognosis or predicting response to therapy or toxicity for cancer. The Cancer Diagnosis Program (CDP) and the Cancer Therapy Evaluation Program (CTEP) at the NCI are cooperatively sponsoring this FOA with the purpose to transition of candidate biomarkers from initial correlative observations into diagnostics that are suitable for use in clinical trials to assess the clinical validity of a marker. This program will support research projects to improve clinical decision-making in the care of cancer patients and as such will support studies that use tumor specimens linked to specific treatment and clinical outcome information. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 89221 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Nanoscience and Nanotechnology in Biology and Medicine (R21) Contact: Piotr Grodzinski Tel: Email: grodzinp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-149.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications that apply nanoscience and nanotechnology approaches to address problems in biology and medicine. The purpose of this FOA is to provide support for cutting-edge nanoscience and nanotechnology research that can lead to biomedical breakthroughs and new investigations into the diagnosis, treatment and management of an array of diseases and traumatic injuries. Nanoscience and nanotechnology have the capacity to drive a new wave of medical innovation through the engineering of bioactive nanoscale structures, processes and systems based on the advancement of our understanding of biology at the nanoscale. Therefore, this FOA will also support research projects that develop new or improved nanotechnology and nanoscience-based tools, methods, concepts, and devices that lead to a better understanding of basic biology in addition to conducting translational biomedical studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 90756 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) Contact: Andrew N Freedman, Ph.D. Tel: 301-435-6819 Email: freedmaa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-026.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites research applications from clinicians, epidemiologists, geneticists, statisticians, and translational researchers working in the field of cancer control and prevention to improve existing models for cancer risk and prognosis by developing innovative research projects that use existing data; develop new models for cancer risk and prognosis; and validate new models and evaluate their utility in research and clinic settings. To explore this opportunity, the NCI Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Treatment and Diagnosis (DCTD) encourage applications for research projects to develop, apply, and evaluate new and existing cancer risk and prognostic prediction models for use by researchers, clinicians, and the general public. This FOA is designed to provide a mechanism of support for investigators to address two major challenges in model development, which are: integrating diverse types of data (e.g., clinical, demographic, pathologic, environmental, epidemiologic, outcomes, and genetic data from varied data marts or warehouses); and ensuring adequate validation (i.e., using multiple separate populations to define sensitivity, specificity, and positive and negative predictive values). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 92792 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) Contact: Young S. Kim, Ph.D. Tel: 301-496-0126 Email: yk47s@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-088.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications for exploratory research on the role of nutrition in cancer prevention. Specifically, this FOA seeks to promote cancer prevention research to identify and characterize molecular targets for bioactive food components. For the purpose of this FOA, a bioactive food component is defined as a dietary constituent that has a health benefit by altering one or more cellular processes when provided in quantities over and beyond that needed for basic nutrition. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 99326 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) Contact: James V. Tricoli, Ph.D. Tel: 301-496-1591 Email: tricolij@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-08-267.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for applications from institutions and organizations that are interested in developing and testing innovative methods in cancer detection, diagnosis, and prognosis. The NCI is especially interested in research studies that focus on the development and testing of improved methods for detecting specific characteristics of cancer, which can be subsequently used for the clinical management of cancer patients or individuals who are at risk for (developing) cancer. It is important that research studies focus on the search for molecular and cellular differences between tumors, pre-malignant, or normal tissues. The studies should determine the clinical translational significance of these differences by correlation with clinical parameters, in order to answer clinical problems related to detection, diagnosis, treatment, and prognosis. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 07174 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Center for Complementary and Alternative Medicine/NIH/DHHS Title: Preliminary Clinical Studies in Preparation for Large Interventional Trials of Complementary and Alternative Medicine (CAM) Therapies (R34) Contact: Wendy Weber, ND, PhD, MPH Tel: 301-402-1272 Email: weberwj@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-163.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications early phase clinical research and development on high priority CAM interventions. This mechanism is intended to support the development of methodology and the preliminary data needed for planning and design of subsequent, larger randomized clinical trials, cluster randomized trials or cohort studies. This mechanism is not appropriate for support of randomized clinical trials to test or determine efficacy. It is appropriate for development of preliminary studies that will contribute to the design of either efficacy or real-world effectiveness studies. This FOA will utilize the R34 grant mechanism. --------------------------------------------------------------- Program Number: 87574 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Center for Complementary and Alternative Medicine/NIH/DHHS Title: Biology of Manual Therapies (R21) Contact: Partap Khalsa, D.C., Ph.D., D.A.B.C.O., Program Officer Tel: 301-594-3462 Email: khalsap@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-210.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications that propose to investigate the basic science and mechanisms of action underlying the biomechanical, immunological, endocrinological and/or neurophysiological consequences of manual therapies, such as spinal manipulation, mobilization and massage therapy. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 00883 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Eye Institute/NIH/DHHS Title: NEI Clinical Study Planning Grant Program (R34) Contact: Donald F. Everett, M.A. Tel: 301-451-2020 Email: dfe@nei.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-017.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study’s rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. The Clinical Study Planning Grant is designed to facilitate activities central to the refinement of a study’s protocol and procedures and the development of a detailed MOP. The NEI Clinical Study Planning Grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures and/or assess recruitment potential. The Clinical Study Planning Grant is applicable to both epidemiologic and clinical trial research studies. This FOA will utilize the Clinical Study Planning Grant Program for Clinical Trials (R34) mechanism. --------------------------------------------------------------- Program Number: 06863 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Eye Institute/NIH/DHHS Title: NEI Research Grants for Secondary Data Analysis (R21) Contact: Natalie Kurinji, Ph.D. Tel: 301-451-2020 Email: kurinijn@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-252.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications from institutions/organizations that propose to conduct secondary data analyses utilizing existing database resources. Applications may be related to, but must be distinct from, the specific aims of the original data collection. The NEI supports an extensive portfolio of clinical trials and large-scale epidemiologic research projects, wherein numerous data collection activities are required to meet each project’s specific aims. The resultant wealth of data generated by these studies often provides unique, cost-effective opportunities to investigate additional research questions or develop new analytical approaches secondary to a project’s originally intended purpose. Data are not limited to that collected under NEI support but these data are of highest programmatic interest. The R21 may be used to develop new statistical methodologies or to test hypotheses using existing data. Applicants should consider the relevance of their proposed analyses to NEI programs and priorities as described in the “National Plan for Eye and Vision Research” available at http://www.nei.nih.gov. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04736 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Nutrition and Physical Activity Research to Promote Cardiovascular and Pulmonary Health (R21) Contact: Catherine Loria, Ph.D. Tel: 301-435-0702 Email: loriac@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-244.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications that propose research on the roles of nutrition and physical activity in the development, prevention, and management of cardiovascular diseases (CVD) or pulmonary diseases. In particular, the FOA aims to (1) improve knowledge of the contribution of diet and physical activity to these conditions and how sleep influences these relationships, (2) increase the evidence base for refining public health recommendations and clinical guidelines regarding these lifestyle behaviors, and (3) develop and test strategies to improve the adoption of these recommendations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 08320 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Virtual Reality Technologies for Research and Education in Obesity and Diabetes (R21) Contact: Abby G. Ershow, Sc. D., FAHA Tel: 301-435-0550 Email: ershowa@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-212.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsor invites exploratory/developmental research applications that capitalize on the unique capabilities of Virtual Reality (VR) technologies to visualize outcomes, teach, motivate, and to extend the health care and learning environments, in order to foster desirable eating, physical activity, self-care, and other health-related behaviors necessary for prevention and management of obesity and diabetes. Of highest interest are well-designed multidisciplinary projects drawing on expertise in VR technologies and biomedical behavioral, and pedagogical sciences. The overall goal is to develop the potential of VR technologies as research tools for behavioral science-oriented studies in diabetes and obesity, and as practical tools for clinical and public health-level prevention and management of obesity and diabetes. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 82113 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Directed Stem Cell Differentiation for Cell-Based Therapies for Heart, Lung, and Blood Diseases (R21) Contact: John W. Thomas, Ph.D. Tel: 301-435-0065 Email: ThomasJ@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-248.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor invites applications that propose to define the factors and mechanisms controlling the differentiation of embryonic or adult stem or progenitor cells, either in vitro or in vivo. It is designed to stimulate new scientific advances in stem cell differentiation including technology research that may not be hypothesis driven. The long range goal of this program is the development of methods to direct the differentiation or development of stem cells along specific cell lineages to yield replacement cells for clinical use, whether the replacement cells are formed in vitro for delivery or formed in vivo in the tissue or organ environment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23663 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Grant Award (R21) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-251.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose exploratory or novel studies that break new ground or extend previous discoveries toward new directions or applications. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 58251 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03) Contact: Dr. Jean E. McEwen Tel: 301-402-4997 Email: jean.mcewen@nih.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-249.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects. Of particular interest are projects that propose focused legal, economic, philosophical or historical analyses of new or emerging issues. This FOA will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 77653 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: NIOSH Exploratory and/or Developmental Grant Program (R21) Contact: Maryann Monroe Tel: 412-386-4453 Email: MPMonroe@cdc.gov Website:          http://www07.grants.gov/search/search.do?oppId=46756&mode=VIEW Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-139.html Deadline Note: This program expires September 8, 2012 SYNOPSIS: The sponsor provides support for research related to occupational safety and health. Eligible applicants are domestic and foreign for-profit or non-profit organizations, public or private institutions, such as universities, colleges, hospitals, and laboratories, units of state and local governments, eligible agencies of the federal government, faith-based or community based organizations, and Indian Tribes, Tribal Government, and/or Organizations. The R21 award mechanism will be used. --------------------------------------------------------------- Program Number: 88007 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute for Occupational Safety & Health/CDC/DHHS Title: NIOSH Small Research Grant Program (R03) Contact: Susan B. Board, M.S., Scientific Program Officer Tel: 404-498-2530 Email: sboard@cdc.gov Website:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-138.html Full Program:          http://www07.grants.gov/search/search.do?oppId=46753&mode=VIEW Deadline Note: This FOA will expire on September 8, 2012. SYNOPSIS: The sponsor provides support for projects designed to develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, to explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and to translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This FOA will utilize the NIH Small Research Grant (R03) award mechanism, --------------------------------------------------------------- Program Number: 25971 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Research to Advance Vaccine Safety (R01) Contact: Barbara Mulach, Ph.D. Tel: 301-496-1884 Email: bmulach@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-038.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) invites studies that address scientific areas potentially relevant to vaccine safety such as 1) physiological and immunological responses to vaccines and vaccine components, 2) how genetic variations affect immune/physiological responses that may impact vaccine safety, 3) identification of risk factors and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines, 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems, or 5) the application of genomic/molecular technologies to improve knowledge of vaccine safety. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 94374 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21) Contact: David R. Johnson, Ph.D. Tel: 301- 496-7104 Email: drjohnson@niaid.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAS-10-148.html Deadline Note: This program will expire on February May 8, 2013. SYNOPSIS: The sponsors provide support for innovative exploratory/developmental investigations in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 94375 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Allergy and Infectious Diseases/NIH/DHHS Title: Small Grants on Primary Immunodeficiency Diseases (R03) Contact: David R. Johnson, Ph.D. Tel: 301- 496-7104 Email: drjohnson@niaid.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-147.html Deadline Note: This FOA will expire on May 8, 2013. SYNOPSIS: The sponsors invite applications for small grants in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in primary immunodeficiency diseases research, are encouraged to apply to this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 27786 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS Title: Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R21) Contact: Hung Tseng, Ph.D. Tel: 301-496-0810 Email: tsengh@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-132.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. TThis program will expire on May 8, 2015. SYNOPSIS: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications for basic and translational studies aimed at understanding the mechanisms of itch sensation and developing methods to modulate and control itch sensation in disease and rehabilitation. The purpose is to accelerate discovery in this nascent field and to apply new knowledge to improve human conditions relevant to the NIAMS mission. This FOA intends to support a broad range of investigations using animal and human models, with an emphasis on multidisciplinary collaboration for rapid bench-to-bedside exchange of information and therapy development. This FOA is not intended to support applications proposing clinical trials. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24411 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Biomarkers: Bridging Pediatric and Adult Therapeutics (R03) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-323.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Letters of intent may be submitted thirty days prior to the application deadline(s). The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. Projects supported by this FOA will be confined to those biomarkers that correlate with a clinical observation, have been extensively studied in adults, and for which there is solid evidence that they have pediatric applications. Discovery of new biomarkers for use in new drug development or in preclinical studies are not part of this FOA. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24414 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Biomarkers: Bridging Pediatric and Adult Therapeutics (R21) Contact: George P. Giacoia, MD Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-324.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Letters of intent may be submitted thirty days prior to the application deadline(s). The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications from institutions or organizations that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity and response to therapy. Projects supported by this FOA will be confined to those biomarkers that correlate with a clinical observation, have been extensively studied in adults, and for which there is solid evidence that they have pediatric applications. Discovery of new biomarkers for use in new drug development or in preclinical studies are not part of this FOA. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27982 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Research on Emergency Medical Services for Children (EMSC) [R21] Contact: Lynne Haverkos, M.D., M.P.H. Tel: 301-435-6881 Email: lh179r@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-142.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Child Health and Human Development (NICHD) and National Institute of Mental Health (NIMH) invite applications dealing with the following areas of research included under the term EMSC: prevention research to reduce the need for emergency care; clinical research to ensure that children receive high-quality and appropriate medical, nursing and mental health care in an emergency; health systems research, from pre-hospital care, to the emergency department, to in-patient care and return to the community; models to improve service and cost efficiency in pediatric emergency care; and methodological studies to improve the quality of research conducted. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 85920 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Innovative Therapies and Clinical Studies for Screenable Disorders (R21) Contact: Tiina Urv, PhD Tel: 301-402-7015 Email: urvtiin@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-232.html Deadline Note: The deadlines for receipt of full applications are February 16, June 16, and October 16. Non-binding letters of intent are requested thirty days prior to the application receipt date. This program will expire on September 8, 2013. SYNOPSIS: >The sponsor invites applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. This PAR will use the NIH exploratory/developmental research grant (R21) award mechanism. --------------------------------------------------------------- Program Number: 85923 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Innovative Therapies and Tools for Screenable Disorders in Newborns (R03) Contact: Tiina Urv, PhD Tel: 301-402-7015 Email: urvtiin@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-231.html Deadline Note: he deadlines for receipt of full applications are February 16, June 16, and October 16. Non-binding letters of intent are requested thirty days prior to the application receipt date. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 98036 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Developmental Pharmacology (R03) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-11-058.html Deadline Note: The sponsor requests that optional letters of intent be submitted 30 days before application receipt date. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite grant applications for research related to developmental pharmacology. A major aim of this FOIA is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways activity across developmental periods from fetal life to adolescence. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 98448 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: Mechanisms of Adverse Drug Effects in Children (R03) Contact: George P. Giacoia, M.D. Tel: 301-496-5589 Email: gg65m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-052.html Deadline Note: The sponsor requests that optional letters of intent be submitted thirty days prior to the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the molecular, cellular and genetic mechanisms involved in the production of adverse drug reactions in children. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 01128 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Contact: Emily L. Harris, Ph.D., M.P.H. Tel: 301-594-4846 Email: emily.harris@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-10-041.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research projects that involve secondary data analyses or development of statistical methodology using existing genome-wide data, relevant to human dental or craniofacial conditions or traits. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 18248 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Grant Program for New Investigators (R03) Contact: Dr. Melissa Riddle Tel: 301-451-3888 Email: md74u@nih.govriddleme@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-275.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor provides funding to scientists who are in the early stages of establishing an independent research career in dental and craniofacial research. --------------------------------------------------------------- Program Number: 24546 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Immunopathogenesis of HIV/AIDS-related Oral Manifestations and Host Immunity (R21) Contact: Isaac R. Rodriguez-Chavez, Ph.D., M.S., M.H.S. Tel: 301-594-7985 Email: isaac@nidcr.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-333.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after December 7, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose studies to translate new scientific insights about HIV infection, oral pathogen co-infections (viruses, bacteria and fungi) and AIDS-related oral opportunistic infections (viruses, bacteria, and fungi) into better understanding of the immunopathogenesis of these infectious agents to guide translational research focused on the development of novel, oral mucosal prophylactic HIV vaccines as well as therapeutic strategies against HIV, oral co-infections and oral opportunistic infections. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 79254 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) Contact: Dena Fischer, DDS, MSD, MS Tel: 301-594-4876 Email: dena.fischer@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-120.html Deadline Note: This program will expire on May 8, 2012, unless reissued. SYNOPSIS: National Institute of Dental and Craniofacial Research (NIDCR) provides support for meritorious research projects that involve secondary data analyses using existing dental or craniofacial database resources. This program will use the Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 90126 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw (R21) Contact: Jane C. Atkinson, D.D.S., Director Tel: 301-435-7908 Email: jatkinso@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-083.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose to study the underlying pathophysiology of osteonecrosis of the jaw (ONJ), identify risk factors for this condition, establish the natural history of the disease, and generate evidence for its treatment. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 97843 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Dental and Craniofacial Research/NIH/DHHS Title: NIDCR Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant (R34) Contact: Jane C. Atkinson, DDS, Program Director Tel: 301-435-7908 Email: jatkinson@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-338.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for clinical trial planning (R34) grants for the planning and design of clinical trials or biomarker clinical evaluation studies. The R34 grant award will provide support for activities that include, but are not limited to: the establishment of the research team; the development of the clinical protocol and Clinical Investigators Brochure (or equivalent); the development of tools for data management, safety and operational oversight of the research; the definition of recruitment strategies; and all essential elements of the study such as a Manual of Procedures for the clinical trial or biomarker clinical evaluation study, or a draft of the manualized behavioral, community, or services intervention. (See Scope for more detail.) The Clinical Trial or Biomarker Clinical Evaluation Study Planning Grant is not designed for the collection of preliminary data (clinical or pre-clinical), or the collection of prospective data to support the rationale for a clinical trial or study. This program will use the NIDCR Clinical Trial Planning (R34) grant mechanism. --------------------------------------------------------------- Program Number: 27738 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21) Contact: James E. Everhart, M.D., M.P.H. Tel: 301-594-8878 Email: je17g@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-125.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: The sponsors invite applications that propose to conduct secondary analysis of existing data sets relevant to diabetes and endocrine and metabolic diseases; digestive diseases and nutrition, including obesity and eating disorders; and kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28131 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21) Contact: Louis Martey Tel: 301-594-7733 Email: marteylk@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-157.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites pilot and feasibility clinical and behavioral studies related to the prevention or treatment of diabetes and endocrine and genetic metabolic diseases. The Pilot and Feasibility Clinical Research Grants Program is for exploratory, short-term clinical studies, so that new ideas may be investigated without stringent requirements for preliminary data. The short-term studies should focus on research questions that are likely to have high clinical impact. Studies can include testing a new prevention strategy, a new intervention or a unique combination of therapies. A high priority is the use of such studies to help stimulate the translation of promising research developments from the laboratory into clinical practice in the treatment or prevention of diabetes, endocrine diseases and genetic metabolic diseases, including cystic fibrosis. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04682 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of General Medical Sciences/NIH/DHHS Title: Exploratory Innovations in Biomedical Computational Science and Technology (R21) Contact: Peter Lyster, Ph.D. Tel: 301-451-6446 Email: lysterp@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-219.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invites applications for research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. As defined here, biomedical computing or biomedical information science and technology includes database design, graphical interfaces, querying approaches, data retrieval, data visualization and manipulation, data integration through the development of integrated analytical tools, and tools for electronic collaboration, as well as computational and mathematical research including the development of structural, functional, integrative, and analytical models and simulations. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 01328 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) Contact: Mi Hillefors, M.D., Ph.D. Tel: 301-443-1692 Email: mi.hillefors@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-071.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute of Mental Health (NIMH) invites applications for collaborative preliminary intervention studies to evaluate the feasibility, tolerability, acceptability and safety of novel mechanism drug candidates, promising investigational new drugs (INDs), or novel psychosocial strategies for the treatment of mental disorders and for obtaining the preliminary data needed as a pre-requisite to larger-scale (efficacy or effectiveness) intervention or services studies. This FOA should be used when at least two but no more than three sites from different Institutions/Organizations are needed to complete the study. The collaborating studies should be organized in order to increase sample size, accelerate recruitment, and/or increase sample diversity and representation. For a linked set of collaborative R34s, each site shall have its own Program Director/Principal Investigator and provide for a mechanism for cross-site coordination, quality control, database management, statistical analysis, and reporting. This FOA will utilize the NIMH Collaborative R34 award mechanism. --------------------------------------------------------------- Program Number: 20289 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Translational Research for the Development of Novel Interventions for Mental Disorders (R21/R33) Contact: Ann Wagner, Ph.D. Tel: 301-443-5944 Email: awagner@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-177.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2014. SYNOPSIS: The sponsors invite applications o speed the translation of emerging findings on the neuroscience of mental disorders into novel intervention approaches that will ultimately reduce symptoms and/or restore function. This FOA provides support for up to two years (R21 phase) for preliminary, proof-of-principle studies in human participants, followed by up to 3 years of support (R33 phase) for pilot studies to assess the implementation of the intervention, and evaluate the feasibility of conducting a larger trial to assess the efficacy of the intervention. A range of non-pharmacologic treatment approaches will be accepted, including those based on neurophysiological, cognitive, affective, and/or social neuroscience models, basic behavioral science, and neurodevelopmental models. Applications submitted in response to this FOA must involve novel treatment targets, and/or novel and highly innovative approaches to engage and modify known targets. This FOA will utilize the NIH R21/R33 Phased Innovation Award mechanism. --------------------------------------------------------------- Program Number: 24034 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Molecular and Cellular Substrates of Complex Brain Disorders (R21) Contact: Chiiko Asanuma, Ph.D. Tel: 301-443-5288 Email: cs2j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-300.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsor invites applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24281 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Scalable Assays for Unbiased In Vitro Analysis of Neurobiological Function (R21/R33) Contact: Laurie Nadler, Ph.D. Tel: 301-443-5288 Email: lnadler@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-319.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications to develop novel, robust analytical platforms using in vitro assays to reveal changes in neuronal and/or glial function. The goal is to adapt state-of-the-art measures of basic cellular processes or molecular events that are key mediators of nervous system function with the intent to probe mechanisms and/or perturbations in an unbiased and efficient manner. The novel assay platforms would provide opportunities to measure neurobiological endpoints and build a pipeline to be used in the context of target identification and drug discovery. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 26149 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Solicitation of Assays for High Throughput Screening (HTS) to Discover Chemical Probes (R21) Contact: Yong Yao, Ph.D. Tel: 301-443-6102 Email: yyao@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-059.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. Optional letters of intent may be submitted thirty days prior to the relevant application deadline. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: NIH invites applications to form collaborations with an established academic, nonprofit, or commercial high throughput screening (HTS) facility that has the requisite expertise and experience to implement HTS-ready assays for the discovery and development of small molecule chemical probes. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatment relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on assays that provide new insight into important disease targets and processes. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 74259 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Contact: Linda Brady, Ph.D. Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-023.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 88016 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Research on Autism and Autism Spectrum Disorders (R21) Contact: Lisa Gilotty, Ph.D. Tel: 301-443-3825 Email: gilottyl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-160.html Deadline Note: This program will expire on May 8, 2013. SYNOPSIS: >The sponsor invites applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This FOA is intended to support the broad research goals of the Strategic Plan for ASD Research (http://iacc.hhs.gov/reports/2009/iacc-strategic-plan-for-autism-spectrum-disorder-research-jan26.shtml). This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 89591 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award [R21/R33]) Contact: Linda Brady, Ph.D. Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-024.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. This program will use the NIH Exploratory/Developmental Grant and Exploratory/Developmental Grant Phase II Phased Innovation Grant (R21/R33) award mechanisms. --------------------------------------------------------------- Program Number: 90921 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: Drug Discovery for Nervous System Disorders (R21) Contact: Jamie Driscoll Tel: 301-443-5288 Email: jdrisco1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-002.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invites applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91466 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Neurological Disorders and Stroke/NIH/DHHS Title: Neurobiology of Migraine (R21) Contact: Linda L. Porter, Ph.D. Tel: 301-496-9964 Email: porter@ninds.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-259.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications from institutions/organizations that intend to perform innovative research that will expand our current knowledge of neurobiological mechanisms underlying migraine headache, examine the role of neuromodulators, genetic and environmental influences in migraine susceptibility, and explore new targets for therapy development. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05219 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Mechanisms, Models, Measurement and Management in Pain Research (R21) Contact: Dr. Susan Marden, Ph.D., Program Director Tel: 301-496-9623 Email: mardens@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-007.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05221 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Mechanisms, Models, Measurement and Management in Pain Research (R03) Contact: Dr. Susan Marden, Ph.D., Program Director Tel: 301-496-9623 Email: mardens@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-008.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24462 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R03) Contact: Linda S. Weglicki, Ph.D., R.N., M.S.N. Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-328.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24463 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21) Contact: Linda S. Weglicki, Ph.D., R.N., M.S.N. Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-329.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014 . SYNOPSIS: The sponsors invite applications that employ innovative research to identify mechanisms of influence and/or promote positive sustainable health behavior(s) in children and youth (birth to age 18). Positive health behaviors may include: developing healthy sleep patterns, developing effective self-regulation strategies, adaptive decision-making in risk situations, practicing proper dental hygiene, eating a balanced and nutritious diet, engaging in age-appropriate physical activity and/or participating in healthy relationships. Applications to promote positive health behavior(s) should target social and cultural factors, including, but not limited to: schools, families, communities, population, food industry, age-appropriate learning tools and games, social media, social networking, technology and mass media. Topics to be addressed in this announcement include: effective, sustainable processes for influencing young people to make healthy behavior choices; identification of the appropriate stage of influence for learning sustainable lifelong health behaviors; the role of technology and new media in promoting healthy behavior; identification of factors that support healthy behavior development in vulnerable populations, identification of barriers to healthy behaviors; and, identification of mechanisms and mediators that are common to the development of a range of habitual health behaviors. Given the many factors involved in developing sustainable health behaviors, applications from multidisciplinary teams are strongly encouraged. The ultimate goal of this FOA is to promote research that identifies and enhances processes that promote sustainable positive behavior or changes social and cultural norms that influence health and future health behaviors. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27872 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R21) Contact: Karen Huss, PhD, RN, APRN-BC, FAAN, FAAAAI Tel: 301-594-5970 Email: hussk@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-134.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 16, 2012. The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2016. SYNOPSIS: National Institute of Nursing Research (NINR) and National Institute of Environmental Health Sciences (NIEHS) invite applications for interdisciplinary research aimed at promoting health, limiting symptoms and disease, and reducing health disparities in children and older adults living or spending time in non-traditional settings. These settings result in exposure to environmental pollutants and toxins that result in health risks, symptoms, and other health conditions/diseases including lower respiratory diseases, chronic obstructive pulmonary disease, and cardiovascular diseases. Risk identification and symptom management include prevention and behavior changes and actions to maintain health and prevent disease with an emphasis on the individual, family, and community which will advance nursing science. For purposes of this FOA, non-traditional settings, for children and older adults, include, but are not limited to places such as community centers, pre-school and non-traditional school environments (e.g., churches, daycare, home-based schools, dormitories, and alternative schools), child and older adult foster care facilities, older adult day care facilities, half-way homes, assisted living and long-term care facilities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 93596 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute of Nursing Research/NIH/DHHS Title: Reducing Health Disparities Among Minority and Underserved Children (R21) Contact: Dr. Linda S. Weglicki, PhD, RN, MSN Tel: 301-594-6908 Email: weglickils@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-105.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invites applications to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 00898 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Critical Illness and Injury in Aging (R03) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-043.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 00900 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Critical Illness and Injury in Aging (R21) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-044.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for proposing to study mechanisms and management of critical illness and injury, including trauma and neurotrauma, in aging. Studies may be mechanistic, observational, or interventional in nature. Secondary analyses of existing datasets, such as from large observational studies or clinical trials, may be proposed. Animal studies are appropriate in cases where human studies are not feasible. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 01031 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Clinical Trial Planning Grants for Critical Illness and Injury in Aging (R34) Contact: Basil Eldadah, M.D., Ph.D. Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-10-045.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications to develop research protocols for Phase III and IV clinical trials related to critical illness and injury in aging. The planning grant mechanism is intended to permit early peer review of the rationale and design of the proposed Phase III or IV clinical trial, and to support development of a research team, tools for data management and research oversight, recruitment strategies, detailed protocol and Manual of Procedures (MOP), and other essential components necessary for a competitive clinical trial application. This FOA will utilize the Clinical Trial Planning Grant (R34) mechanism. --------------------------------------------------------------- Program Number: 02509 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R21) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-194.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 02510 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R03) Contact: Wen G. Chen, Ph.D. Tel: 301496-9350 Email: chenw@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-09-195.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/organizations that propose to (1) study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain, (2) examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people, (3) evaluate existing pain assessment and/or management approaches in older adults, or (4) develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 05623 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Development and Characterization of Animal Models for Aging Research (R21) Contact: Mahadev Murthy, Ph.D., M.B.A. Tel: 301-402-7749 Email: mmurthy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-015.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics. This FOA encourages applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 11048 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Identification and Characterization of Molecular Targets Within the mTOR Pathway With Potential to Impact Healthspan and Lifespan (R21) Contact: Nancy L. Nadon, Ph.D., Chief Tel: 301-402-7744 Email: nadonn@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-164.html Deadline Note: This program will expire on May 18, 2013. SYNOPSIS: The sponsors invite applications focused on: 1) identifying novel targets within the mTOR (mammalian target of rapamycin) signaling network, the manipulation of which has the potential to promote healthy aging, i.e. extend health span in the aged (NIA interest); and 2) identifying and characterizing dietary constituents that modulate the mTOR pathway and promote cancer prevention (NCI interest). Identification and characterization of targets can utilize a wide range of approaches, including medicinal chemistry, in vitro assays, and studies in lower organisms or mammalian models. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 17845 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Asthma in Older Adults (R21) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-264.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors invite applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 17852 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Asthma in Older Adults (R03) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-265.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsors invite applications that propose to study the pathophysiology, epidemiology, diagnosis, and/or management of asthma in older adults. Much of what is known about asthma in adults is based on studies in younger adult populations; however, the mechanisms underlying asthma in some older adults may differ, which may impact on diagnostic, treatment, and prevention strategies. This FOA is intended to stimulate research to address knowledge gaps and research opportunities in asthma in later life. A variety of study approaches are encouraged with this FOA including basic, translational, clinical, and epidemiological studies. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 23739 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-Related Conditions (R21) Contact: Chhanda Dutta, PhD Tel: 301-435-3048 Email: DuttaC@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-11-280.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications for projects intended to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. For projects proposing basic research that is being conducted in animal models, the potential to treat a clinical age-related pathology must be clearly stated in the proposal. Direct relevance of the data to a clinical aging condition must be established and clearly stated in the application. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24277 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Single Cell Studies in Aging Research (R21) Contact: Dr. Jose Velazquez Tel: 301-496-6428 Email: jvelazqu@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-321.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications hat propose to develop research on single cell biology to enhance the understanding of the mechanisms of normal aging and of age-related diseases. Applications using -omics technologies, imaging, optofluidic platforms, mass spectroscopy, whole genome sequencing, and other tools and technologies at the single cell level are encouraged since it is expected that the single cell approach will improve the determination of unique and biologically significant properties of tissues and organs during the aging process. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25844 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Mechanisms Mediating Osteoarthritis in Aging (R21) Contact: John P. Williams, Ph.D. Tel: 301-496-6402 Email: williamsj6@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-018.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases invite applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms mediating osteoarthritic progression. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 46809 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Grants for Alzheimer's Disease Drug Discovery (R21) Contact: Suzana S. Petanceska, Ph.D. Tel: 301-496-9350 Email: petanceskas@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-151.html Deadline Note: This FOA will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications to advance the discovery of new, efficacious therapies for the treatment, delay of progression, or prevention of Alzheimer’s disease (AD), mild cognitive impairment (MCI) and age-related cognitive decline. This FOA encourages the early stages of drug discovery necessary to identify promising disease-modifying therapies as well as treatments aimed at ameliorating the cognitive and neuropsychiatric/behavioral symptoms characteristic of Alzheimer’s disease. Studies aimed at the discovery and testing of therapies directed at a variety of established as well as novel therapeutic targets are encouraged. The goal is not to duplicate or compete with pharmaceutical companies but to encourage the process of discovering new, innovative, and effective therapeutics for the prevention and treatment of the cognitive impairment and behavioral symptoms associated with Alzheimer's disease. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 82577 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Aging Research Dissertation Awards to Increase Diversity (R36) Contact: Michael-David AAR Kerns, M.B.A., M.S., Ph.D. Tel: 301-402-7713 Email: kernsmd@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-291.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after October 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsor invites applications for dissertation awards in all areas of research within NIA’s strategic priorities to increase diversity of the scientific research workforce engaged in research on aging and aging-related health conditions. This FOA will use the NIH R36 dissertation award mechanism. --------------------------------------------------------------- Program Number: 98218 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: Translational Research at the Aging/Cancer Interface (TRACI) (R21) Contact: Basil Eldadah, MD, PhD Tel: 301-496-6761 Email: eldadahb@nia.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-135.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute on Aging (NIA)and National Cancer Institute (NCI) invite applications for translational research proposals in the overlapping areas of human aging and cancer, linking basic and clinical research relevant to the care of older cancer patients through both bench-to-bedside and bedside-to-bench approaches. Ultimately, information from the research supported by this initiative should improve the health and well-being of elderly patients at risk for, or diagnosed with, cancer and decrease the functional impairment and morbidity associated with cancer in this population. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 03539 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Mechanistic Studies of Pain and Alcohol Dependence (R21) Contact: Mark Egli, Ph.D. Tel: 301-594-6382 Email: megli@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-268.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct mechanistic studies on the relationship between alcohol drinking, alcohol dependence and pain. An association between chronic pain conditions and alcohol dependence has been revealed in numerous studies with episodes of alcohol abuse antedating chronic pain in some people and alcohol dependence emerging after the onset of chronic pain in others. Pain transmission and alcohol’s reinforcing effects share overlapping neural substrates giving rise to the possibility that chronic pain states significantly affect alcohol use patterns and promote the development of dependence and addiction. In addition, long term alcohol intoxication and alcohol dependence induce pain symptoms and may exacerbate chronic pain arising from other sources. The objective of this FOA is to understand genetic, pharmacological and learning mechanisms underlying the association between the propensity to drink alcohol and pain responses. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 09874 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R21) Contact: Max Guo, Ph.D. Tel: 301-443-0639 Email: Max.Guo@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-086.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2010. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study biological processes involving the cellular organelles in alcohol-induced tissue injury. Excessive alcohol consumption can damage many organ systems including the liver, heart, pancreas, brain, and lung. However, the mechanisms for these injuries are currently not fully understood. Cellular organelles play an important role in cellular functions and are significantly involved in alcohol-induced tissue injury. Thus, studies of alcohol’s effects on the structure and function of cellular organelles are critical to better understand the mechanisms of alcohol-induced injuries and to develop new strategies for their diagnosis and treatment. The purpose of this FOA is to: (1) better understand how acute or chronic alcohol consumption affects the structure and function of cellular organelles, and in turn, how these changes contribute to alcohol-induced injury; (2) investigate how variations of proteins in cellular organelles, or their regulation and function, including cellular signaling pathways, contribute to an individual’s response to acute or chronic alcohol intake and alcohol-induced tissue injury; (3) develop potential biomarkers for prognosis and diagnosis of tissue injury, or identify new targets for therapeutic interventions. This FOA aims to foster the utilization of innovative experimental design and emerging technologies, such as genomics, proteomics, metabolomics, bioinformatics, as well as novel microscopic imaging techniques that illuminate functions in intact cells and tissues, to generate new mechanistic and clinical insights into alcohol-induced tissue injuries. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 09878 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Stress Pathways in Alcohol Induced Organ Injury and Protection (R21) Contact: Andras Orosz, Ph.D. Tel: 301-443-2193 Email: orosza@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-094.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2013. SYNOPSIS: The sponsor invites applications that propose studying the role of cellular stress responses, the cytoplasmic classical stress response or heat shock response (HSR) and the endoplasmic reticulum (ER) stress, in alcohol-induced tissue injury and tissue protection. While excessive alcohol use causes organ damage, moderate alcohol consumption may be beneficial. The underlying molecular mechanisms for this apparent dichotomy of alcohol’s harmful and salutary effects are currently not fully understood. Alcohol induces cellular stress pathways in the cytoplasm and in the endoplasmic reticulum that may significantly be involved in alcohol-induced tissue injury or mediate tissue protection depending on the quantity, frequency, duration, and temporal pattern of drinking. Hence, studies of the effects of alcohol on cellular stress pathways are critical to understand the mechanisms of alcohol-induced injuries or protection to develop new strategies for prevention, diagnosis and treatment. The purpose of this FOA is to: (1) acquire insight into how acute or chronic alcohol consumption affects cellular stress pathways and in turn, how these changes contribute to alcohol-induced injury/protection; (2) investigate how alcohol induced stress responses mediate cell survival and death signaling pathways at macromolecular, organelle, cellular and organism level contributing to alcohol-induced tissue injury/protection; (3) develop potential stress related biomarkers for prognosis, diagnosis of tissue injury/protection, furthermore identify new targets for their therapeutic interventions. Utilizing innovative experimental design and emerging technologies, such as deep sequencing, genomics, proteomics, metabolomics, bioinformatics, and novel imaging techniques these investigations are expected to provide a more comprehensive understanding of how alcohol affects the evolutionally conserved stress pathways and elucidate their roles in tissue injuries and repair. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16835 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Endocannabinoid Signaling in Alcohol Consumption, Intoxication and Alcohol Use Disorders (R21) Contact: Qi-Ying Liu, M.D. Tel: 301-443-2678 Email: liuqiy@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-250.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to study the roles and underlying mechanisms of endocannabinoid signaling in alcohol preference, consumption, intoxication and alcohol use disorders, and to explore endocannabinoid signaling system as potential targets for alcohol pharmacotherapy. With increasing knowledge of the function of eCBs in the developing and adult brain and recent behavioral and pharmacological evidence linking alcohol and eCB signaling system, there is now great potential to explore the role of eCB signaling system in alcohol-related behaviors and alcohol use disorders. Studies supported with this FOA will help to gain knowledge about the role and underlying mechanisms of eCB signaling in alcohol preference and consumption; the interactions of acute and chronic alcohol exposure with eCBs at synapses; the effects of such interactions on short- and long-term synaptic plasticity; the role of eCB signaling in the development and maturation of the central nervous system; and the eCB signaling system in fetal alcohol spectrum disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16843 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Treatment of Co-Occurring Alcohol Use Disorders and Depression/Anxiety Disorders (R21) Contact: Deidra Roach, M.D. Tel: 301-443-5820 Email: droach@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-252.html Deadline Note: The sponsor encourages optional letters of intent no more than thirty days before the application due date. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications to support research on the treatment of individuals with co-occurring alcohol use disorders and depression/anxiety. Anxiety disorders include generalized anxiety disorder, social phobia, and posttraumatic stress disorder. The scope of interest includes innovative pharmacological and behavioral treatments based on biological, psychological, behavioral, and social/cultural models of etiology and treatment of comorbid alcohol use disorders and depression/anxiety. In addition, this FOA accepts Comparative and Effectiveness Research applications which compare two or more different existing treatments in this comorbid population. This FOA is limited to depression and anxiety because of the high prevalence of these psychiatric disorders in individuals with alcohol use disorders. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 16994 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Behavioral Regulation Mechanisms of Alcohol Dependence and Related Phenotypes (R21) Contact: Ivana Grakalic, Ph.D. Tel: 301-443-7600 Email: igrakalic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-256.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications that propose to examine the mechanisms of behavioral regulation contributing to the behavioral characteristics of alcohol dependence. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 20845 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Neuroimmune Mechanisms Of Alcohol Related Disorders (R21) Contact: Changhai Cui, PhD Tel: 301-443-1678 Email: changhai.cui@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-065.html Deadline Note: The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 24088 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Secondary Analysis of Existing Alcohol Epidemiology Data (R03) Contact: Wenxing Zha, Ph.D. Tel: 301-443-0633 Email: zhaw@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-309.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor invites applications that propose to conduct secondary analysis of existing data sets. NIAAA seeks to enhance the understanding of the patterns of alcohol consumption and the epidemiology of alcohol-related problems. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 25816 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R21) Contact: M. Katherine Jung, PhD Tel: 301-443-8744 Email: jungma@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-026.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015 . SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from researchers with broad ranges of expertise to study the consequences of alcohol consumption on immune function with the ultimate goal of alleviating infection and reversing alcohol-induced organ damage. Susceptibility to infection and organ damage are the two most common causes of alcohol-related morbidity and mortality. These consequences of alcohol abuse are closely associated with profound impairment of the host innate and adaptive immune systems. The mechanisms of these immune alterations and their link with alcohol-related medical problems are, in most cases, poorly understood. The goal of this FOA is to attract applications on basic and translational research: 1) to identify how alcohol alters immune function; 2) to establish functional links between immune alterations and alcohol related infections and organ damage; and 3) to develop means for mitigating immune impairment with the goal of alleviating alcohol-induced pathology. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 25822 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Effects of Adolescent Binge Drinking on Brain Development (R21) Contact: Dr. Lawrence Baizer Tel: 301-443-9334 Email: baizerl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-028.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28362 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Alcohol Abuse, Sleep Disorders and Circadian Rhythms (R21) Contact: Dr. Lindsey Grandison Tel: 301-443-0606 Email: lindsey.grandison@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-178.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on May 8, 2015. SNYOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies in humans and animal models on the relationships between alcohol abuse, circadian rhythms and sleep disorders. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87411 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS Title: Mechanisms of Alcohol-associated Cancers (R21) Contact: M. Katherine Jung, PhD Tel: 301-443-8744 Email: jungma@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-147.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2015. SYNOPSIS: National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Cancer Institute (NCI) invite applications from researchers with broad ranges of expertise to study the mechanisms by which alcohol increases cancer risk. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 75557 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: Proteomics in Auditory Developmental and Disease Processes (R21) Contact: Nancy L. Freeman, Ph.D. Tel: 301-402-3458 Email: freeman@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-078.html Deadline Note: This program will expire on January 8, 2013. SYNOPSIS: The sponsor provides support to expand support of proteomic research in the auditory system. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 04580 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Optimization of Small Molecule Probes for the Nervous System (R21) Contact: Hari Singh, Ph.D., Program Director Tel: 301-435-1310 Email: hs87j@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-251.html Deadline Note: The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsors invite applications from institutions/ organizations that propose to develop new small molecule probes for investigating biological function in the nervous system via the application of advanced medicinal chemistry and the biological testing of compounds. Eligible investigators will have identified probe candidates via screening of small molecule collections, using in vitro assays of biological activity developed to interrogate these collections, and be able to show that the structural features of these small molecules are related to their biological activity. Proposals should nominate small molecule probe candidates from distinct structural series for the further, iterative design and testing of analogues in structure-activity relationship studies, using in vitro assays of biological function adapted to the medium throughput screening requirements of this work. These studies should have the goal of developing a small molecule probe possessing the attributes (eg: affinity, selectivity, activity) required for its use in future pharmacological studies proposed by the investigator. Applicants are strongly encouraged to utilize publicly available cheminformatic capabilities for the acquisition of compounds, and semi-custom synthesis of analogues. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 05472 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R34) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-013.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for evidence-based treatment research through 1) the development, manualization, standardization, early-stage efficacy and/or pilot testing of novel or adapted treatments and/or interventions (i.e. Stage 1 treatment research, see below), 2) the refinement, modification, adaptation and/or pilot testing of interventions with demonstrated efficacy for use in broader scale efficacy or effectiveness trials, or 3) novel treatment research that requires preliminary testing or development. It is expected that research conducted via this R34 mechanism will primarily consist of Stage I treatment development research that will provide feasibility, tolerability, and acceptability information and/or pilot data for larger scale Stage II or Stage III behavioral and integrative treatment studies. This FOA seeks to support research, as described above, within the domains of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. This FOA will use the R34 mechanism. --------------------------------------------------------------- Program Number: 07869 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Technology-Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34) Contact: Shoshana Y. Kahana, Ph.D. Tel: 301-443-2261 Email: kahanas@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-12-118.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after April 7, 2012. The deadlines for receipt of standard R21 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) invites applications to test the utility and implementation of technological tools, including mobile devices, to promote engagement in Human Immunodeficiency Virus (HIV) care among substance abusing populations with HIV. Research projects may focus on (a) the use of technology to directly improve patient-level outcomes (i.e., adherence); (b) the capacity of HIV treatment providers and related service delivery organizations to adopt and integrate such technologies to promote HIV treatment outcomes; or (c) the use of technology to improve the organization and delivery of HIV treatment and services. This FOA will utilize the R34 grant mechanism. --------------------------------------------------------------- Program Number: 09040 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Gene-Environment Interplay in Substance Use Disorders (R21) Contact: Naimah Weinberg, M.D. Tel: 301-402-1908 Email: nw46w@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-236.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23177 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Epidemiology of Drug Abuse (R21) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-231.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor offers support for research projects to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 23178 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Epidemiology of Drug Abuse (R03) Contact: Marsha F. Lopez, Ph.D., M.H.S. Tel: 301-443-6504 Email: lopezmar@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-232.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsor offers support for research projects to enhance our understanding of the nature, extent, distribution, etiology, and consequences of drug use, abuse, and addiction across individuals, families, communities, and diverse population groups. This Program strongly encourages applications that address multiple levels of causation, reflecting the breadth of epidemiology research, that are transdisciplinary in nature and apply novel methods that allow for the advancement of science (e.g., those that investigate interplay among genetic, environmental, and developmental factors, or those that examine how aspects of social environments affect health outcomes), as well as those that take advantage of the investments made by NIH and other funders by using existing data to inform our understanding of drug abuse epidemiology and etiology in a creative and cost efficient manner. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 26300 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Imaging - Science Track Award for Research Transition (I/START) [R03] Contact: Steven Grant, Ph.D. Tel: 301-443-4877 Email: sgrant@nida.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-066.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2015. SYNOPSIS: National Institute on Drug Abuse (NIDA) invites applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 28320 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Contact: Jacqueline Lloyd, Ph.D. Tel: 301-443-8892 Email: lloydj2@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-171.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 16, 2012. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications for (a) pilot and/or feasibility testing of new, revised, or adapted preventive intervention approaches targeting the initiation of drug and alcohol use, the progression to abuse or dependence, and the acquisition or transmission of HIV infection among diverse populations and settings; and (b) pre-trial feasibility testing for prevention services and systems research. This R34 mechanism does not support the development of intervention protocols, manuals, or the standardization of protocols. It is expected that research conducted via this R34 mechanism will consist of early stage efficacy, effectiveness or services research that will provide intervention pilot and/or feasibility data that is a pre-requisite for submitting larger drug or alcohol abuse and/or drug- or alcohol-related HIV prevention intervention studies. This FOA will utilize the NIH Planning Grant (R34) award mechanism. --------------------------------------------------------------- Program Number: 32445 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral Science Track Award for Rapid Transition (B/START) (R03) Contact: Paul Schnur, Ph.D. Tel: 301-443-1887 Email: pschnur@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-09-239.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2012. SYNOPSIS: The sponsor provides support to facilitate the entry of beginning investigators into the field of behavioral science research. To be appropriate for a B/START award, research must be primarily focused on behavioral processes and research questions. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 87632 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-048.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 87634 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Contact: Cora Lee Wetherington, Ph.D. Tel: 301-435-1319 Email: cwetheri@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PA-11-049.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsors invite applications to advance research on male-females differences in drug and alcohol abuse and addiction and on factors specific to women. Both human and animal model studies are sought. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 89265 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Behavioral & Integrative Treatment Development Program (R03) Contact: Lisa Onken, Ph.D. Tel: 301-443-2235 Email: Lisa_Onken@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-011.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2013. SYNOPSIS: The sponsors invite applications for discrete, well-defined projects that can be completed within two years with limited resources. Projects of interest fall within the research domain of behavioral, combined, sequential, or integrated (behavioral/pharmacological) (1) drug abuse treatment interventions, including interventions for patients with comorbidities, in diverse settings; (2) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (3) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (4) interventions to treat chronic pain. Specific examples include: 1) Stage I pilot or feasibility studies; 2) secondary analysis of existing data; 3) small, self-contained research projects; 4) development of research assessments or methodology; and 5) development of new research technology. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 91124 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R03) Contact: John Satterlee, Ph.D. Tel: 301-435-1020 Email: satterleej@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-035.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 91126 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Functional Genetics, Epigenetics, and Non-coding RNAs in Drug Addiction (R21) Contact: John Satterlee, Ph.D. Tel: 301-435-1020 Email: satterleej@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-034.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014. SYNOPSIS: The sponsor invites applications for basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 91696 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) – NIDA (R21/R33) Contact: Rao S. Rapaka, Ph.D. Tel: 301-435-1304 Email: rr82u@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAS-10-274.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. This program will expire on September 8, 2013. SYNOPSIS: The sponsor invites applications for basic chemistry research applied to drug abuse and addiction. This FOA will utilize the Exploratory/Developmental Phased Innovation (R21/R33) grant mechanism. --------------------------------------------------------------- Program Number: 92005 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Neuroscience Research on Drug Abuse (R21) Contact: Nancy S. Pilotte, Ph.D., Chief Tel: 301-435-1317 Email: npilotte@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-269.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 92008 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Neuroscience Research on Drug Abuse(R03) Contact: Nancy S. Pilotte, Ph.D., Chief Tel: 301-435-1317 Email: npilotte@nida.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-270.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 93879 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: National Institute on Drug Abuse/NIH/DHHS Title: Gene-Environment Interplay in Substance Use Disorders (R03) Contact: Naimah Weinberg, M.D. Tel: 301-402-1908 Email: nw46w@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-11-237.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors provide support to stimulate and expand research on the interplay of genetic and environmental factors in the genesis, course, and outcomes of substance and alcohol use disorders (SUDs). Previous work in genetic epidemiology and molecular genetics has established that SUDs are highly heritable, developmental disorders with important genetic substrates. Building on these findings, new studies using genetically informative approaches are needed to elucidate the complex interplay of genetic and environmental factors in developmental trajectories of SUDs and comorbid conditions, deepen and refine phenotypic definitions of SUDs, and meet the methodologic challenges of the field. Such studies hold great potential to promote understanding of the true contributions of both genetic and environmental factors to initiation, progression, comorbidity, adverse outcomes, and desistance of SUDs; to elucidate mechanisms of risk; and to enhance opportunities for translation to treatment, prevention, gene-finding and molecular studies. This program will use the NIH Small Research Grant (R03) award mechanism. --------------------------------------------------------------- Program Number: 24152 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Office of Behavioral and Social Sciences Research/NIH/DHHS Title: Systems Science and Health in the Behavioral and Social Sciences (R21) Contact: Patricia L. Mabry, PhD Tel: 301-402-1753 Email: mabryp@od.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-315.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after September 16, 2011. Letters of intent may be submitted thirty days prior to application receipt dates. The deadlines for receipt of standard R01 applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2014. SYNOPSIS: The sponsors invite applications for that propose to develop basic and applied projects utilizing systems science methodologies relevant to human behavioral and social sciences and health. This FOA is intended to encourage a broader scope of topics to be addressed with systems science methodologies, beyond those encouraged by existing open FOAs. Research projects applicable to this FOA are those that are either applied or basic in nature (including methodological development), have a human behavioral and/or social science focus, and feature systems science methodologies. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 10017 --------------------------------------------------------------- ***Deadlines: 6/16/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: Development of Animal Models and Related Biological Materials For Research (R21) Contact: Michael C. Chang, Ph.D. Tel: 301-435-0744 Email: changmic@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-10-138.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: February 16, June 16, and October 16 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2010. SYNOPSIS: The sponsor solicits applications from institutions/ organizations that propose to develop, characterize or improve animal models for human disease or to improve diagnosis and control diseases of laboratory animals that may interfere with research. Models to be considered must be applicable to the research interests of two or more categorical NIH Institutes/Centers. Investigators considering applying are strongly encouraged to consult with NCRR program staff as early as possible to be advised whether this FOA is appropriate. Proposals to develop models that would not have broad applications, but would apply only to a specific disease or category of research, should be proposed to the appropriate categorical institute of the National Institutes of Health (NIH), e.g., models or model systems with primary focus on cancer or heart diseases should contact those categorical institutes at NIH to discuss alternative funding opportunities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 27313 --------------------------------------------------------------- ***Deadlines: 6/17/2012 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS Title: RFA-DK-12-504--Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4) Contact: Beena Akolkar, Ph.D. Tel: 301-594-8812 Email: akolkarb@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-12-504.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after June 17, 2012. The deadline for receipt of optional letters of intent is June 17, 2012. The deadline for receipt of full applications is July 17, 2012 , by 5:00 PM local time of applicant organization. SYNOPSIS: National Institutes of Health (NIH) and its participating Institutes invite applications from the Principal Investigators of the six current Clinical Centers (CCs) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study of type 1 diabetes (T1D) etiology. The TEDDY study involves the rigorous investigation of TEDDY subjects, including data and samples, for the identification of infectious agents, dietary factors, or other environmental factors associated with onset of T1D and/or T1D associated autoimmune markers. The six current CCs have been involved in study design and data and biosample acquisition since the inception of the TEDDY consortium. The CCs have recruited participants and followed the subjects over the past 10 years. This FOA is a one-time solicitation to support the CCs to allow them to continue to retain, follow clinically, and collect biosamples from TEDDY subjects for an additional 5 years. This FOA will utilize the NIH UC4 High Impact Research and Research Infrastructure - Cooperative Agreement Programs. --------------------------------------------------------------- Program Number: 28071 --------------------------------------------------------------- ***Deadlines: 6/17/2012 Sponsor: National Institute of Environmental Health Sciences/NIH/DHHS Title: RFA-ES-12-001--Children's Environmental Health and Disease Prevention Research Centers (P01) Contact: Kimberly Ann Gray, Ph.D. Tel: 919-541-0293 Email: gray6@niehs.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-ES-12-001.html Deadline Note: The deadline for receipt of optional letters of intent is June 17, 2012. The deadline for receipt of full applications is July 17, 2012. SYNOPSIS: National Institute of Environmental Health Sciences (NIEHS) and National Center for Environmental Research (NCER) invite applications to support a transdisciplinary program of basic and applied research to examine the effects of environmental factors on children’s health and well-being. Research conducted through the Centers should include substantive areas of science in children’s health while incorporating innovative technologies and approaches and links to the environment. The revised program encourages strong links between disciplines in the basic, applied, clinical and public health sciences to prevent disease and promote health in all children. This FOA will utilize the NIH P01 Research Program Projects award mechanism. --------------------------------------------------------------- Program Number: 00738 --------------------------------------------------------------- ***Deadlines: 6/17/2012 Sponsor: Rural Utilities Service/Department of Agriculture Title: Public Television Station Digital Transition Grant Program Contact: Petra Schultze, Financial Analyst Tel: 202-690-4493 Email: petra.schultze@wdc.usda.gov Website:          http://www.gpo.gov/fdsys/pkg/FR-2012-05-18/html/2012-12024.htm Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=171574 Deadline Note: Paper copies must carry proof of shipping no later than July 17, 2012 to be eligible for FY 2012 grant funding. Electronic copies must be received by July 17, 2012 to be eligible for FY 2012 grant funding. SYNOPSIS: The sponsor announces the Public Television Digital Transition Grant Program application window for fiscal year FY 2012. The FY 2012 funding for the Public Television Station Digital Transition Grant Program is $3,000,000. --------------------------------------------------------------- Program Number: 27619 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: National Aeronautics & Space Administration Title: ROA 2011: System-Wide Safety Assurance Technologies Project (SSAT2) Contact: Ashok N. Srivastava Tel: Email: Ashok.N.Srivastava@nasa.gov Website:          http://www.grants.gov/search/search.do;jsessionid=wvKrPv2phP5Ljh1yWnLdxj0ycWGGxQtb5Z2cl3xzLXn1ZPGBffhX!-1021879135?oppId=168833&mode=VIEW Full Program:          http://nspires.nasaprs.com/external/solicitations/solicitationAmmendments.do?method=init&solId={2344F7C4-8CF5-D17B-DB86-018B0B184C63}&path=open Deadline Note: Notices of intent are due May 14. 2012. Full proposals will be due June 18, 2012. SYNOPSIS: The System-Wide Safety and Assurance Technologies Project (SSAT) project will identify risks and provide knowledge required to safely manage increasing complexity in the design and operation of vehicles and the air transportation systems, including advanced approaches to enable improved and cost-effective verification and validation of flight-critical systems. SSAT is focused on methods to assess and ensure system-wide safety of complex aviation systems. The project will emphasize proactive methods and technologies, and utilize a systems analysis approach to identify key issues and maintain a portfolio of research leading to potential solutions. A proactive approach to managing system safety requires (1) the ability to monitor the system continuously and to extract and fuse information from diverse data sources to identify emergent anomalous behaviors after new technologies, procedures, and training are introduced; and (2) the ability to reliably predict probabilities of the occurrence of hazardous events and of their safety risks. --------------------------------------------------------------- Program Number: 28683 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: National Energy Technology Laboratory/Department of Energy Title: Novel Sensing and Monitoring Technologies for Subsurface Detection of CO2 Contact: Maureen Davison Tel: 412-386-5163 Email: Maureen.Davison@netl.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=8KvWPxsbfSsJh9Bz353208t32drzj31Lm891H1nMnXTf1lLBqTdV!477727685?oppId=170233&mode=VIEW Full Program:          https://www.fedconnect.net/FedConnect/?doc=DE-FOA-0000732&agency=DOE SYNOPSIS: The overall goal of the Department of Energy’s (DOE’s) programs have been to develop and advance technologies that will significantly improve the efficacy of the geologic carbon storage monitoring technologies, reduce the cost of implementation, and be ready for widespread commercial deployment between 2020 and 2030. This Funding Opportunity Announcement (FOA) complements a primary objective of the DOE’s Carbon Storage Program: to ensure 99% permanence through the monitoring, measurements, and accounting for CO2 injected in the geologic formations. This FOA requests applications that develop deep subsurface monitoring sensor technologies to ensure secure geologic storage of CO2 as described in the following program area of interest. It is envisioned that awards under this action will be structured as two to three year awards with decision points. Project continuation will be determined through continuation applications at the end of each budget period for all projects. --------------------------------------------------------------- Program Number: 26665 --------------------------------------------------------------- ***Deadlines: 6/18/2012 Sponsor: U.S. Agency for International Development Title: Health Strategic Information (SI) Contact: USAID/Mozambique Tel: (258-1) 35 20 00 Email: apssi@usaid.gov Full Program:          http://www07.grants.gov/search/synopsis.do;jsessionid=sZBmPdZLvpDp2t3RmwzV92M8BFmm9hgzMv2L2QQNYFk53yYGxwsX!-1373114776 Deadline Note: Deadline for questions is February 1, 2012, 17:30 Maputo Time; Deadline for receipt of Concept Papers is March 1, 2012; Final Closing Date of Annual Program Statement (APS): June 18, 2012. SYNOPSIS: The United States Government as represented by the United States Agency for International Development (USAID) is seeking concept papers and eventual full applications from non-governmental organizations working in Mozambique (both registered local and international) in HIV-AIDS for a program titled: Strategic Information (SI). This APS solicits concept papers for appropriately designed monitoring and evaluation support programs to support the capacity of the Mozambican National Council for Combating AIDS (CNCS) to continue to build capacity of their existing central- and sub-national monitoring and evaluation data systems. These programs will continue to support the existing monitoring and evaluation systems that CNCS has in place, specifically the national HIV/AIDS database and the ongoing work of CNCS and affiliated international donor organizations to increase provincial level M&E capacity to use and manage data. Sub-national M&E capacity should be focused around effective data collection and reporting with both paper-based and electronic data systems and a better understanding of M&E and epidemiology concepts for enhanced program management. Special consideration will be given to concept papers proposing implementation of targeted, sustainable, evidencebased, effective capacity building activities, best practices recommendations and ways forward in terms of building provincial and community level M&E capacity. --------------------------------------------------------------- Program Number: 28132 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Heart, Lung, and Blood Institute/NIH/DHHS Title: Integrative Omics Data Analysis for Discovery in Lung Diseases (R01) Contact: Weiniu Gan, Ph.D. Tel: 301-435-0202 Email: ganw2@nhlbi.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-155.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 19 annually. The deadline for receipt of optional letters of intent is May 19 annually. The deadline for receipt of full applications is June 19 annually, by 5:00 PM local time of applicant organization. SYNOPSIS: National Heart, Lung, and Blood Institute (NHLBI) invites applications to: (1) generate systems-level models of pulmonary pathobiology through integrative analyses of existing omics (e.g., genomics, transcriptomics, proteomics, metabolomics) data; and (2) experimentally test novel predictions of these models using human tissues/cells and/or mammalian animal models. This FOA will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 28161 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-005--Specialized Centers of Excellence in ELSI Research (CEER) (P50) Contact: Ms. Joy T. Boyer Tel: 301-402-4997 Email: jb40m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-005.html Deadline Note: The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is .July 19, 2012. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for the support of Specialized Centers (P50) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information. CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities. In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate. Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. This FOA will utilize the NIH P50 Specialized Center award mechanism. --------------------------------------------------------------- Program Number: 28162 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Human Genome Research Institute/NIH/DHHS Title: RFA-HG-12-012--Exploratory Centers of Excellence in ELSI Research (CEER) (P20) Contact: Ms. Joy T. Boyer Tel: 301-402-4997 Email: jb40m@nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-12-012.html Deadline Note: The deadline for receipt of optional letters of intent is June 19, 2012. The deadline for receipt of full applications is .July 19, 2012. SYNOPSIS: National Human Genome Research Institute (NHGRI) invites applications for the support of Exploratory Centers (P20) of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). Exploratory Centers will support expanding or modifying existing resources at an institution for the purpose of developing a Specialized Center (P50) CEER application. The CEER program is designed to develop and support trans-disciplinary research teams that have the expertise and flexibility to anticipate, conduct research on, and respond quickly to a range of ELSI issues related to the rapidly increasing availability and use of genomic approaches and information. CEERs are intended to provide an opportunity to cross disciplinary boundaries and create new research opportunities between and among investigators such as those in the basic genomic and social sciences, clinical and health policy research, ethics, law, the humanities, and various stakeholder communities. In addition, CEERs will play a role in ensuring that relevant ELSI research findings and deliberations are made available to policy makers as appropriate. Finally, CEERs will be responsible for contributing to training the next generation of ELSI researchers, with particular emphasis on training researchers from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds. This FOA will utilize the NIH P20 Exploratory Grants award mechanism. --------------------------------------------------------------- Program Number: 28288 --------------------------------------------------------------- ***Deadlines: 6/19/2012 Sponsor: National Institute on Aging/NIH/DHHS Title: National Institute on Aging: Revision Requests for Active Alzheimer's Disease Centers (P50) Contact: Creighton Phelps, PhD Tel: 301-496-9350 Email: phelpsc@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PA-12-170.html Deadline Note: The deadlines for receipt of standard applications under this announcement are: June 19, 2012; and then January 25, May 25, and September 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2015. SYNOPSIS: National Institute on Aging (NIA) invites revision applications to ongoing NIA-supported Alzheimer's Disease Centers (P50) in order to expand the scope of the existing award. Revision applications should include proposal of a new core or project. Revision applications may not request support beyond the end date of the Parent P50 award. This FOA will utilize the NIH P50 Specialized Center mechanism. --------------------------------------------------------------- Program Number: 28261 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Department of Health & Human Services Title: RFP -- SBSA -- Chemical Synthesis Facility Contact: Timni Mahase, Contract Specialist Tel: 301-435-8867 Email: timni.mahase@nih.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=60b68122b88f2b58340c7a479c6ae1a9&tab=core&_cview=0 SYNOPSIS: A -- CHEMICAL SYNTHESIS FACILITY - PACKAGE #1 SOL NIH-NICHD-CPR-201207 POC Timni Mahase, Phone: 301-435-8867, Adelola Kellum, Phone: 3014356955 WEB: FBO.gov Permalink https://www.fbo.gov/spg/HHS/NIH/NICHD/NIH-NICHD-CPR-2012-07/listing.html E-MAIL: timni.mahase@nih.gov, kelluml@mail.nih.gov timni.mahase@nih.gov, kelluml@mail.nih.gov NAICS: 541712 See Attached Document. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=ed9fa10d4e6db6a7ad3e20fdac71dbb0&tab=core&_cview=0Posted 04/20/12 (W-SN02727603). (0111) --------------------------------------------------------------- Program Number: 22801 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: Department of the Army Title: DoD Autism Pilot Award Contact: Tel: Website:          http://www.grants.gov/search/search.do;jsessionid=rRxQPhxQB2n1XJ228rDPBZZKvHGLXDLZXTk0mGGw6vhZxbpmsZPX!917914427?oppId=168755&mode=VIEW Deadline Note: The pre-application submission deadline is June 20, 2012. The invited application submission deadline is September 20, 2012. SYNOPSIS: The Pilot Award seeks applications from all areas of basic and preclinical research. The FY12 ARP Pilot Award encourages applications that address the critical needs of the ASD community. --------------------------------------------------------------- Program Number: 00810 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Contact: Phillip J. Daschner, Ph.D. Tel: 301-496-1951 Email: PD93U@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-094.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . NCI will not accept letters of intent under this FOA. The deadlines for receipt of full applications June 20 annually and November 20 annually. This program will expire on November 21, 2014. SYNOPSIS: The Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), at the National Cancer Institute (NCI), invite grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research and to provide resources for those investigators that may need additional support on their path to successfully compete for R01 funding in basic mechanistic research in understanding cancer health disparities. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 00811 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Basic Cancer Research in Cancer Health Disparities (U01) Contact: Phillip J. Daschner, Ph.D. Tel: 301-496-1951 Email: PD93U@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-095.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . NCI will not accept letters of intent under this FOA. The deadlines for receipt of full applications June 20 annually and November 20 annually. This program will expire on November 21, 2014. SYNOPSIS: The Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB), at the National Cancer Institute (NCI), invite grant applications from investigators interested in conducting basic research studies into the biological causes and mechanisms of cancer health disparities. These awards will support pilot and feasibility studies, development and testing of new methodologies, secondary data analyses, and innovative mechanistic studies that investigate biological/genetic bases of cancer health disparities. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research and to provide resources for those investigators that may need additional support on their path to successfully compete for R01 funding in basic mechanistic research in understanding cancer health disparities. This FOA will use the NIH Cooperative Agreement (U01) grant mechanism. --------------------------------------------------------------- Program Number: 02576 --------------------------------------------------------------- ***Deadlines: 6/20/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) Contact: Anil Wali, Ph.D. Tel: 301-496-7344 Email: walia@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-096.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after . NCI will not accept letters of intent under this FOA. The deadlines for receipt of full applications June 20 annually and November 20 annually. This program will expire on November 21, 2014. SYNOPSIS: The Center to Reduce Cancer Health Disparities (CRCHD) and the Division of Cancer Biology (DCB) of the National Cancer Institute (NCI), invite applications by investigators from diverse backgrounds underrepresented in basic and biomedical cancer research. The NIH recognizes a unique and compelling need to promote diversity in the NIH-funded research workforce. The purpose of this FOA is to improve the diversity of the NCI-funded research workforce by supporting and recruiting eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences including individuals from underrepresented racial and ethnic groups, individuals with disabilities, and individuals from socially, culturally, economically, or educationally disadvantaged backgrounds that have recently and demonstrably inhibited their ability to pursue a career in health-related research. This funding opportunity will also provide a bridge to investigators that have completed their research training and may need extra time to develop a research project grant application. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28816 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: Bureau of Land Management/Department of the Interior Title: RFP -- Least Tern/Pipping Plover Habitat Assessment Contact: Rebecca A Undlin Tel: Email: rundlin@blm.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=0f74d26a6b727032a60deb767b05ff6c&tab=core&_cview=0 SYNOPSIS: B -- LEAST TERN/PIPPING PLOVER HABITAT ASSMNT SOL L12PS00612 DUE 06212 POC Rebecca A Undlin WEB: FBO.gov Permalink https://www.fbo.gov/spg/DOI/BLM/MT/L12PS00612/listing.html E-MAIL: rundlin@blm.gov rundlin@blm.gov NAICS: 541620The Bureau of Land Management has a requirement for surveying/mapping/identifying Islands/Gravel Bars; Adult Least Terns/Piping Plovers and nests/eggs; and salt cedar/Russian Olive/leafy spurge infestation along the Yellowstone River from Miles City MT downstream to the confluence with the Missouri River. Work will beperformed from July 1, 2012 through August 15, 2012. The solicitation will be postsed on/about May 31, 2012. No hard copies of the solicitation will be sent out by this office and will be available at www.fedconnect.net. Response date for the quotes will be on/about June 21, 2012. Please check the solicitation for allrequired documentation to be submitted. This is a total small business set aside under NAICS code 541620 with a size standard of $7.0 million. The estimated value is between $25,000 and $100,000. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=0f74d26a6b727032a60deb767b05ff6c&tab=core&_cview=0 Posted 05/17/12 (W-SN02751223). (0138) --------------------------------------------------------------- Program Number: 96133 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: Institute of Education Sciences/Department of Education Title: Institute of Education Sciences (IES): Research on Statistical and Research Methodology in Education Contact: Emily Doolittle Tel: 202-219-1412 Email: Phil.Gagne@ed.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=149633 SYNOPSIS: The sponsor announces the availability of funds for the Institute of Education Sciences (IES): Research on Statistical and Research Methodology in Education program. The central purpose of the Institute's research grant programs is to provide parents, educators, students, researchers, policymakers, and the general public with reliable and valid information about education practices that support learning and improve academic achievement and access to education opportunities for all students. --------------------------------------------------------------- Program Number: 27325 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Remote Sensing of Water Quality Contact: Jared K. Entin Tel: 202-358-0275 Email: Jared.K.Entin@nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={05711E06-C496-B2BC-064D-0A5F6B2CDEC3}&path=open Full Program:          http://www.grants.gov/search/search.do;jsessionid=mkJsP66YYGbxmyQLDDbLM5bQTQx02N1vB2GMnYJVtHp1HTRSqGY0!-1021879135?oppId=171536&mode=VIEW Deadline Note: The sponsor requests, but does not require, submission of optional letters of intent by June 21, 2012. The deadline for submission of applications is August 22, 2012. SYNOPSIS: NASA solicits projects that improve remote sensing capability of water quality. While proposed “field campaigns” are acceptable, proposers are encouraged to keep their efforts small and targeted to the specific work proposed. NASA may seek to leverage all the funded investigations and investigators to help generate a plan for a larger field campaign that would collect a much larger set of environmental descriptors. --------------------------------------------------------------- Program Number: 27969 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Cancer Institute/NIH/DHHS Title: RFA-CA-12-006--Cancer Target Discovery and Development (CTDD) Network (U01) Contact: Daniela S. Gerhard, Ph.D., Director Tel: 301-451-8027 Email: gerhardd@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-006.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 21, 2012. The deadline for receipt of optional letters of intent is May 21, 2012. The deadline for receipt of full applications is June 21, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: National Cancer Institute (NCI) invites applications for innovative research on high throughput approaches to the discovery and characterization of new cancer targets and their modulators. Projects resulting from this FOA are expected to bridge the gap between the enormous volumes of data generated by the comprehensive molecular characterizations of many cancer subtypes and the ability to use these data for the development of human cancer therapeutics and associated response markers. Applicants must propose research projects focused on high-throughput identification and/or characterization of potential targets for cancer therapy, and/or the identification of small molecules that modulate validated cancer targets. Proposed projects are expected to combine in-depth mining of large-scale genomic data, systems biology analyses and/or experimental approaches to provide initial characterization of functional significance. This characterization may involve the studies of modulation/perturbation of the potential targets (or target combinations) using, e.g., small molecules and/or oligonucleotides. Development and/or improvement of technologies serving the main goals of the project may also be proposed. In addition to conducting individual research projects, the CTDD awardees will also be expected to contribute to trans-Network activities, including participation in joint pilot research projects. Successful applicants will join the existing Network. This program will use the NIH U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 25484 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: RFA-DC-12-005--Improving Access to Hearing Health Care (STTR) [R41/R42] Contact: Roger L. Miller, Ph.D Tel: 301-402-3458 Email: millerog@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-DC-12-005.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 22, 2012. The deadlines for receipt of optional letters of intent are: January 22, 2012; May 21, 2012; September 22, 2012; January 22, 2013; May 21, 2013; September 22, 2013. The deadlines for receipt of full applications are: February 22, 2012; June 21, 2012; October 22, 2012; February 22, 2013; June 21, 2013; October 22, 2013, by 5:00 PM local time of applicant organization. SYNOPSIS: The sponsor invites applications for Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose the development and translation of technologies to improve hearing healthcare outcomes. Responsive applications must seek to increase utilization of hearing health care technology by underserved patients and thus reduce health disparities. This FOA will utilize the R41/R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, and Fast-Track applications. --------------------------------------------------------------- Program Number: 27593 --------------------------------------------------------------- ***Deadlines: 6/21/2012 Sponsor: National Institutes of Health/DHHS Title: RFP -- AMENDMENT -- NIH Tetramer Core Facility Contact: Tom Bahrami, Contracting Officer Tel: 301-451-2654 Email: bahramit@niaid.nih.gov Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=36a1be72bf6cb82522f12ff513b016d2&tab=core&_cview=0 SYNOPSIS: A -- NIH TETRAMER CORE FACILITY SOL RFP-NIAID-DIAT-NIHAI2011132 POCom Bahrami, Phone: 3014512654, Liem T. Nguyen, Phone: 301-496-0612 WEB: FBO.govPermalink https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DIAT-NIHAI2011132/listing.html E-MAIL: bahramit@niaid.nih.gov, lnguyen@niaid.nih.gov bahramit@niaid.nih.gov, lnguyen@niaid.nih.gov NAICS: 541711 Introduction The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH),of the Department of Health and Human Services (DHHS) supports research relatedto the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Allergy, Immunology and Transplantation, has a requirement for continuing the NIH Tetramer Core Facility contract. The scope of activities to be conducted by the NIH Tetramer Core Facility Contractor include synthesis and distribution of soluble MHC-peptide tetramer and related reagents to the global research community, and performance of research and development to improve tetramer technologies and increase the types of products available to the biomedical research community. Such reagents include, but are not limited to, mouse, non-human primate, human, and other mammalian MHC class I monomers and tetramers; custom and pre-made mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer labeling/detection. Description The scope of activities to be carried out by the NIH Tetramer Core Facility Contractor is: synthesis and distribution of soluble MHC-peptide tetramer and related reagents to the global research community; and performance of research and development to improve tetramer technologies and increase the types of products available to the biomedical research community. Such reagents include, but are not limited to, mouse, non-human primate, human, and other mammalian MHC class I monomers and tetramers; custom and pre-made mouse, non-human primate, human, and other mammalian class II tetramers; non-classical MHC TL, Qa-1, and mammalian CD1 monomers and tetramers; CD1d and other MHC ligands; and fluorophores for tetramer detection. The major functions to be carried out by the contractor are: A. Operate a tetramer production facility B. Operate a distribution, tracking, and reporting system of reagents produced C. Maintain a NIH Tetramer Core Facility website and provide related maintenance D. Conduct tetramer technology research and development E. Manage the Tetramer Core Facility program While the NIH Tetramer Core Facility is responsible for providing ligands (peptidic and nonpeptidic) for all pre-made reagents (where required), the NIH Tetramer Core Facility is NOT responsible for supplying ligands for custom MHC Class I and II monomer and tetramer production. Ligands for custom monomer/tetramer synthesis will be provided by the approved requestors, where required. It is anticipated that one cost reimbursement term, level of effort contract will be awarded for a 1-year period of performance beginning on or about 3/1/2013. OPTIONS 1-6: EXTEND TERM OF THE CONTRACT. The Government may extend the contract period of performance by one year. The total period of performance resulting from base period plus exercising all term option years is seven years. If Options 1-6 are exercised, the services required will be the same as provided during the base year. OPTIONS 7-13: INCREASE IN LEVEL OF EFFORT. The level of effort may be increased by 2,254 hours up to 4 (four) times per year for a total increase of 9,016 hours in the contract base year and in each year in which Options 1-6 is exercised. Options will be evaluatedwith the base requirements of the statement of work. It is estimated that the provision of FTEs will be approximately 10.8. For this solicitation, the NIAID requires proposals to be submitted in three methods: (1) Paper, (2) Disc (CD or DVD), and (3) Online via the NIAID Electronic Contract Submission System (eCPS). The content of the paper, disc, and online proposals must be identical. Submission of proposals by facsimile or e-mail is not acceptable. For directions on usingeCPS, go to the website https://ecps.niaid.nih.gov and then click on "How to Submit." To submit online using eCPS, offerors must have a valid NIH electronic Research Administration (eRA) Commons account, which provides authentication and serves as a vehicle for secure transmission of documents and communication with the NIAID. The eRA Commons registration process may take up to 4 weeks. For more information, please see http://era.nih.gov/applicants/how-to_steps.cfm#register.Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about 3/23/2012, and may be accessed through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=36a1be72bf6cb82522f12ff513b016d2&tab=core&_cview=0 Posted 03/08/12 (W-SN02692352). (0068) --------------------------------------------------------------- Program Number: 28433 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Food & Drug Administration Title: RFA-FD-12-020--Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability (U01) Contact: Stephanie Kim Tel: 240-276-9308 Email: Stephanie.Kim@fda.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-FD-12-020.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 1, 2012. The sponsor will not accept letters of intent under this FOA . The deadline for receipt of full applications is June 22, 2012 by 5:00 PM local time of applicant organization. SYNOPSIS: FDA invites applications to study the effect of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability. Formulations having the same active and inactive ingredients in the same concentrations may still exhibit differences in physicochemical properties due to differences in the manufacturing process. Key physicochemical properties which impact clearance, distribution, and drug release will be investigated. This FOA will utilize the U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 11279 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Planetary Atmospheres Contact: Kelly Fast Tel: 202-358-0768 Email: kelly.e.fast@nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={79B2C6F9-B9F1-BBAA-5F02-2C32BFFFAE01}&path=open Full Program:          http://www.grants.gov/search/search.do;jsessionid=H0NXP0ZGp8xPYrY1TN91pv3yQWHr5vhbGGmCXsFcmt5QVylpg7QJ!-2099600874?oppId=159473&mode=VIEW Deadline Note: A brief letter of intent is requested, although not required, and should be submitted by April 27, 2012. Full applications will be due on June 22, 2012. SYNOPSIS: The Planetary Atmospheres program supports scientific investigations that contribute to the understanding of the origins and evolution of the atmospheres of planets and their satellites and of comets. Its broad objectives include the determination of compositions, dynamics, energetics, and chemical behaviors of planetary atmospheres. --------------------------------------------------------------- Program Number: 22255 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Contact: Linda Brady, Ph.D., Director Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-207.html Deadline Note: The deadlines for receipt of optional letters of intent are: September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013. The corresponding deadlines for receipt of full applications are: October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013 . This program will expire on February 23, 2013. SYNOPSIS: The sponsors provide support for multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U19 Research Program – Cooperative Agreements award mechanisms. --------------------------------------------------------------- Program Number: 77083 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute of Mental Health/NIH/DHHS Title: National Cooperative Drug Discovery/ Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Contact: Linda Brady, Ph.D., Director Tel: 301-443-3563 Email: lbrady@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-206.html Deadline Note: The deadlines for receipt of optional letters of intent are: September 26, 2011; January 24, 2012; May 22, 2012; September 24, 2012; January 22, 2013. The corresponding deadlines for receipt of full applications are: October 24, 2011; February 24, 2012; June 22, 2012; October 22, 2012; February 22, 2013 . This program will expire on February 23, 2013. SYNOPSIS: The sponsors provide support for multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready drugs for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) invite applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate medications to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH UM1 Multi-Component Research Project Cooperative Agreements award mechanisms. --------------------------------------------------------------- Program Number: 91083 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: National Institute on Deafness & Other Communication Disorders/NIH/DHHS Title: NIDCD Research Grants for Translating Basic Research into Clinical Tools for Human Health (R01) Contact: Amy M. Donahue, Ph.D. Tel: 301-402-3458 Email: donahuea@nidcd.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-11-003.html Deadline Note: The deadlines for receipt of optional letters of intent are: May 22, 2012, January 22, 2013 and September 22, 2013. The deadlines for receipt of full applications are: June 22, 2012, February 22, 2013 and October 22, 2013. This program will expire on October 23, 2013. SYNOPSIS: The sponsor offers support for applications which translate basic research findings into clinical tools for better human health in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language. The intent of this Funding Opportunity Announcement (FOA) is to provide a new avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Multi-institutional, multi-disciplinary, and academic-industrial collaborations studies are encouraged. This FOA is not intended for outcome studies, the extension of ongoing clinical research studies, the optimization of current clinical protocols, or pre-translational studies. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 82750 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Office of Research Infrastructure Programs/NIH/DHHS Title: NCRR Science Education Partnership Award (SEPA) (R25) Contact: L. Tony Beck, Ph.D. Tel: 301-435-0805 Email: beckl@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-10-206.html Deadline Note: The deadline for receipt of optional letters of intent is May 22, 2012. The deadline for receipt of full applications is June 22, 2012. This FOA will expire on June 23, 2012. SYNOPSIS: The sponsor invites applications to its SEPA program for the development and evaluation of innovative research education programs to improve PreK-12 research career opportunities and the community's understanding of the health science advances supported by the National Institutes of Health (NIH)-funded clinical and basic research. SEPA encourages dynamic partnerships between biomedical and clinical researchers and PreK-12 teachers and schools and other interested organizations. Particular importance will be given to applications that target PreK-12 and/or ISE/media topics that may not be addressed by existing curriculum, community-based or ISE/media activities. This FOA will use the NIH Research Education (R25) grant mechanism. --------------------------------------------------------------- Program Number: 25833 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Office of Research on Women's Health/NIH/DHHS Title: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R01) Contact: Charles Wells, Ph.D. Tel: 301-402-1770 Email: wells1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-032.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 24, 2012. The deadlines for receipt of optional letters of intent are: January 24, 2012 (passed); May 22, 2012; September 24, 2012; January 22, 2013; May 24, 2013; September 24, 2013; January 24, 2014; May 26, 2014; September 24, 2014. The deadlines for receipt of full applications under this announcement are: February 24, 2012; June 22, 2012; October 24, 2012; February 22, 2013; June 24, 2013; October 24, 2013; February 24, 2014; June 24, 2014; October 24, 2014, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on October 25, 2014. SYNOPSIS: The sponsors invite applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers, innovative treatment modalities, and/or the modifiable risk and protective processes specifically targeted by preventive and/or treatment interventions. This program will use the NIH Research Project (R01) award mechanism. --------------------------------------------------------------- Program Number: 25834 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: Office of Research on Women's Health/NIH/DHHS Title: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R21) Contact: Charles Wells, Ph.D. Tel: 301-402-1770 Email: wells1@mail.nih.gov Full Program:          http://grants1.nih.gov/grants/guide/pa-files/PAR-12-033.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after January 24, 2012. The deadlines for receipt of optional letters of intent are: January 24, 2012 (passed); May 22, 2012; September 24, 2012; January 22, 2013; May 24, 2013; September 24, 2013; January 24, 2014; May 26, 2014; September 24, 2014. The deadlines for receipt of full applications under this announcement are: February 24, 2012; June 22, 2012; October 24, 2012; February 22, 2013; June 24, 2013; October 24, 2013; February 24, 2014; June 24, 2014; October 24, 2014, by 5:00 PM local time of applicant organization. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on October 25, 2014. SYNOPSIS: The sponsors invite applications that propose to examine the etiology, diagnosis, pathophysiology, and treatment of chronic fatigue syndrome (CFS), sometimes referred to as myalgic encephalomyelitis (ME), in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among patient populations, the common mechanisms influencing the multiple body systems that are affected in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of the disease process and provide evidence based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers, innovative treatment modalities, and/or the modifiable risk and protective processes specifically targeted by preventive and/or treatment interventions. This program will use the NIH Exploratory/Developmental (R21) grant mechanism. --------------------------------------------------------------- Program Number: 28500 --------------------------------------------------------------- ***Deadlines: 6/22/2012 Sponsor: U.S. Trade and Development Agency Title: RFP -- AMENDMENT--Brazil - CAGECE Tertiary Wastewater Treatment Plants and Automated Water and Sewage Control System Project Contact: Anthony O'Tapi Tel: 703-875-4357 Full Program:          https://www.fbo.gov/?s=opportunity&mode=form&id=22b4a38d6248388d7cb6e0651b48ba3d&tab=core&_cview=0 SYNOPSIS: B -- BRAZIL - CAGECE TERTIARY WASTEWATER TREATMENT PLANTS AND AUTOMATED WATERAND SEWAGE CONTROL SYSTEM PROJECT SOL 2012-51013A POC Anthony O'Tapi,hone: 703-875-4357 WEB: FBO.gov Permalink https://www.fbo.gov/spg/TDA/TDA1/TDA1/2012-51013A/listing.html E-MAIL: aotapi@ustda.gov aotapi@ustda.gov NAICS: 541690 POC Anthony O'Tapi, USTDA 1000 Wilson Boulevard, Suite 1600 Arlington, VA 22209-3901 Tel: (703) 875-4357 Fax: (703) 875-4009 ***Please do not contact contracts office*** Proposal Submission Place: Marcondes Sobreira CAGECE Av. Dr. Lauro Vieira Chaves, 1030 - Vila União Fortaleza, CE, Brazil, 60422-901 Phone: 011 55 (85) 3101-2001 The Grantee invites submission of qualifications and proposal data (collectively referred to as the "Proposal") from interested U.S. firms that are qualified on the basis of experience and capability to develop a feasibility study to determine the technical and financial viability of developing twotertiary wastewater treatment plants, as well as a roadmap and implementation plan for an automated water and sewage control system for the Ceara Water and Sewage Treatment Company (CAGECE). This Feasibility Study will determine the technical and financial viability of developing two tertiary wastewater treatment plants as well as a roadmap and implementation plan for an automated water and sewage control system. The Terms of Reference (TOR) for this Feasibility Study are attached as Annex 5. The U.S. firm selected will be paid in U.S. dollars from a $579,895 grant to the Grantee from the U.S. Trade and Development Agency (USTDA). A detailed Request for Proposals (RFP), which includes requirements for the Proposal, the Terms of Reference, and a background definitional mission report are available from USTDA, at 1000 Wilson Boulevard, Suite 1600, Arlington, VA 22209-3901. To request the RFP in PDF format, please go to: https://www.ustda.gov/businessopps/rfpform.asp Requests for a mailed hardcopy version of the RFP may also be faxed to the IRC, USTDA at 703-875-4009. In the fax, please include your firm's name, contact person, address, and telephone number. Some firms have found that RFP materials sent by U.S. mail do not reach them in time for preparation of an adequate response. Firms that want USTDA to use an overnight delivery service should include the name of the delivery service and your firm's account number in the request for the RFP. Firms that want to send a courier to USTDA to retrieve the RFP should allow one hour after faxing the request to USTDA before scheduling a pick-up. Please note that no telephone requests for the RFP will be honored. Please check your internal fax verification receipt. Because of the large number of RFP requests, USTDA cannot respond to requests for fax verification. Requests for RFPs received before 4:00 PM will be mailed the same day. Requests received after 4:00 PM will be mailed the following day. Please check with your courier and/or mail room before calling USTDA. Only U.S. firms and individuals may bid on this USTDA financed activity. Interested firms, their subcontractors and employees of all participants must qualify under USTDA's nationality requirementsas of the due date for submission of qualifications and proposals and, if selected to carry out the USTDA-financed activity, must continue to meet such requirements throughout the duration of the USTDA-financed activity. All goods and services to be provided by the selected firm shall have their nationality, source and origin in the U.S. or host country. The U.S. firm may use subcontractors from the host country for up to 20 percent of the USTDA grant amount. Details of USTDA's nationality requirements and mandatory contract clauses are also included inthe RFP. Interested U.S. firms should submit their Proposal in English directlyto the Grantee by 1:00 pm (Local time), June 22nd, 2012 at the above address. Evaluation criteria for the Proposal are included in the RFP. Price will not be afactor in contractor selection, and therefore, cost proposals should NOT be submitted. The Grantee reserves the right to reject any and/or all Proposals. The Grantee also reserves the right to contract with the selected firm for subsequentwork related to the project. The Grantee is not bound to pay for any costs associated with the preparation and submission of Proposals. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=22b4a38d6248388d7cb6e0651b48ba3d&tab=core&_cview=0 Posted 05/02/12 (W-SN02736793). (0123) --------------------------------------------------------------- Program Number: 26360 --------------------------------------------------------------- ***Deadlines: 6/24/2012 Sponsor: Fogarty International Center/NIH/DHHS Title: Training Programs for Critical HIV Research Infrastructure for Low- and Middle-Income Country Institutions (G11) Contact: Jeanne McDermott Tel: 301-496-1492 Email: jeanne.mcdermott@nih.gov Full Program:          http://grants.nih.gov/grants/guide/pa-files/PAR-12-069.html Deadline Note: The deadline for receipt of optional letters of intent is June 24 annually. The deadline for receipt of full applications is July 24 annually. This FOA will expire on July 25, 2014. SYNOPSIS: National Institutes of Health (NIH) invites U.S. institutions with research collaborations at low-and middle-income country (LMIC) institutions to submit applications for training programs to strengthen the leadership and expertise in selected critical research infrastructure areas at their collaborating LMIC institutions. This FOA will utilize the NIH G11- Extramural Associate Research Development Award. --------------------------------------------------------------- Program Number: 22088 --------------------------------------------------------------- ***Deadlines: 6/25/2012 Sponsor: Bureau of Justice Statistics/Department of Justice Title: Visiting Fellow: Criminal Justice Statistics Program Contact: Gerard F. Ramker, Deputy Director Tel: 202-307-0765 Email: askbjs@usdoj.gov Website:          http://www.grants.gov/search/search.do;jsessionid=95ZHPthGGchjR8x2yb1wWmcJCSplpDVGXWvCL0Lh0mFCQyy5yTQJ!64499778?oppId=170194&mode=VIEW Full Program:          http://bjs.ojp.usdoj.gov/content/pub/pdf/vfcjsp12_sol.pdf Deadline Note: Registration is required prior to submission. OJP strongly encourages registering with Grants.gov several weeks before the deadline for application submission. The deadline for applying for funding is June 25, 2012. SYNOPSIS: The sponsor is seeking applications for funding for one or more BJS Visiting Fellows to work in its Criminal Justice Statistics Programs with existing BJS data. --------------------------------------------------------------- Program Number: 28723 --------------------------------------------------------------- ***Deadlines: 6/25/2012 Sponsor: Food & Drug Administration Title: Enhancing Post-Market Surveillance Through Developing Registries for Medical Device Epidemiology (U01) Contact: Mary Beth Ritchey Tel: 301-796-6638 Email: Maryelizabeth.Ritchey@fda.hhs.gov Full Program:          http://grants1.nih.gov/grants/guide/rfa-files/RFA-FD-12-028.html Deadline Note: Applications may be submitted to Grants.gov in response to this announcement on or after May 21, 2012. The deadline for receipt of optional letters of intent is June 1, 2012. The deadline for receipt of full applications is June 25, 2012, by 5:00 PM local time of applicant organization. SYNOPSIS: FDA's Center for Devices and Radiological Health (CDRH) invites applications: (1) To develop registries and consortia in key medical device areas to implement new registry methodologies that strategically broaden the scope of the US and international postmarket surveillance system; and (2) To address identified gaps in the current postmarket surveillance system by developing new methodologies for registry data collection and linkage, or by adapting known methodologies to medical devices; and (3) To develop novel methodology that allows for use of the registry data collection infrastructure to serve multiple purposes including postmarket surveillance, device tracking through Unique Device Identifiers (UDI), prospective embedded studies, quality improvement, and other uses. This program will use the U01 Research Project – Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 08295 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: Directorate for Engineering/NSF Title: Industry/University Cooperative Research Centers Contact: Rathindra DasGupta Tel: 703-292-8353 Email: rdasgupt@nsf.gov Website:          http://www.grants.gov/search/search.do?oppId=131673&mode=VIEW Full Program:          http://www.nsf.gov/pubs/2012/nsf12516/nsf12516.htm Deadline Note: The June 29, 2012 and January 2, 2012 deadline dates refers to mandatory letters of intent. Planning Grant and Full Center Proposals will be due by September 28, 2012 and March 6, 2012. SYNOPSIS: The Industry/University Cooperative Research Centers (I/UCRC) program develops long-term partnerships among industry, academe, and government. The centers are catalyzed by a small investment from the National Science Foundation (NSF) and are primarily supported by industry center members, with NSF taking a supporting role in the development and evolution of the center. Each center is established to conduct research that is of interest to both the industry members and the center faculty. An I/UCRC contributes to the Nation's research infrastructure base and enhances the intellectual capacity of the engineering and science workforce through the integration of research and education. As appropriate, an I/UCRC uses international collaborations to advance these goals within the global context. --------------------------------------------------------------- Program Number: 25196 --------------------------------------------------------------- ***Deadlines: 6/26/2012 Sponsor: U.S. Geological Survey/Department of the Interior Title: Cooperative Research Units Program FY 2012 Contact: Laura Mahoney, Grant Analyst Tel: 703-648-7344 Email: lmahoney@usgs.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=126793 SYNOPSIS: The sponsor announces the availability of funds for the Cooperative Research Units Program FY 2012. This grant is designed to facilitate the linkage of the research and information needs of federal, state and other natural resource managers and professionals with the expertise and facilities of leading research universities, and graduate student training. --------------------------------------------------------------- Program Number: 28123 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Endowment for the Humanities/Natl. Fndn. on the Arts & Humanities Title: Humanities Initiatives: Hispanic-Serving Institutions Contact: Tel: 202-606-8471 Email: hi@neh.gov Website:          http://www07.grants.gov/search/search.do;?oppId=161916&mode=VIEW Full Program:          http://www.neh.gov/grants/education/humanities-initiatives-hispanic-serving-institutions SYNOPSIS: NEH Humanities Initiatives are intended to strengthen and enrich humanities education and scholarship at Hispanic-Serving Institutions. These grants may be used to enhance the humanities content of existing programs, develop new programs, or lay the foundation for more extensive endeavors in the future.. --------------------------------------------------------------- Program Number: 83718 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Endowment for the Humanities/Natl. Fndn. on the Arts & Humanities Title: Humanities Initiatives for Faculty at Tribal Colleges and Universities Contact: Tel: 202-606-8471 Email: hi@neh.gov Website:          http://www.neh.gov/files/grants/humanities-initiatives-tribal-jun-27-2012.pdf Full Program:          http://www07.grants.gov/search/search.do;jsessionid=Tc5LNt8dDLhfvj8DvhtcMxsZPdYwPGpqWxD0nl6j1hFVPDGCPqGh!-1702297235?oppId=87473&mode=VIEW SYNOPSIS: Humanities Initiatives for Faculty are intended to strengthen and enrich humanities education and scholarship at tribal colleges and universities. These grants may be used to enhance the humanities content of existing programs, develop new programs, or lay the foundation for more extensive endeavors in the future. --------------------------------------------------------------- Program Number: 26420 --------------------------------------------------------------- ***Deadlines: 6/27/2012 Sponsor: National Institute of Child Health and Human Development/NIH/DHHS Title: RFA-HD-13-005--Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54) Contact: Stuart B. Moss, PhD Tel: 301-435-6979 Email: mossstua@mail.nih.gov Full Program:          http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-13-005.html Deadline Note: The deadline for receipt of optional letters of intent is May 27, 2012. The deadline for receipt of full applications is June 27, 2012. SYNOPSIS: National Institute of Child Health and Human Development (NICHD) invites applications for the re-competition of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR). The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) provides funding for a limited number of research centers in the reproductive sciences. These centers provide an arena for multidisciplinary interactions between basic and clinical scientists interested in establishing high quality translational research programs in the area of reproductive health and infertility. The centers also serve as a national resource for the training and career development of new scientists electing to pursue careers conducting translational research in high priority areas of reproduction and infertility. Finally, center investigators are expected to participate in important community outreach and education efforts to increase awareness and convey the importance and implications of their research activities to the general public.. This FOA will utilize the NIH U54 Specialized Center- Cooperative Agreements award mechanism. --------------------------------------------------------------- Program Number: 23184 --------------------------------------------------------------- ***Deadlines: 6/28/2012 Sponsor: Bureau of Reclamation/Department of the Interior Title: WaterSMART Applied Science Grants for the Desert Landscape Conservation Cooperative Contact: Michelle Maher Tel: 303-445-2025 Email: mmaher@usbr.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=171515 SYNOPSIS: The sponsor announces the availability of funds for the WaterSMART Applied Science Grants for the Desert Landscape Conservation Cooperative program. Resource managers concerned with conservation of natural and cultural resources are faced with increasing challenges. Such challenges may include changing water availability, changing land use, preserving traditional or historical sites, areas, landscapes, and/or resources, sensitive species protection and recovery, invasive species, and a range of other complex issues — all of which are further complicated as the impacts of climate change are realized. In response, the Bureau of Reclamation (Reclamation) is participating in the Desert Landscape Conservation Cooperative (LCC). --------------------------------------------------------------- Program Number: 23192 --------------------------------------------------------------- ***Deadlines: 6/28/2012 Sponsor: Bureau of Reclamation/Department of the Interior Title: WaterSMART Applied Science Grants for the Southern Rockies Landscape Conservation Cooperative Contact: Michelle Maher Tel: 303-445-2025 Email: mmaher@usbr.gov Full Program:          http://www07.grants.gov/search/search.do?&mode=VIEW&oppId=171516 SYNOPSIS: The sponsor announces the availability of funds for the WaterSMART Applied Science Grants for the Southern Rockies Landscape Conservation Cooperative program. Cooperative Resource managers concerned with conservation of natural and cultural resources are faced with increasing management challenges. Such challenges may include water scarcity, land-use conversion, impacts to traditional or historical resources, sensitive species protection and recovery, invasive species, and a range of other complex issues —all of which are amplified by climate change. In response, the Bureau of Reclamation (Reclamation) is participating in the Southern Rockies Landscape Conservation Cooperative (LCC). --------------------------------------------------------------- Program Number: 28724 --------------------------------------------------------------- ***Deadlines: 6/28/2012 Sponsor: National Energy Technology Laboratory/Department of Energy Title: Unconventional Gas and Oil Technologies Contact: Anne M. Cary Tel: 412-386-5885 Email: anne.cary@netl.doe.gov Website:          http://www.grants.gov/search/search.do;jsessionid=Nzt8PzGDgCJPJ4jkyF6GJt2JjMdfD5lPVqTrc1LpN3wb5G82t0sS!-253887325?oppId=170615&mode=VIEW Full Program:          https://www.fedconnect.net/fedconnect/?doc=DE-FOA-0000724&agency=DOE SYNOPSIS: The intent of this Department of Energy (DOE), National Energy Technology Laboratory (NETL) funding opportunity announcement (FOA) is to select and award projects in FY12 that focus on improving recovery from liquid-rich shale reservoirs and to advance the development of “next generation” carbon dioxide (CO2) enhanced oil recovery (EOR) technologies. This announcement is a critical component of the DOE portfolio to advance the sustainable development of domestic gas and oil resources and it will support ongoing programmatic efforts to (1) improve our understanding of the occurrence, producability, and environmental impacts of unconventional shale resources and (2) expand the use of a greenhouse gas to increase the recovery of domestic oil resources. --------------------------------------------------------------- Program Number: 03409 --------------------------------------------------------------- ***Deadlines: 6/28/2012 Sponsor: National Institute of Food and Agriculture/Department of Agriculture Title: Integrated Research, Education, and Extension Competitive Grants Program--National Integrated Water Quality Program Contact: Dr. Michael P. O'Neill Tel: 202-205-5952 Email: moneill@nifa.usda.gov Website:          http://www.nifa.usda.gov/funding/rfas/pdfs/12_water_quality.pdf Full Program:          http://www07.grants.gov/search/search.do;jsessionid=JqYrPrldQ8TycTkHP86HM6L1Bs21971g4t582Vs2xWbbTP93Dsf4!109354571?oppId=169780&mode=VIEW SYNOPSIS: NIFA announces the availability of grant funds and requests applications for the Integrated Research, Education, and Extension Competitive Grants Program – National Integrated Water Quality Program (NIWQP) for fiscal year (FY) 2012 to address critical agricultural water quality issues in the United States. The amount available for support of this program in FY 2012 is approximately $4.0 million. --------------------------------------------------------------- Program Number: 01356 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Physical Oceanography Contact: Dr. Eric Lindstrom Tel: 202-358-4540 Email: Eric.J.Lindstrom@nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={40AF4187-005B-B1D3-B070-A9BB3F5E58A3}&path=open Full Program:          http://www.grants.gov/search/search.do;jsessionid=rh8QPJGD5lJ2JcGtLcJYlGpqT4qTWQGMd8Vn6gD4SknjvXW2HxDS!-889918338?oppId=148636&mode=VIEW Deadline Note: Optional letters of intent are requested to be submitted by April 30, 2012. Full applications are due June 29, 2012. SYNOPSIS: NASA’s Physical Oceanography program supports basic research and analysis activities that enable development of NASA’s current and future physical oceanography satellite missions and the scientific interpretation of data from them. The primary centers of support for the Physical Oceanography program are at the NASA Goddard Space Flight Center Laboratory for Hydrospheric Processes, the NASA Jet Propulsion Laboratory Earth Science Directorate, and the external (non-NASA) scientific community. This announcement serves as the vehicle for participation in the Physical Oceanography program for all institutions. --------------------------------------------------------------- Program Number: 14304 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: National Aeronautics & Space Administration Title: ROSES 2012: Planetary Protection Research Contact: Dr. Catharine A. Conley, Planetary Protection Officer Tel: 202-358-3912 Email: HQ-PPR@mail.nasa.gov Website:          http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={AD1F30F3-3214-8940-7338-CA5DFAE6221E}&path=open Full Program:          http://nspires.nasaprs.com/external/solicitations/solicitationAmmendments.do?method=init&solId={4DF6A47E-EDC1-20F2-11FB-8BDF6890024A}&path=open Deadline Note: Optional letters of intent are due by June 30, 2012. Full proposals are due September 3, 2012. Notices of Intent are now due on June 29, 2012, and Proposals are now due September 5, 2012. SYNOPSIS: Proposals are sought for new projects in planetary protection that are not within the scope of the Astrobiology: Exobiology and Evolutionary Biology program. Proposals submitted in response to this program element should be for new work that is not currently supported by NASA or for successor proposals that seek to extend to their next logical phase those tasks performing research in Planetary Protection that are currently funded but whose periods of performance will expire in 2012. --------------------------------------------------------------- Program Number: 27106 --------------------------------------------------------------- ***Deadlines: 6/29/2012 Sponsor: Office of Naval Research Title: FY 13 Communications and Networking Discovery and Invention Contact: Dr. Santanu Das Tel: Email: santanu.das@navy.mil Full Program:          http://www07.grants.gov/search/search.do;jsessionid=cvbfPywF5L6r3n2x3ytNwRM1RJKkLH0JgVtXJxlhp7s8Sjhlxy2J!-16379161?oppId=142735&mode=VIEW Deadline Note: White papers are due March 23, 2012. Full proposals are due June 29, 2012. SYNOPSIS: The goal of the Communications and Networking Program within the Office of Naval Research (ONR) Code 312 is to support the FORCEnet vision by developing measurable advances in technology that can directly enable and enhance end-to-end connectivity and quality-of-service for mission-critical information exchange among such widely dispersed naval, joint, and coalition forces. The vision is to provide high throughput robust communications and networking to ensure all warfighters -- from the operational command to the tactical edge -- have access to information, knowledge, and decision-making necessary to perform their assigned tasks. The Office of Naval Research (ONR) plans to award multiple technology development contracts (particularly cost plus fixed fee (CPFF) type contracts) and grants that represent the best value to the Government in accordance with the evaluation criteria. ONR is seeking participants for this program that are capable of supporting the goals described in this announcement. Offerors have the opportunity to be creative in the selection of the technical and management processes and approaches to address the research topics. ONR anticipates an annual budget of approximately $2,000,000 for this program.